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Abstract  VII
MicroRNAs in the bovine ovary and placentas derived from in vivo, in vitro and nuclear 
transfer pregnancies 
 
MicroRNAs are the major class of gene regulating molecules playing pivotal roles at post-
transcriptional level. Identification and expression profiling are the initial steps to understand 
their regulation of biological processes. Despite increasing efforts in miRNAs characterization 
in different species, little is known in the bovine reproductive tissues especially in ovary and 
placenta. Two subsequent studies were carried out to the expression of miRNAs in bovine ovary 
and Day-50 placenta derived from different sources of pregnancy. The first study aims to 
identify and characterize miRNAs in bovine ovary through cloning, expression analysis and 
target prediction. The constructed miRNA library revealed cloning of 50 known and 24 novel 
miRNAs. Among these, 38 were new miRNAs which were derived from 43 distinct loci with 
characteristic secondary structure. Most of the miRNAs were cloned multiple times and thereby 
reflecting their expression level and potential role in the ovary. Analysis of identified miRNAs 
in different intra-ovarian structures and other tissues reveals their stage and tissue specific 
expression patterns. Furthermore, in silico target prediction and Gene Ontology analysis of the 
targets genes identified several biological processes and pathways underlying the ovarian 
function. Results of this study suggest the presence of miRNAs in the bovine ovary; thereby 
elucidate their potential role in regulating diverse mechanisms underlying the ovarian 
functionality.  
 
The second study aimed to elucidate the difference in expression profile of miRNAs in the 
placenta at day 50 derived from Somatic cell nuclear transfer (SCNT), in vitro production (IVP) 
and artificial insemination (AI) pregnancies by quantifying 377 miRNAs. The study reveals a 
massive deregulation of miRNAs which were poorly reprogrammed and affected as large 
chromosomal cluster as well as miRNA families in the NT and IVP placenta compared to that 
of AI. Furthermore, cell specific localization miRNAs in the expanded blastocysts and 
expression profiling in different developmental stages of embryos and placenta identified that 
the major deregulation of miRNAs arises at day 50 of NT and IVP pregnancies. This 
deregulation were found to be less dependent on global DNA methylation, rather aberrant 
miRNA processing molecules were evidenced. Among them, observed down regulation of 
AGO2 could be a reason for global down regulation of miRNAs in the NT or IVP placenta. 
Identified deregulation of miRNAs might associate to the abnormal placentogenesis in NT or 
IVP pregnancies, which are the results of aberrant genetic and epigenetic modification. Result 
of this study will help to move one step closer towards improving the efficiency of nuclear 
transfer pregnancy.  
 
Altogether, the present study has discovered miRNAs in the bovine ovary and elucidated the 
pattern of expression of miRNAs along with their regulatory mechanism in the placenta derived 
from pregnancies of various origins. 
Abstract (German)  VIII
Untersuchung von MicroRNAs in bovinen Ovarien und Plazenten aus geklonten, in 
vivo und in vitro erzeugten Trächtigkeiten 
 
MicroRNAs gehören zur großen Klasse der genregulierenden Moleküle und spielen eine 
bedeutende Rolle auf der posttranskriptionellen Ebene. Die Identifikation und die Erstellung 
von Expressionsprofilen sind die ersten Schritte für ein besseres Verständnis der miRNA und 
ihrer Beteiligung an der Regulierung von biologischen Prozessen. Trotz der zunehmenden 
Charakterisierung der miRNA in verschiedenen Spezies, sind kaum Untersuchungen in bovinen 
Ovarien und Plazenten bekannt. In zwei Studien wurde die miRNA Expression in bovinen 
Ovarien und in Plazenten am Tag 50 der Trächtigkeit, in unterschiedlich erzeugten 
Schwangerschaften untersucht. Das Ziel der ersten Studie war die Identifizierung und 
Charakterisierung von miRNAs in klonierten bovinen Ovarien, Expressionsanalysen sowie 
Target-Vorhersagen. Die konstruierte miRNA-Bibliothek ergab 50 bekannte und 24 neue 
miRNAs. Unter diesen waren 38 neue bovine miRNAs die von 43 eindeutigen Loci abgeleitet 
werden konnten, die eine charakteristische sekundäre Struktur zeigten. Durch die mehrfache 
Klonierung der meisten miRNAs, konnte ihr Expressionsniveau in den Ovarien erfasst werden. 
Analysen von miRNAs in unterschiedlichen intra-ovariellen Strukturen sowie anderen Geweben 
zeigten ihr phasen- und gewebsspezifisches Expressionsmuster. Des Weiteren konnte durch 
bioinformatische Auswertungen und Gen Ontology Analysen der Target Gene verschiedene 
biologische Prozesse und Pathways der Ovarienfunktion identifiziert werden. Die Ergebnisse 
dieser Studie deuten auf das Vorhandensein von miRNAs in bovinen Ovarien hin und 
verdeutlichen die potenzielle Bedeutung in der Regulierung diverser Mechanismen der 
Ovarienfunktion. Die zweite Studie sollte die Unterschiede von Expressionsprofilen von 
miRNAs in Plazenten am Tag 50 der Trächtigkeit von SCNT, IVP und AI Schwangerschaften 
durch Quantifizierung von 377 miRNAs aufklären. Die Studie zeigte eine starke reduzierte 
Expression und eine geringe Reprogrammierung der miRNAs in NT und IVP im Vergleich zu 
AI. Diese miRNAs gehören vermutlich zu einer miRNA Familie in einem chromosomalen 
Cluster. Des Weiteren zeigten zellspezifische Lokalisationen von miRNAs in der 
expandierenden Blastozyste und Expressionsprofile von unterschiedlichen Entwicklungsstadien 
im Embryo und in der Plazenta, dass die wichtigsten Deregulierungen von miRNAs am Tag 50 
der Trächtigkeit in NT und IVP entstehen. Diese Deregulierung erwies sich als weniger 
abhängig von einer globalen DNA-Methylierung, vielmehr wurde eine Abweichung in den 
miRNA-Prozessgenen belegt. Von diesen könnte die reduzierte Expression von AGO2 die 
Ursache für die globale Deregulierung der miRNAs in NT oder IVP Plazenten sein. Die 
identifizierten Deregulationen der miRNAs könnten im Zusammenhang mit abnormaler 
Plazentogenese in NT oder IVP Trächtigkeiten stehen. Die Ursachen für Abnormalitäten in der 
Plazentogenese liegen in genetischen und epigenetischen Modifikationen.  
Zusammenfassend konnte durch diese Studien miRNAs in bovinen Ovarien identifiziert werden 
und Expressionsmustern der miRNAs sowie ihre regulierenden Mechanismen in der Plazenta 
von unterschiedlichen Trächtigkeiten beschrieben werden.  
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General introduction 1
1 General introduction 
 
1.1 miRNAs in the bovine ovary 
 
Folliculogenesis is the result of series of complex and coordinated processes, which 
include morphological and functional changes in different types of follicular cells and 
their interactions. Sequential recruitment, selection and growth of the follicles, atresia, 
ovulation and luteolysis are dynamically regulated events that occur on a cyclical basis 
within the ovary. These processes are under control of closely coordinated endocrine 
and paracrine factors to develop a number of ovulatory follicles that are species and 
breed dependent (Hunter et al. 2004). All those events entail substantial changes and 
balance between many processes such as the cell cycle, cellular growth, proliferation, 
differentiation, angiogenesis, steroidogenesis and atresia to determine the ultimate fate 
of follicles. All of these steady state cyclic changes are controlled by tightly regulated 
expression and interaction of a multitude of genes in different compartments of the 
ovary (oocyte, cumulus granulosa, mural granulosa cells and theca cells) to facilitate 
oocyte development (Bonnet et al. 2008).  
 
In oogenesis and embryo development, there are different mechanisms regulating gene 
expression at the post-transcriptional level. These include events of mRNA adenylation 
and deadenylation, the CAP structure at the 5’ end of the mRNA and the effective 
action of mRNA binding factors (Eichenlaub-Ritter and Peschke 2002, Piccioni et al. 
2005). Recently, a new post-transcriptional gene regulation is opened up after promising 
discovery of hundreds of miRNAs in different mammalian species. Diverse expression 
pattern of miRNAs and high number of their potential target mRNAs suggests their 
involvement in the regulation of various developmentally related genes at post-
transcriptional level (Alvarez-Garcia and Miska 2005, Ambros 2004, Bartel 2004, Chen 
and Rajewsky 2007, Lai 2003, Lau et al. 2001, Plasterk 2006). The tiny (18-24 nt in 
length) and single-stranded miRNAs are derived from primary transcripts termed as 
"pri-miRNAs”, which have an RNA hairpin structure of 60-120 nt with a mature 
miRNA in one of the two strands. This hairpin in turn is cleaved from the pri-miRNA in 
the nucleus by the double-strand-specific ribonuclease, Drosha (Lee et al. 2002). The 
resulting precursor miRNA (or pre-miRNA) is transported to the cytoplasm via a 
process that involves Exportin-5 (Yi et al. 2003) and subsequently cleaved by Dicer 
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(Lee et al. 2003) to generate a short, double-stranded (ds) RNA duplex. One of the 
strands of the miRNA duplex is incorporated into a protein complex termed RNA 
induced silencing complex (RISC). RISC is guided by the incorporated miRNA strand 
to mRNAs containing complementary sequences in 3´ untranslated region, which 
primarily results in inhibition of mRNA translation (Pillai et al. 2005). Those mRNAs 
which are repressed by miRNAs are further stored in the cytoplasmic foci called P-
bodies (Liu et al. 2005a, Liu et al. 2005b, Rehwinkel et al. 2005).  
 
Several studies have shown the involvement of miRNAs in animal development. 
Inhibition of miRNA biogenesis has resulted in developmental arrest in mouse and fish 
(Bernstein et al. 2003, Giraldez et al. 2005, Wienholds et al. 2003). Similarly, loss of 
important miRNA processing machinery, Dicer1 resulted in female infertility in mouse 
(Otsuka et al. 2007, Otsuka et al. 2008). Targeted knockdown of mir-17-5p and let-7p in 
wild type mice revealed impaired corpus luteum (CL) angiogenesis and decreased 
serum progesterone levels. In the same study, injection of these miRNAs revealed the 
restoration of vasculature within the CL and increased progesterone levels (Otsuka et al. 
2008). In addition to loss-of-function approach, efforts have been done to identity 
miRNAs by cloning. For example, small RNA-cDNA libraries from the ovaries of 2-
wk-old and adult mice have generated a number of miRNAs with potential role in 
ovarian function (Ro et al. 2007b). Subsequent study on ovarian miRNAs in mouse 
showed the post-transcriptional regulation of CtBP1 gene by miR-132 and miR-212 in 
cultured granulosa cells (Fiedler et al. 2008). In addition to miRNA, several other non-
coding small RNAs including rapiRNAs, napiRNAs, rasiRNAs and tncRNAs are 
identified and reported in different species (Ambros et al. 2003b, Aravin et al. 2003, 
Reinhart et al. 2002).  
 
Bio-informatic approaches and construction of small RNA-cDNA libraries from bovine 
adipose tissue, mammary gland, embryo, thymus, small intestine, mesenteric lymph 
node and abomasum lymph node have identified most of presently annotated bovine 
miRNAs (Coutinho et al. 2007, Gu et al. 2007). The number of bovine miRNAs (117) 
in comparison to Human (695), Chicken (475), Mouse (488), Chimpanzee (595), 
Rhesus Monkey (463) in miRBase 12.0 are inadequate to disclose global miRNAs 
regulation of gene expression for various biological functions and disease conditions. 
Recently, the dynamics of miRNAs expression during bovine oocyte maturation in vitro 
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have been studied using heterologous approach (Tesfaye et al. 2009). This together with 
previous report in mouse supports the possible role of miRNAs during follicular 
development and oocyte growth. Identifying entire set as well as ovary-specific 
miRNAs may lead to understanding miRNA-guided gene regulation in the ovary. So, 
the present study has been conducted with the objective to get insight into the miRNA 
population present in bovine ovary by investigating their characteristics, expression 
pattern and features of their target genes. 
 
1.2 miRNAs in the placentas derived from in vivo, in vitro and somatic 
cell nuclear transfer pregnancies 
 
Animal Cloning is a break-through technology with emerging potential applications in 
agricultural and biomedical research, but the technology is hindered by very low rates of 
live birth due to high incidence of placental abnormalities leading to embryonic losses 
(De Sousa et al. 2001, Hill et al. 2000, Humpherys et al. 2002, Ogura et al. 2002, Ono et 
al. 2001, Stice et al. 1996, Yang et al. 2007). The major source of these abnormalities is 
thought to be due to genetic and epigenetic modifications arise from improper 
reprogramming of the donor cell after nuclear transfer, but the effect last long 
throughout the embryonic development (Jouneau and Renard 2003, Latham 2004, 
Piedrahita et al. 2004, Santos and Dean 2004, Smith and Murphy 2004, Tamada and 
Kikyo 2004).  
 
Incomplete epigenetic reprogramming of the donor cell nucleus by the cytoplasm of the 
oocyte during early development leads to postimplantation lethality with ultimate 
placental defects (Lambertini et al. 2008, Niemann et al. 2008, Wagschal and Feil 2006, 
Yang et al. 2007). Key mechanisms underlying this epigenetic reprogramming are DNA 
methylation, histone remodeling and telomere maintenance, which are involved in the 
control of gene expression, X chromosome inactivation and genomic imprinting 
(Holmes and Soloway 2006, Li et al. 1993, Perecin et al. 2009), but all mechanisms are 
not contributing equally to the embryonic and extra-embryonic lineage (McGrath and 
Solter 1984, Oudejans et al. 1997, Surani et al. 1984, Wagschal and Feil 2006). 
Specially, genomic imprinting has been shown to be less or not dependent on DNA 
methylation in the placenta for its somatic maintenance than in the embryo. Rather, 
placenta-specific imprinting involves repressive histone modifications and non-coding 
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RNAs (Brockdorff 2002, Higashimoto et al. 2002, Lewis et al. 2004, Li et al. 1993, 
Sado et al. 2000, Sado and Ferguson-Smith 2005, Yatsuki et al. 2004).  
 
When considering non-coding RNAs, miRNAs a recently discovered class of small 
RNAs appeared as first and foremost epigenomic tool or modifier that regulate gene 
expression epigenetically at the post-transcriptional or transcriptional level and were 
found to play important roles including but not restricted to cell proliferation, apoptosis, 
diseases and differentiation during mammalian development (Ambros 2004, Bartel 
2004, Kloosterman and Plasterk 2006). They were found to be targeted by epigenetic 
modification and eventually controlling epigenetics and some imprinted miRNAs found 
to undergo subsequent epigenetic reprogramming in mouse embryos (Cui et al. 2009, 
Kircher et al. 2008, Williams et al. 2007). Many of the miRNAs have been predicted 
and found to have pivotal roles in controlling DNA methylation, regulating chromatin 
structure and controlling telomere recombination (Benetti et al. 2008a, Benetti et al. 
2008b, Fabbri et al. 2007, Guil and Esteller 2009, Lewis et al. 2005, Lujambio and 
Esteller 2007, Ting et al. 2008, Valeri et al. 2009). Interestingly, they could be 
imprinted like genes and many of X-linked microRNAs escape meiotic sex 
chromosome inactivation (Kanellopoulou et al. 2009, Song et al. 2009). 
 
Taking all promising information together, this experiment has been conducted to 
answer even more deep question by quantifying 377 miRNAs in the placenta derived 
from artificial insemination (AI), in vitro produced (IVP), nuclear transfer (NT) 
pregnancy at day 50 and in the donor fibroblast cells along with their detailed 
characterization. Present study hypothesized that aberrant expression of transcriptional 
regulatory miRNA molecules during redifferentiation for placentogenesis leading to 
abnormal genetic and epigenetic modification in the placenta of cloned conceptuses are 
likely caused by re-programming errors after cloning and in vitro culture. The 
objectives of the study were to identify the expression pattern of miRNAs in the 
placentas derived from in vitro and nuclear transfer pregnancies compared to the 
placenta from the in vivo or artificial insemination pregnancies. 
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2 Literature review 
 
This chapter addresses the fundamental aspects and current knowledge on miRNAs 
mediated regulation of bovine ovarian development, folliculogenesis, ovarian 
steroidogenesis, fertilization, early embryonic development, implantation and placental 
functions in addition to the overview of miRNAs biosynthesis and their mechanisms of 
regulation of gene expression. Sound ovarian physiology and folliculogenesis is leading 
to ovulation of competent oocyte, which is directly related to successful fertilization, 
embryogenesis and subsequently pregnancy outcome. So, beside the major 
investigations on miRNAs which are carried out in the ovary and placenta derived from 
artificial insemination, in vitro production and nuclear transfer pregnancy for this 
dissertation, miRNAs in other associated sequential events are also presented to 
maintain logical flow and their inter-relationship. However, a large portion of this 
review is focused on basics of ovary and placenta in relation to miRNAs. The review 
concludes in the end of respective sections with a problem statement and the rationale 
for conducting the research contained within this dissertation. 
 
2.1 Brief overview of miRNAs 
 
Genomic research over the past few years has exposed a striking result in the discovery 
of noncoding RNAs (ncRNAs) as a representation of a substantial component of all 
metazoan genomes. Among the noncoding RNAs, microRNAs (miRNAs), so called 
because of their tiny size (~18-24 nucleotides long) currently represent a new class of 
small RNA molecules, those are receiving the highest interest as they inhibit translation 
and/or induce degradation of protein-coding mRNAs that contain complementary 
sequences to miRNAs (Gu et al. 2007, Ying and Lin 2006). miRNAs are first identified 
simply as a part of 'junk' RNA, in 1993 by Victor Ambros and his colleagues Rosalind 
Lee and Rhonda Feinbaum at Harvard University, while studying developmental 
mutants of the nematode Caenorhabditis elegans. During analyzing a putative 'protein', 
lin-4, a sequence regulating heterochronic temporal control of development, the 
research team has identified that lin-4 has no protein, but actually a short hairpin RNA. 
Since the discovery of the founding members of the microRNA family, lin-4 and let-7 
(Lee et al. 1993, Reinhart et al. 2000, Wightman et al. 1993), hundreds of miRNAs have 
been identified in insects, plants, animals and viruses by small RNA cDNA library 
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construction, advance sequencing techniques and bioinformatic analysis (Berezikov et 
al. 2006, Lau et al. 2001, Lee et al. 2001, Stark et al. 2007). miRNAs were found to 
down regulate gene expression by base pairing with the 3´ untranslated regions (3´ 
UTRs) of target messenger RNAs (mRNAs) (Lee et al. 1993, Reinhart et al. 2000, 
Wightman et al. 1993). Advances in the analysis of this widespread class of miRNA 
molecules after initial discovery, has opened up a new layer of gene regulation in many 
organisms. Mechanism for the generation of miRNAs in the cells, their mode of 
regulation as well as the available methodological approaches to study such miRNAs 
mediated post transcriptional gene regulation are presented bellow.  
 
2.1.1 Biogenesis of miRNAs and their regulation of gene expression 
 
Following sections highlight the synthesis of miRNAs, from primary transcription up to 
formation of mature functional state through a group of processing factors and miRNAs 
mediated genetic or epigenetic regulation of post transcriptional gene expression. 
 
2.1.1.1 Biogenesis of miRNAs 
 
Most miRNA genes are transcribed by RNA polymerase II (Pol II) to generate a 
primary transcript called ‘primary miRNA’ (pri-miRNA), which can range in size from 
several hundred nucleotides (nt) to tens of kilobases (kb) (Cai et al. 2004, Lee et al. 
2004) (Figure2.1). Like mRNAs, Pol II transcribed pri-miRNAs contain 5’ cap 
structures, are polyadenylated and may be spliced (Bracht et al. 2004, Cai et al. 2004). 
The tiny (18-24 nt in length) and single-stranded miRNA molecule, derived from this 
pri-miRNAs, having a RNA hairpin structure of 60-120 nt with a mature miRNA in one 
of the either two strands (Figure 2.1). The pri-miRNA is processed within the nucleus 
by a multi-core protein complex called the Microprocessor, which is composed of the 
RNAse III enzyme Drosha and the double-stranded RNA binding domain (dsRBD) 
protein DGCR8/Pasha (Denli et al. 2004, Gregory et al. 2004, Han et al. 2004, 
Landthaler et al. 2004, Lee et al. 2003). This microprocessor cleaves the hairpin from 
the pri-miRNA in the nucleus (Lee et al. 2002). The resulting precursor miRNA (pre-
miRNA) is transported to the cytoplasm via a process that involves binding of Exportin-
5 to pre-miRNA through recognizing the 2-nt 3’overhang produced by RNAse III 
mediated cleavage (Yi et al. 2003). This pre-miRNA undergoes a cleavage mediated by 
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another RNAse III enzyme, Dicer, which interacts with the dsRBD proteins TRBP to 
generate the mature ~22nt miRNA:miRNA* duplex (Chendrimada et al. 2005, 
Forstemann et al. 2005, Hutvagner et al. 2001, Jiang et al. 2005a, Ketting et al. 2001, 
Lee et al. 2003, Lee et al. 2006, Saito et al. 2005). Subsequently, TRBP/Loquacious 
recruits the Argonaute protein and together with Dicer they form a trimeric complex 
that initiates the assembly of the RNA-induced silencing complex (RISC), a 
ribonucleoprotein (RNP) complex (Gregory et al. 2005, Maniataki and Mourelatos 
2005). Based on the relative stability of the two ends of the duplex, the miRNA strand, 
with relatively unstable base pairs at the 5’ end, remains incorporated into the RISC, 
whereas the passenger strand, or miRNA* strand, is degraded (Leuschner and Martinez 
2007, Matranga et al. 2005, Schwarz et al. 2003). 
 
 
Figure 2.1: Biogenesis of miRNAs and their mechanism of gene regulation. 
Argonaute proteins 1-4 (Ago1-4), inhibition of initiation of translation (-), 
Promoting deadenylation (+), 7-methyl-G cap (m7G)  
 
Recently, it is proposed that an alternative pathway also involved in microRNA 
biogenesis from the pre-miRNA hairpin to the mature functional miRNA (Diederichs 
and Haber 2007)(Figure 2.2) where, Ago2 has been found as a highly specialized 
member of the Argonaute family with an essential nonredundant Slicer-independent 
function within the mammalian miRNA pathway (O'Carroll et al. 2007). Ago2-
mediated pre-miRNA cleavage has been observed in the processing of miRNAs derived 
from the 5´-arm of the pre-miRNA hairpin having no mismatches at the immediate 
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cleavage site (Diederichs and Haber 2007, Han et al. 2006). The product of Ago2-
mediated pre-miRNA cleavage (ac-pre-miRNA), was found to be an intrinsic on-
pathway intermediate during miRNA biogenesis and hence a substrate to Dicer, or it 
could be a byproduct which cannot be further processed toward the mature miRNA. 
These data identify the ac-pre-miRNA as a pathway intermediate in miRNA biogenesis 
that is generated from the pre-miRNA by Ago2 and serves as a substrate for Dicer to 
mature into the active miRNA. Although some microRNAs are processed by Drosha 
(also known as Rnasen), its maturation does not require Dicer. Instead, the pre-miRNA 
becomes loaded into Ago and is cleaved by the Ago catalytic centre to generate an 
intermediate 3´ end, which is then further trimmed and processed into mature miRNA 
(Cheloufi et al. 2010). So, Ago2-mediated cleavage of pre-miRNAs, followed by 
uridylation and trimming, generates functional miRNAs independently of Dicer 
(Cifuentes et al. 2010). 
 
 
Figure 2.2: Alternative model of miRNA processing including the ac-pre-miRNA. 
After nuclear export, the pre-miRNA binds to a preformed complex of 
Dicer, TRBP and Ago2 to build the RISC-Loading Complex (RLC). This 
model of miRNA processing includes an additional endonuclease step in 
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which Ago2 cleaves the pre-miRNA within the RLC generating the nicked 
ac-pre-miRNA hairpin (shown in gray box). The impact of Dicer and TRBP 
on the Ago2 cleavage step, as well as the influence of Ago2 to Dicer 
cleavage, have not been determined, these proteins are depicted with a 
dashed outline. Since miRNA maturation is diminished but not completely 
abrogated in Ago2-KO MEF cells, a less efficient salvage pathway is likely 
to exist that either omits the ac-pre-miRNA (left arm of the pathway) or 
generates it by using a different, unknown RNase. The left arm of the 
pathway is also likely used for miRNAs derived from the 3´ arm of the pre-
miRNA and miRNAs with mismatches at the cleavage site. After cleavage 
by Dicer, the resulting miRNA duplex is unwound, Dicer and TRBP 
dissociate, the passenger strand of the miRNA duplex is degraded and the 
mature miRNA forms the RISC together with Ago2. The stabilization of 
mature miRNAs by Ago proteins is independent of this Ago2-specific 
processing step (modified from Diederichs and Haber 2007). 
 
2.1.1.2 miRNA mediated regulation of gene expression 
 
miRNAs incorporated within the RISC complex, direct RISC to downregulate 
expression of target mRNAs containing complementary sequences in 3´ untranslated 
region to 7- to 8-nt region of 5´ end of miRNA called seed sequence (Pillai et al. 2005) 
(Figure 2.1). Depending on the degree of complementarity between the miRNA and the 
target sequence, mRNAs are either cleaved or degraded (perfect or near perfect 
complementarity) or their translation is repressed (imprecise complementarity) 
(Hutvagner and Zamore 2002, Martinez and Tuschl 2004). The miRNP complex which 
is loaded onto the target mRNA exhibits direct or indirect effect in translational 
repression. Direct effects occur either through inhibition of initiation of translation 
through binding of Ago2 to m7G (7-methyl-G cap) results in prevention of ribosome 
association with the target mRNA, or through inhibition of translation post-initiation, 
which includes premature ribosome drop off, slowed or stalled elongation and co-
translational protein (Figure 2.1).  
 
In addition to direct effects on translation (or protein accumulation), miRNPs can have 
other effects on targeted mRNAs, including promoting deadenylation, which might 
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result in degradation (increased turnover) (Nilsen 2007). Recent reports have also 
indicated that miRNA with or without perfect sequence complementarity, can cause an 
increase in mRNA degradation by endonucleolytic cleavage or deadenylation, 
respectively (Jackson and Standart 2007) or changes in proteins associated with RISC 
can cause a shift from translational inhibition to translational enhancement (Orom et al. 
2008, Vasudevan et al. 2007). Translational repression and/or deadenylation occurs 
followed by decapping and exonuclease mediated degradation if base-pairing is partially 
complementary or in the case of perfect complementarity and provided the miRNP 
contains specifically Ago2, may result in endonucleolytic cleavage of the mRNA at the 
site where the miRNA is annealed (Standart and Jackson 2007). Those mRNAs which 
are repressed by miRNAs are further stored in the cytoplasmic foci called P-bodies (Liu 
et al. 2005a, Liu et al. 2005b, Rehwinkel et al. 2005). miRNAs have found to play an 
integral part of animal gene regulatory networks as one of the most abundant classes of 
gene regulators. Roughly 30% of all animal genes are predicted to be targeted by 
miRNAs. An algorithm which attempts to identify miRNA target sites without relying 
on cross-species conservation or miRNA sequences (Miranda et al. 2006) predicts even 
higher numbers of miRNA regulated genes.  
 
2.1.1.3 Regulation of genes by miRNA mediated epigenetics 
 
The term epigenetics refers to all heritable changes in gene expression that are not 
associated with concomitant alterations in the DNA sequence. Reversible DNA 
methylation and histone modifications are known to have profound effects on 
controlling gene expression. Correct DNA methylation patterns are paramount for the 
generation of functional gametes with pluripotency states, embryo development, 
placental function and the maintenance of genome architecture and expression in 
somatic cells. Aberrancies in both the epigenetic and in the miRNA regulation of genes 
have been documented to be important in diseases and early development. However, 
little is known about the miRNAs mediated epigenetic processes or epigenetic control 
of miRNAs expression, which could be potentially involved in regulating reproduction 
and early development. The potential role of Dicer has been postulated in 
heterochromatin formation (Fukagawa et al. 2004). In addition, Dicer-deficient mutants 
are shown to reduce epigenetic silencing of expression from centromeric repeat 
sequences as a result of alterations in DNA methylation and histone modifications 
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(Kanellopoulou et al. 2005). As contradictory to this, no apparent changes were 
observed in the centromeric heterochromatin later on (Murchison et al. 2005). However, 
result in the recent study has shown the Dicer deficient stem cells to have reduced levels 
of both de novo DNA methylation and DNA methyltransferases (Dnmts) (Benetti et al. 
2008b, Sinkkonen et al. 2008) as well as increased telomere recombination and 
elongation (Benetti et al. 2008b). This result supports a model in which the miR-290 
cluster maintains ES cells by controlling de novo DNA methylation via Rbl2 and 
indirectly telomere homeostasis and by repressing the self-renewal program through 
modulating the epigenetic status of pluripotent genes upon differentiation [reviewed in 
(Wang et al. 2009)].  
 
Epigenetic regulation by the miRNAs has opened up a new dimension of mode of 
regulation from translational suppression and classical RNAi degradation. In addition to 
regulation of gene expression at the posttranscriptional level in the cytoplasm, recent 
findings suggest additional roles for miRNAs in the nucleus. miRNAs which are 
encoded within the promoter region of genes could be involved in silencing such genes 
at transcriptional level epigenetically. Such cis-regulatory roles of miRNAs have been 
observed in transcriptional silencing of POLR3D expression and endothelial nitric oxide 
synthase (eNOS) promoter activity (Kim et al. 2008, Zhang et al. 2005). Moreover, 
miR-122 has been shown to facilate replication of hepatitis C viral RNAs without 
affecting mRNAs translation or RNA stability (Jopling et al. 2005).  
 
Recently, aberrant epigenetic reprogramming of imprinted miR-127 in cloned murine 
embryos has been reported in relation to the aberrant epigenetic reprogramming of the 
mouse retrotransposon-like gene Rtl1 (Cui et al. 2009). miRNA mediated switching of 
chromatin remodeling complexes in neural development by repression of BAF53a has 
been observed in mouse (Yoo et al. 2009). This repression is accomplished through the 
3´ UTR of BAF53a and mediated by the simultaneous activities of miR-9* and miR-
124. Repressor-element-1-silencing transcription factor participates in this switch by 
repressing miR-9* and miR-124, thereby permitting BAF53a expression in neural 
progenitors. Interestingly, the aberrant DNA methylation and histone modifications 
were found to simultaneously induce silencing of miRNAs in colorectal cancer 
(Bandres et al. 2009). The relation of miRNA and epigenetics is presently being 
elucidated. So, much less is known about the specific miRNA and their targets to 
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regulate epigenetic machinery or epigenetic regulation of specific miRNAs that are 
required for normal physiological condition or for any phenotypic effects, but this area 
of research is rapidly moving forward. 
 
2.1.2 Methodological approaches to discover, expression profiling and functional study 
of miRNAs 
 
Substantial attempts have been made to recognize new miRNAs like molecules since 
their early discoveries. The approaches, which were effectively used to identify new 
miRNA sequences, can be classified in to four major groups. Those are - computational 
approach, through library construction, heterologous approach and finally by advanced 
nucleotide sequencing methods. The least proficient advance is the identification of 
miRNAs through computational approach or genetic screening. In addition to lin-4 and 
let-7 miRNAs, founder member of miRNAs family, hundreds of miRNAs in different 
species has been identified by forward genetic screening. But now-a-days the most 
efficient way of miRNA discovery is through construction of cDNA libraries of 
endogenous small RNAs (Ambros and Lee 2004, Berezikov et al. 2006). Different 
approaches to construct small RNAs cDNA library are presented in the figure 2.3. 
Briefly, size-fractioned RNA from diverse sources is ligated to 5' and 3' adapter 
molecules, which are then, reverse transcripted and subsequently amplified by PCR in 
order to construct a cDNA library. The PCR products are concatemerized by DNA 
ligation and cloned into the sequencing vectors for identification (Berezikov et al. 
2006). Small RNA is discovered by cDNA cloning, is categorised as a miRNA when it 
meets up certain criteria. First, the small RNA sequence should be at the arm of a 60-80 
nucleotide hairpin RNA structure.  
 
Second, if the small RNA is not cloned repeatedly, the expression of the small RNA 
should be established experimentally, classically by Northern blotting or by other 
defined methods. The sequence in most cases should also be phylogenetically conserved 
between related species (Ambros et al. 2003a). Third, the heterologous approach refers 
detection of known miRNAs from known species in a new species followed by detailed 
characterizations. This approach is carried out either by real time qRT-PCR or through 
microarray based technologies or by the both methods. However, the approach is 
limited to only conserve miRNAs families and requires further validation either by 
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sequencing or by northern blotting. So, one of the limitations of heterologous 
approaches is the requirement of prior sequence information, to be used for probe 
design. Until recently, this method has been limited mostly to that found in public 
databases (i.e. miRBase), having been gathered mainly through a combination of 
bioinformatics and extensive cloning experiments. Forth, instead of individual clone 
sequencing, deep sequencing of small RNA libraries is an effective approach to uncover 
rare and lineage- and/or species-specific miRNAs in any organism by utilizing 
massively parallel sequencing, generating millions of small RNA sequence reads from a 
given sample. Deep sequencing technology is becoming more available to researchers 
studying microRNAs and the analysis of profiling data by deep sequencing may be 
carried out using both publicly available and custom-made software. This approach is 
not dependent on any prior sequence information instead, providing information about 
all RNA species in a given sample and allowing for discovery of novel miRNAs or 
other types of small RNAs. Thus providing an excellent tool for those studying species 
where limited sequence information is currently available. Additionally, new sequence 
information provided by deep sequencing can be used to design microarray probe 
content for future large scale expression studies. 
 
Diverse approaches have been followed to profile miRNA expression, such as Northern 
blotting with radiolabeled probes (Sempere et al. 2004, Valoczi et al. 2004), 
oligonucleotide macroarrays (Krichevsky et al. 2003), quantitative PCR-based 
amplification of precursor or mature miRNAs (Jiang et al. 2005b, Schmittgen et al. 
2004, Shi and Chiang 2005), bead-based profiling methods (Barad et al. 2004, Lu et al. 
2005) and DNA microarrays spotted onto glass surfaces (Babak et al. 2004, Baskerville 
and Bartel 2005, Liu et al. 2004, Miska et al. 2004). The most extensively used 
technique to profile the expression of hundreds of miRNAs are miRNA microarrays 
(Babak et al. 2004, Barad et al. 2004, Baskerville and Bartel 2005, Krichevsky et al. 
2003, Liu et al. 2004, Miska et al. 2004, Sun et al. 2004, Wienholds et al. 2005).  
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Figure 2.3: Approaches to discover miRNA by small RNAs-cDNA library construction. 
 In 1, total RNA is separated on a polyacrylamide gel and the fraction 
corresponding to RNAs of 18–25 nt is recovered. In 2, a 3′ adapter can be 
introduced in different ways: the adapter can be ligated to a 
dephosphorylated RNA, which is then phosphorylated (2a); a preadenylated 
adapter can be ligated to RNA without free ATP in the reaction (2b); or the 
RNA can be polyadenylated by poly(A) polymerase (2c). In 3, a 5′ adapter is 
introduced either by ligation (3a), or by template switching during reverse 
transcription (3b). In 4, cDNA is amplified by PCR and cloned into a vector 
to create a library. Alternatively, PCR products can be sequenced directly by 
single-molecule sequencing methods (massive parallel sequencing) (adapted 
from Berezikov et al. 2006).  
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The usual microarray systems are not favourable to detect miRNAs as short targets. 
Consequently most of the miRNA microarray systems targeted pre-miRNA expression 
instead of mature miRNAs (Barad et al. 2004). Nevertheless, miRNA processing can be 
regulated and pre-miRNA expression may not always correlate to the mature miRNAs 
(Obernosterer et al. 2006). Recent microarray studies for detecting mature miRNAs by 
specific probes (like LNA modified probs), though closely sequence-related miRNAs 
might also be cross-hybridized. This constitutes an efficient methodology using locked 
nucleic acid (LNA)-modified oligonucleotides to screen in a parallel fashion for the 
expression of a large number of miRNAs through extensive sample collections. Where, 
there is no need for RNA size fractionation and/or amplification and that can 
discriminate among closely related miRNA family members (Castoldi et al. 2006). For 
sensitive miRNA array analysis, to compare the miRNA expression profiles of tumor 
and normal adjacent tissues from lung, colon, breast, bladder, pancreatic, prostate or 
thymus cancer microarray platform has already been used. For absolute quantification 
of miRNA expression, Northern blot assay is preferred for some cases over microarray. 
Several miRNAs has already profiled in different samples related to diseases, 
development and differentiation. Studies on miRNAs expression profiles in cancer 
samples have identified a handful of miRNAs that are differentially regulated in tumors, 
suggesting a possible link between miRNAs and oncogenesis (Calin et al. 2002). 
 
 
 
Figure 2.4: Experimental strategies to study miRNA function using molecular, genetic 
and bioinformatic techniques (adapted from Krützfeldt et al, 2006) 
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Experimental strategies to study miRNA function using molecular, genetic and 
bioinformatic techniques are shown in figure 2.4. Identification of miRNAs in the 
distinct cell types can be achieved by qRT-PCR, microarray expression profiling or 
random sequencing of miRNAs from any given tissue or cells. The effect of collective 
silencing of miRNA expression can be studied by inactivation of Dicer by appropriate 
methods. Alternatively, the expression of specific miRNAs can be manipulated by 
either over expression or gene silencing. Gene-expression analysis can then be used to 
validate miRNA targets and analyze phenotypes. Expression profiling can be used to 
test whether miRNA levels are altered in specific disease states to screen the functions 
of specific miRNAs. Thereafter, altered miRNA profiles can then be restored in vivo by 
over expression or silencing of specific miRNAs. The effect on the disease phenotype 
and gene expression at mRNAs or protein level can then be assessed (Krutzfeldt et al. 
2006). Aside from direct experimental tests for site function, further indication of the 
importance of the seed region in miRNA target recognition has been inferred from 
computational studies showing significant overrepresentation of conservation of 
matches to miRNA seeds or, in some cases, avoidance of miRNA seed matches 
(Brennecke et al. 2005, Farh et al. 2005, Krek et al. 2005, Lewis et al. 2005, Stark et al. 
2005, Xie et al. 2005). miRNA targets have been predicted using different 
computational approaches but to validate such miRNA-target interactions there is no 
high throughput approaches and must be tested one by one in reporter assays. However, 
from the recent study (Easow et al. 2007, Karginov et al. 2007) it seems that a quite 
large fraction of miRNA targets are not significantly destabilized at the mRNA level or 
that the magnitude of repression conferred by the miRNA is small. This could be the 
general case for miRNA-target relationships in which the miRNA is not absolutely 
required to reduce the target expression to an inconsequential level, but to buffer it to 
optimal levels, when it is required for optimum cellular functions. 
 
2.2 Overview of role of miRNAs in reproduction 
 
miRNAs are estimated to comprise 1–5% of animal genes (Bartel 2004, Bentwich et al. 
2005, Berezikov et al. 2005) or a given genome could encode nearly thousands of 
miRNAs (Bentwich et al. 2005). Moreover, a typical miRNA regulates hundreds of 
target genes (Brennecke et al. 2005, Krek et al. 2005, Lewis et al. 2005, Xie et al. 2005) 
and altogether they could target a large proportion of genes up to 30% of the genome 
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(Lim et al. 2005). Changes in the expression of even a single miRNA found to have a 
significant impact on the outcome of diverse cellular activities. Inhibition of miRNA 
biogenesis has been found to be resulted in developmental arrest in mouse and fish 
(Bernstein et al. 2003, Giraldez et al. 2005, Wienholds et al. 2003) and female infertility 
in mouse (Otsuka et al. 2007, Otsuka et al. 2008). miRNAs seem well suited to maintain 
the delicate balance between normal reproductive biology, system development and 
tissue maintenance versus deregulated growth and tumor formation. These small non-
coding RNAs have been found to play a central role in various cellular activities, 
including developmental processes, cell growth, differentiation and apoptosis, cell–cell 
communication, inflammatory and immune responses through gene expression stability. 
As many of these processes are an integrated part of gonadal functions, germ cell 
formation, differentiation, uterine and oviductal cellular activities during different stage 
of reproduction and steroid synthesis, it is possible to postulate the potential role of 
miRNAs in regulation of reproductive processes along with other physiological 
functions. Alteration of the expression of miRNAs in any of these processes could lead 
to subsequent infertility, reproductive and other steroid-dependent disorders with 
ultimate failure in reproduction. Investigation on the potential role of miRNA in 
reproduction up-to-date has been accomplished by the different approach. First, by 
identifying the population of miRNAs in the germ cells and reproductive tissues 
through cloning method. Second, by investigating the expression of candidate miRNA 
or group of miRNAs using microarray platform or RT-PCR approach. Third, by 
localizing candidate miRNA in the tissue or cell using in-situ hybridization approach. 
Forth, by knocking down global miRNA expression by creating Dicer1 knockout mice. 
Finally, by investigating specific miRNA function through using the oligonucleotide 
inhibitors and/or miRNA mimics or precursors. There are substantial studies by using of 
the first and second approach to discover and detect the expression of miRNAs in the 
sperm, oocyte, granulosa cells, and preimplantation embryos during spermatogenesis, 
fertilization, oocyte and embryonic development providing initial evidence for the 
potential involvement of miRNAs in reproduction. In addition, the depletion of global 
miRNAs by knocking out Dicer in various reproductive cells and tissues of mouse 
supplements and provides the eventual functional importance of miRNAs in 
reproduction. 
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2.3 Mammalian ovarian functions and miRNAs 
 
Ovary, the primary gonad is only the source of female germ cells called oocyte which is 
the pre-requisite for sexual reproduction and female hormones namely estrogen and 
progesterone for the regulation of sexual behavior and function as well as maintenance 
of pregnancy. All the processes which are involving in the development of follicles and 
steroidogenesis in ovary are dependent on complex- co-coordinated cyclic mechanisms 
from the beginning of development of ovary upto the end of reproductive age. Brief 
overview of development, structure, functions and particularly follicular development in 
the ovary are presented in the following sub-sections. In addition, initial evidences for 
the involvement of miRNAs although it is very limited but discussed later on.  
 
2.3.1 Structural-functional insight in to the ovary 
 
The process of oocyte development involves gradual ovarian follicular development 
from primordial follicles. Folliculogenesis is the developmental process in which an 
activated primordial follicle develops to a preovulatory size following the growth and 
differentiation of the oocyte and its surrounding granulosa cells. During 
folliculogenesis, a follicle may be classified as primordial, primary, secondary or 
tertiary (antral, vesicular). This classification is commonly based on the size of oocyte, 
the morphology of granulosa cells and the number of granulosa cell layers surrounding 
the oocyte. Following sections describe in brief about the development of ovary, 
different ovarian cell types and mechanisms of ovarian follicular development as a main 
ovarian function and their transcriptional regulation. 
 
2.3.1.1 Formation of ovary and different ovarian cell types 
 
Gonadal ridges develop as a thickening of the coelomic epithelium on the medial aspect 
of the mesonephric kidneys (Dyce et al. 1996) and make connections with mesonephric 
tissue by rete-ovarii (Byskov and Hoyer 1994). At the gonadal ridge, oogonia become 
enclosed in germ-cell cords (Byskov and Hoyer 1994), consisted of epithelial cells and 
oogonia (Hirshfield and DeSanti 1995), which are delineated from surrounding 
mesenchymal cells by a basal lamina (Byskov and Hoyer 1994). The epithelial cells or 
the somatic cells are originated from the coelomic epithelium haveing cuboidal or 
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spherical nuclei and serve as precursors to the granulosa or follicular cells (Hirshfield 
and DeSanti 1995). The mesenchymal or stromal cells are originated from the stratified 
medial aspect of the mesonephric kidney having elongated nuclei and give rise to theca 
cells (Hirshfield and DeSanti 1995). In cattle, the gonadal ridge is transformed to a 
definitive ovary by Day 40 of gestation. With the disruption of the germ cell cords, the 
ovary divides into cortical and medullary parts (Smitz and Cortvrindt 2002). Developed 
ovary consists of stromal tissue containing primordial follicles (homologous to tubules 
in the testis) and also interstitial glands (homologous to Leydig cells). As in the male, 
gamete production comprises mitosis, meiosis and maturation. However, in the female 
the primordial germ cells that entered the embryonic gonad continued their development 
and proliferated mitotically. They are known as oogonia during this process and they 
stop once they have entered their first meiotic division which is known as primary 
oocytes. As they enter meiosis, the oocytes become surrounded by single flatten layer of 
granulosa cells to form primordial follicles. From puberty, a few primordial follicles 
recommence growth every day, so a continuous trickle of developing follicles is 
formed. 
 
2.3.1.2 Bovine ovarian follicular dynamics 
 
Development of follicles within the ovary is a dynamic process which occurs 
throughout the menstrual/estrous cycle and involves recruitment of follicles into the 
growing pool, physiologic selection of an ovulatory follicle and ovulation or regression. 
Although the fate of the vast majority of follicles is atresia, a single follicle (in 
monovular species) is somehow selected for continued development and eventual 
ovulation. Sequential recruitment, selection and growth of the follicles, atresia, 
ovulation and luteolysis, which are reoccurred on a cyclical basis within the ovary are 
resulting in the development of a number of ovulatory follicles (Hunter et al. 2004). 
Essentially all of these steady state cyclic changes are controlled by tightly regulated 
expression and interaction of a multitude of genes and their proteins in different 
compartments of the ovary (oocyte, cumulus granulosa, mural granulosa, internal and 
external theca cells) during the follicular programme with the ultimate goal of oocyte 
development (Bonnet et al. 2008). There is a large pool of resting (primordial) follicles 
in the mammalian ovary (~100,000 follicles), which are released from the resting pool 
throughout the life cycle. But, there are a few hundred growing follicles in the bovine 
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ovary at any one time (Erickson 1966). The ultimate fate for most of the follicles is 
atresia, which may occur at any stage but the dominant follicle (DF) must survive and 
become the part of healthy pool of antral follicles.  
 
Figure 2.5: Bovine ovarian follicular wave dynamics (adapted from lucy et al, 1992) 
 
Bovine follicular development found to be occurred in a wave like pattern which 
includes 2 or 3 waves and transient increases in FSH secretion precede the emergence of 
follicular waves in cattle (Figure 2.5) (Fortune 1994, Webb et al. 1992). Where as, a 
subsequent decrease in circulating FSH concentrations is temporally associated with 
selection of the dominant follicle (Adams et al. 1992) as has been observed in primates. 
Hence, it is assumed that it is the ability of follicles to respond to the endocrine 
environment on an individual basis that dictates their particular patterns of growth and 
development (Zeleznik and Hillier 1984). Granulosa cells acquire FSH receptors and 
theca cells acquire LH receptors before follicular recruitment (wave emergence) and 
selection of the dominant follicle proceeds (Richards 1994). During the later stages of 
follicle development, the granulosa cells of large healthy, estrogen-secreting follicles 
also acquire LH receptors (Ireland and Roche 1982, Ireland and Roche 1983b, Ireland 
and Roche 1983a, Spicer et al. 1986b, Xu et al. 1995). During the bovine estrous cycle, 
granulosa cells of large healthy antral follicles have more LH receptors than smaller 
atretic follicles (Ireland and Roche 1982, Ireland and Roche 1983a, Ireland and Roche 
1983b, Spicer et al. 1986a) and levels of messenger RNA (mRNA) for LH receptor in 
granulosa cells of dominant follicles increase as follicular development progresses (Xu 
et al. 1995). It has been suggested that the acquisition of LH receptors on granulosa 
cells plays an important role in the selection of dominant follicles (Jolly et al. 1994, 
Spicer et al. 1986b, Xu et al. 1995, Zeleznik and Hillier 1984). 
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2.3.1.3 Transcriptional regulation of ovarian folliculogenesis 
 
Transition from primordial to primary follicles commences the follicular growth, which 
are regulated by multiple genes. Variety of locally produced growth factors along with 
gonadotropins have been identified (Bao and Garverick 1998, Gutierrez et al. 2000) by 
mouse knockout study (Matzuk and Lamb 2002) and reviewed (Knight and Glister 
2006, McNatty et al. 2005, Skinner 2005). Most noteworthy among these are members 
of the TGF-beta superfamily (including the BMP, their receptors and GDF-9), bFGF, 
EGF (Knight and Glister 2006, McNatty et al. 2005, Webb and Campbell 2007), IGF 
and IGFBP (Lucy 2000, Spicer 2004, Webb et al. 2003) (Figure 2.6). Oocyte-specific 
transcriptional regulators (Figla, Nobox, Sohlh1 and Lhx8), oocyte-secreted factors 
(Gdf9 and Bmp15), as well as genes expressed in the granulosa and other surrounding 
somatic cells were found to initiate and control follicular growth (Dumesic and Abbott 
2008, Matzuk and Lamb 2002). Among the key intra-ovarian factors, the transforming 
growth factor b (TGFb) family members, including bone morphogenetic protein-4 have 
been identified as regulators of primordial germ cell generation (van den Hurk and Zhao 
2005) (Figure 2.6).  
 
 
Figure 2.6: TGF-β superfamily members and their associated receptors and binding 
proteins in the ovarian cells. Members of this family are expressed by theca 
cells, granulosa cells and oocytes consistent with their proposed roles as 
intrafollicular autocrine (white arrows) and paracrine (black arrows) 
signaling molecules (adapted from Knight and Glister 2003). 
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Participation of follicle pool in recruitment is FSH-dependent, which later on acquires 
LH receptors in the granulosa and theca cells and becomes dependent on LH (Ireland 
and Roche 1983a). Once the dominant follicle exposed to LH surge, its fate is ovulation 
and its cells will differentiate into the corpus luteum, unless and otherwise lead them to 
be atretic (Valdez et al. 2005). In addition, the dominant follicle is dependent on growth 
factors for promoting the G1- to S-phase transition of the cell cycle and prevent 
apoptosis of granulosa cells (Quirk et al. 2004). Even though a persistent follicle with a 
low-level progestogen treatment have been shown to retain its capacity (Savio et al. 
1993, Sirois and Fortune 1990) to trigger an LH surge and ovulate less healthy oocytes 
by premature activation (Revah and Butler 1996). The LH surge converts the 
proliferating cells of the follicle into dormant cells that are resistant to apoptosis (Quirk 
et al. 2004). In response to FSH, the granulosa cell–derived factors such as kit ligand, 
transforming growth factor α (TGF-α) and epidermal growth factor (EGF) activate the 
resting follicular growth (Figure 2.7). 
 
Figure 2.7: Diagram 
summarising experimental 
observations on follicle
stage-dependent expression 
of TGF-β superfamily 
members in ruminants and 
their putative roles as 
intrafollicular autocrine or 
paracrine signaling 
molecules. Superscripts (o, 
g, and t) refer to oocytes, 
granulosa cells and theca 
cells, respectively. Adopted 
from (adapted from Knight 
and Glister 2003). 
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The interactions between ovarian germ (oocytes) and somatic cells (granulosa cells) and 
expression of several intra-ovarian autocrine/paracrine regulators (FSH, estrogen and 
androgen receptors) are the major contributing factors in the ovary leading to preantral 
and antral follicles development (Filicori et al. 2003). But, how all these receptors 
proteins are being regulated in temporal manner rapidly is not yet understood. 
 
2.3.2 miRNAs in the mammalian ovarian functions  
 
Available information on expression and regulation of miRNAs in the mammalian 
ovary are presented and discussed below.  
 
2.3.2.1 Expression and regulation of miRNAs in the ovarian cells 
 
Dynamically regulated, complex and coordinated ovarian functions include sequential 
recruitment, selection and growth of the follicles, atresia, ovulation and luteolysis are 
under control of closely coordinated endocrine and paracrine factors. All these factors 
are controlled by tightly regulated expression and interaction of a multitude of genes in 
different compartments of the ovary (Bonnet et al. 2008). As one of the major classes of 
gene regulators, miRNAs are considered to be involved in the regulation of ovarian 
genes (Hossain et al. 2009, Ro et al. 2007a). Several studies expanding from 
identification and expression profiling to functional involvement of miRNAs in the 
ovary have been carried out in different animal species. Four attempts have led to 
identify the distinct and major population of miRNAs in 2 weeks old and adult mouse 
ovary (Ro et al. 2007b), adult mouse ovary and testis (Mishima et al. 2008) and new 
born mouse ovary through small RNA library construction and sequencing (Ahn et al. 
2010). Abundant miRNAs which were observed in newborn and adult mouse ovary are 
presented in figure 2.8. The presence of miRNAs and their differential expression can 
give the primary clue for their potential role in ovarian functions. However, discovery 
and further functional characterization of miRNAs in the bovine ovary along with 
different ovarian cell types (oocyte, granulosa, theca cells and ovarian stroma) at 
different follicular stage or at different estrus cycle remains to be elucidated. Several 
studies highlighted the expression and regulation of some individual miRNAs in 
different ovarian cells especially in oocyte and granulosa cells. After disclosing the 
absence or less role of sperm born miRNAs in mammalian fertilization (Amanai et al. 
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2006), further studies were directed towards these two cell types (oocyte and granulosa). 
For example, the first attempt was made in 2006 and the study identified small number 
of miRNAs as well as some other small noncoding RNAs (rasiRNAs, gsRNAs) in 
mouse oocyte (Watanabe et al. 2006). However, further identification of entire set of 
miRNAs in oocytes through direct cloning method is still missing rather more initiative 
has been taken for microarray or RT-PCR based miRNAs detection through 
homologous or heterologous approaches. 
 
 
 
 
Figure 2.8: Different stages of ovarian development and a subset of abundant miRNAs 
that are expressed at the newborn ovary and adult stages. (A) Newborn 
ovary and (C) 7-week (adult) mouse ovary. Germ-cell clusters (GCC), 
primordial follicles (PF), secondary follicles (SF), and antral follicles (AF) 
are indicated by appropriate arrows. miRNAs abundantly expressed are 
listed below the corresponding stage of ovarian development (adapted from 
Zhao and Rajkovic 2008). 
 
The Microarray experiments have shown that Dicer1 is highly expressed and 
functionally important in the oocytes during folliculogenesis as well as in the mature 
oocytes (Choi et al. 2007, Murchison et al. 2007, Su et al. 2002). Conditional knockout 
of Dicer1 in growing oocytes revealed unaffected oocyte growth and folliculogenesis 
during the early stage but meiosis I has been found to be arrested with defective spindle 
organization in oocytes lacking Dicer1 (Murchison et al. 2007). Transcriptional analysis 
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through microarray experiments has identified the major portion of the transcripts as 
misregulated in Dicer1-deficient oocytes. Moreover, Dicer knock out ovaries are found 
to have increased rate of apoptosis (Figure 2.9). These efforts not only provide initial 
evidence for the role of miRNAs in the oocyte but also suggested that a large proportion 
of the maternal genes are directly or indirectly under the control of miRNAs (Murchison 
et al. 2007, Tang et al. 2007). Information on the regulatory role of miRNAs in the 
ovarian cells of ruminants compared to human and mouse are so limited and these are 
the open field for the researcher working on ruminant reproductive biology. Currently, 
the expression and functional evidence of miRNAs in the follicular theca cells in any 
physiological states of any species remains to be elucidated.  
 
 
 
 
 
 
 
 
 
 
Figure 2.9: Dicer1 knock out ovaries have increased apoptosis. Comparison of ovarian 
histology from 12-wk-old control (A) and cKO (B) females shows that 
Dicer1 mutant ovaries contain follicles at all stages of folliculogenesis as 
well as corpora lutea (cl). Despite these observations, a trend toward 
increased atretic follicles in cKO ovaries at 6 wk of age. TUNEL staining of 
6-wk-old ovaries from control (C) and cKO (D) mice revealed increased 
apoptotic granulosa cells (green/yellow) in the Dicer1 mutant. Nuclei are 
counterstained with propidium iodide (red). E, TUNEL-negative control. F, 
High magnification of TUNEL positive follicles in the Dicer1 cKO ovary. 
Note that granulosa cells (gc, arrowheads) are TUNEL positive, whereas 
oocytes (oo, arrow) are negative. G, The proportion of TUNEL-positive 
follicles was quantified and found to be significantly higher in cKO ovaries 
(44.9±5.4%) as compared with control ovaries (23.5±10.8%), * P <0.05 
(Student’s t test), (adapted from Nagaraja et al. 2008). 
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2.3.2.2 Ovarian steroidogenesis and miRNAs 
 
Recent studies revealed interesting relationship between ovarian steroids and miRNAs. 
Several studies suggested ovarian steroid dependent biogenesis & maturation of 
miRNAs and reversely some set of miRNAs could regulate the secretion of ovarian 
steroid. It has been demonstrated that ovarian steroids influence the expression of some 
miRNAs (hsa-miR20a, hsa-miR21 and hsa-miR26a) in endometrial stromal cell and 
glandular epithelial cell in human (Pan et al. 2007). The molecular mechanism by which 
ovarian steroids regulate the expression of miRNAs is unclear but such regulatory 
function has been suggested to alter the expression of their target genes and cellular 
activities manifested by their products thereby (Pan et al. 2007). It has been also shown 
that LH/hCG regulates the expression of selected miRNAs, which affect 
posttranscriptional gene regulation in mouse within ovarian granulosa cells (Fiedler et 
al. 2008). Estrogen was found to suppress the levels of a set of miRNAs in mice and 
human cultured cells through estrogen receptor α (ERα) by associating with the Drosha 
complex and preventing the conversion of pri-miRNAs into pre-miRNAs (Yamagata et 
al. 2009). As down-regulation of miRNAs appeared to stabilize human VEGF mRNA, 
the posttranscriptional control by estrogen appears to mediate the half-life of estrogen 
target genes via regulated miRNA maturation (Yamagata et al. 2009). In addition, 
upregulation of subset of miRNAs in female mice lacking estrogen receptor α and down 
regulation of some miRNAs in the estrogen target organ (Uterus) was observed 
following estradiol (E2) treatment in ovariectomized female mice (Macias et al. 2009). 
Altogether, these studies suggested that ERα bound to E2 inhibits the production of a 
subset of miRNAs by a mechanism whereby ERα blocks Drosha-mediated processing 
of a subset of miRNAs by binding to Drosha in a p68/p72-dependent manner and 
inducing the dissociation of the microprocessor complex from the pri-miRNA (Macias 
et al. 2009).  
 
In contrast, some miRNAs are also found to play important role in the ovarian 
steroidogenesis (Sirotkin et al. 2009). Genome-wide screening of miRNAs revealed the 
involvement of miRNAs in control of release of the ovarian steroid hormones 
progesterone, androgen and estrogen in human ovarian cells (Sirotkin et al. 2009). They 
have evaluated the effect of transfection of cultured primary ovarian granulosa cells 
with gene constructs encoding the majority of identified human pre-miRNAs on release 
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of progesterone, testosterone and estradiol. These results revealed thirty-six out of 80 
tested miRNA constructs inhibiting the progesterone release in granulosa cells and 10 
miRNAs have been found to promote progesterone release. Subsequent transfection of 
cells with antisense constructs to two selected miRNAs (miR-15a and miR-188) 
revealed induction of progesterone output due to lack of blockage of progesterone 
release. While fifty-seven tested miRNAs were found to inhibit testosterone release, 
only one miRNA (miR-107) enhanced testosterone output. Fifty-one miRNAs 
suppressed estradiol release, while none of the 80 miRNAs tested were found to 
stimulate it (Sirotkin et al. 2009). The complex regulatory mechanisms for controlling 
miRNAs biogenesis by the steroids or vice versa are still unclear. The involvement of 
miRNAs for such mechanisms as regulator of several hundreds of genes as potential 
target could be much higher than ever speculated. While the investigations on the 
involvement of miRNAs in ovarian function and steroidogenesis in mouse and human 
are progressing, no information was available in case of bovine. Even the identity, 
existence, characteristics, expression pattern, functions and regulatory mechanisms was 
completely unknown until the work has been carried out as part of this dissertation.   
 
2.4 miRNAs in embryogenesis and early development 
 
Following sections discussed the fundamentals of mammalian embryogenesis from 
fertilization to preimplantation embryo development association of miRNAs in the 
relevant processes. 
 
2.4.1 Fertilization, embryogenesis and miRNAs 
 
Following ovulation, the cumulus-oocyte complex (COC) is released into the perionetal 
or bursal cavity where it is picked up by the infundibulum of the oviduct. Cilia covering 
the exterior surface of the infundibulum direct the COC into the oviduct (Talbot et al., 
2003). Immediately prior to ovulation, elevated estradiol concentrations increase height 
(Murray, 1996) and ciliation of the luminal epithelial cells of the fimbria and ampulla 
(Murray, 1995, 1996) to facilitate COC transport to the ampulla, the site of fertilization. 
Prior to fertilization, sperm deposited into the reproductive tract must undergo a process 
termed “capacitation”. Capacitation is mediated by cAMP-dependent protein tyrosine 
phosphorylation (Wassarman, 1999) and involves a series of functional, biochemical 
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and biophysical modifications of the ejaculated spermatozoa to allow for proper 
fertilization of the oocyte (Baldi et al., 2000). These modifications of the spermatozoa 
include increased membrane fluidity due to loss of cholesterol and remodeling of the 
sperm surface proteins, increased intracellular Ca
2+ 
and pH and membrane 
hyperpolarization (Baldi et al., 2000; Töpfer-Pertersen et al., 2000). These changes of 
the spermatozoa during capacitation induce hyperactivated motility of the sperm and 
allow the sperm cell to respond to stimuli that induce the acrosome reaction upon 
interaction with the oocyte’s zona pellucida (Baldi et al., 2000). This reaction facilitates 
the degradation and sperm penetration of the zona pellucida and subsequently exposes 
the equatorial segment of the sperm, which allows for fusion of the sperm membrane 
with the oolemma (Roldan et al., 1994; Baldi et al., 2000). The steroids progesterone 
and estradiol also mediate the acrosome reaction. Moreover, estradiol modulates that 
action of progesterone to ensure the appropriate time of the acrosome reaction (Baldi et 
al., 2000).  
 
Following the acrosome reaction the spermatozoa passes through the zona pellucida, the 
sperm head crosses the perivitelline space and the equatorial segment of the sperm then 
fuses to the oocyte plasma membrane (Yanagimachi, 1988). The fusion of the 
spermatozoa with the oocyte results in oocyte activation characterized by exocytosis of 
cortical granules and the resumption of meiosis of the oocyte. Prior to activation, the 
nucleus of the oocyte is in the metaphase stage of the second meiosis, where it was 
arrested following the transition from the dictyate stage of prophase I and the exclusion 
of the first polar body following the LH surge (Jones, 2005). The basic steps involved in 
the mammalian fertilization are presented in figure 2.10. 
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Figure 2.10: Basic steps of mammalian fertilization.  
(A) Binding of sperm to the zona pellucida of oocyte induces the sperm 
acrosome reaction. The release of lytic enzymes from the acrosome and the 
forward motility of the sperm permit penetration of the zona pellucida. 
After fusion with the egg's plasma membrane, the sperm enters the 
cytoplasm and forms the male pronucleus of the one cell zygote. Following 
fertilization, the zona pellucida is biochemically modified to prevent 
additional sperm binding (B) The acrosome, a lysosomallike structure on 
the anterior head of sperm, contains an inner and outer membrane that fuse 
during the acrosome reaction (adapted from Dean, 1992). 
 
The resumption of meiosis results in cell cycle resumption, extrusion of the second 
polar body and the formation of the female pronucleus. Likewise, the sperm nucleus 
decondences and transforms into the male pronucleus. The sperm and egg pronuclei 
come into close approximation, their nuclear envelopes disintegrate and their 
chromosomes mingle for the first mitotic division (cleavage). The mingling of the 
chromosomes can be considered the end of fertilization and the beginning of embryonic 
development (Yanagimachi, 1988). Regarding molecular aspects of oocyte-sperm 
membrane interaction, several important molecules were identified as pivotal regulator. 
As many as two-dozen different sperm proteins have been implicated in species-specific 
binding of sperm to eggs (Snell and White 1996, Wassarman 1999). These include a 
variety of enzymes (such as β-galactosyltransferase and α-fucosyltransferase, protein 
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tyrosine kinase (ZRK) and phospholipase A2) and lectin-like proteins (such as mannose- 
and galactose-binding proteins and spermadhesins), as well as several other sperm 
proteins (such as zonadhesin and sperm protein-56 (SP56)).  
 
In addition, results of recent experiments with homozygous-null mice have implicated 
two members of the ADAM (so-called because they contain a disintegrin and a 
metalloprotease domain) family of proteins, sperm β-fertilin and cyritestin, as potential 
EBPs (Cho et al. 1998, Primakoff and Myles 2000, Shamsadin et al. 1999). Binding of 
sperm to the egg plasma membrane is thought to be mediated by this member of the 
ADAM family of transmembrane proteins on sperm and integrin α6β1 receptors on eggs 
(Snell and White 1996, Wassarman 1999). Two mouse-sperm ADAM proteins in 
particular, the heterodimer fertilin (- , ADAM-1; - , ADAM-2) and cyritestin (ADAM-
3), have been studied in some detail and found to interact with integrin in the egg 
plasma membrane through their disintegrin domains. Results of recent studies indicate 
that at least two components that are essential for intracellular membrane fusion in 
somatic cells, Rab3A GTPase and SNAREs, may be present in mammalian sperm and 
may participate in membrane fusion during the acrosome reaction (Iida et al. 1999, 
Ramalho-Santos et al. 2000). Results of several investigations indicate that CD9 a 
member of the tetraspan superfamily of integral plasma-membrane proteins that 
associate with each other, as well as with a subset of β1 integrins and integrin α6β1 in 
the egg plasma membrane has a vital function in sperm–egg fusion in mice (Chen et al. 
1999). 
 
While considering miRNAs, it has been shown that miRNAs are present in mouse 
sperm structures that enter the oocyte at fertilization (Amanai et al. 2006). The sperms 
were found to contain a broad profile of miRNAs and a subset of potential mRNA 
targets, which were expressed in fertilizable metaphase II (mII) oocytes. Similarly, 
oocytes were found to have transcripts responsible for miRNAs processing and 
regulatory mechanisms namely RNA-induced silencing complex (RISC) catalytic 
subunit, EIF2C3. However, the levels of sperm-borne miRNA (measured by 
quantitative PCR) were found to be very low relative to those of unfertilized mII 
oocytes and fertilization did not alter the mII oocyte miRNA repertoire that included the 
most abundant sperm-borne miRNAs. Coinjection of mII oocytes with sperm heads plus 
anti-miRNAs to suppress miRNA function did not perturb pronuclear activation or 
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preimplantation development. In contrast, nuclear transfer by microinjection altered the 
miRNA profile of enucleated oocytes. These data suggest that sperm-borne prototypical 
miRNAs play a limited role in mammalian fertilization or early preimplantation 
development (Amanai et al. 2006).  
 
2.4.2 miRNAs and preimplantation embryo development 
 
Early embryonic development is characterized by the number of nuclei (blastomere) 
present within the developing embryo. Following fertilization, the cell formed by the 
union of parental chromosomes is referred to as a zygote, which is then undergoes a 
number of cleavage and resulting in the development of a 2-, 4-, 8- and 16- cell embryo. 
Early embryonic developmental events in domestic animals are presented in figure 2.11. 
As cleavage continues, the blastomeres compact, merging into a single mass of cells 
called a morula. It is at this point that the embryo moves from the oviduct into the 
uterus, which occurs between days 4 to 5 of pregnancy in the bovine (El-Banna and 
Hafez 1970). During this period genes encoding E-cadherin, β-cantenin and ZO-1 are 
responsible for gap junction assembly and trophectoderm differentiation (Watson et al. 
1999). The next distinguishing event is blastocoel formation, which is accomplished by 
the development of a differentiated polarized epithelium (trophectoderm) that 
implements a Na/K-ATPase ion transport pump to force fluid into the blactocoel cavity 
(Biggers et al. 1988). The blastocoel will eventually turn into the cavity of the yolk sac 
(Schlafer et al. 2000). Cells forming the outer wall of the blastocyst assume specialized 
function and are known as trophoblast cells. At one pole of the hollow blastocyst, 
another type of specialized cells called the inner cell mass (ICM) form. This cluster of 
cells will become the embryo proper. From the ICM, two distinct cell layers develop; 
the endoderm, which lines the yolk sac and the mesoderm which extends from the ICM 
to form a layer between the trophectoderm and the endoderm (Schlafer et al. 2000). The 
initial development of the preimplantation embryo is controlled by maternally inherited 
molecules in the oocyte but upon the embryonic genome activation which begins at 2-
cell stage during this early embryogenesis and eventually acquires developmental 
control (Maddox-Hyttell et al. 2003). This shift from maternal to zygotic genomic 
control is referred to as the maternal/zygotic transition (MZT). A unique feature of early 
embryonic cells is their ability to maintain a full range of developmental capacity, 
termed totipotency. Blastomeres maintain complete totipotency until the 16-cell stage of 
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development, afterward increasing differentiation of cell lineages prevents complete 
totipotency (Pedersen 1988). Lineages differentiation of trophectoderm and ICM results 
in loss of totipotency of the trophectoderm cells.  
 
 
 
Figure 2.11: Early embryonic developmental events in domestic animals.  
Fertilization occurs in the oviduct and morula-stage embryos enter the 
uterus where they develop into spherical blastocyst and hatch from the 
zona pellucida by actions of proteases. Thereafter, spherical blastocysts 
migrate, change to a tubular and then a filamentous form due to rapid 
elongation of trophectoderm before initiation of implantation (adapted 
from Bazer et al. 2009). 
 
In mouse, pluripotent cells can be characterized by the expression of specific gene 
transcripts such as octamer-binding transcription factor-4 (Oct-4), alkaline phsophatase, 
E-cadherin, stage-specific embryonic antigen-1 (SSEA1), zinc-finger protein-42 
(REX1) and Nanog (Boiani and Scholer 2005). In 2-, 4-, 8- and 16-cell bovine embryo, 
mRNA for Oct-4 has been found to be absent or very low but increased during morula 
development. Elevated expression of Oct-4 in the ICM and down regulation in the 
trophectoderm is reflecting the loss of totipotency in trophectoderm cells (Kurosaka et 
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al. 2004). During the progress of embryonic development, the blastocyst with three 
concentric cell layers (trophectoderm, mesoderm and endoderm), expands, hatches from 
the zona pellucida and begins to elongate. Hatching of bovine blastocyst occurs between 
days 9 and 10 of gestation (Guillomot 1995, Maddox-Hyttel et al. 2003). Following 
blastocyst hatching there is no definitive cellular contact between the trophectoderm and 
the endometrial epithelium for several days during embryo elongation in ruminants 
(Spencer et al., 2004a) and the embryo appears spherical and then becomes ovoidal. The 
embryo appears tubular in shape and finally assumes a filamentous appearance by 
approximately day 13 to 14 of gestation as elongation progressed (Guillomot 1995, 
Maddox-Hyttel et al. 2003, Spencer et al. 2004). 
 
The well-orchestrated expression of genes that are derived from the maternal and/or 
embryonic genome is required for the onset and maintenance of distinct morphological 
changes during the embryonic development. Optimum regulation of genes or critical 
gene regulatory event in favor of early embryonic development have been shown to be 
directly (individual miRNAs study) or indirectly (disrupting miRNAs biogenesis) under 
the control of miRNAs. Disruption of Dicer1 - an enzyme important for biogenesis of 
miRNAs and RNA interference related pathways in mammals was first demonstrated 
and shown that loss of Dicer1 lead to lethality early in development, where Dicer1-null 
embryos were found to be depleted of stem cells in mouse (Bernstein et al. 2003). 
Another report has been published in the same year to show the importance of Dicer1 in 
vertebrate development through inactivation of the Dicer1 in zebrafish and subsequently 
observed the early developmental arrest (Wienholds et al. 2003). While defective 
generation of miRNAs was observed in Dicer-null mouse embryonic stem cells with 
severe defects in differentiation both in vitro and in vivo, the re-expression of Dicer in 
the knockout cells has been found to rescue these defective phenotypes (Kanellopoulou 
et al. 2005). Additionally, maternal miRNAs have been shown to be essential for the 
earliest stages of mouse embryonic development through the loss of maternal 
inheritance of miRNAs following specific deletion of Dicer from growing oocytes 
(Tang et al. 2007). So, these initial reports suggest that miRNAs are essential for 
embryonic development as the effect of loss of Dicer1 could primarily arise from an 
inability to process endogenous miRNAs which later on functioning in the gene 
regulation.  
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The role of miRNAs has been suggested first for differentiation or maintenance of tissue 
identity during early embryonic development in zebrafish (Wienholds et al. 2005). 
Several attempts were made to clone miRNAs from the embryo or embryonic tissues to 
understand the miRNA-mediated regulation of embryonic development. A significant 
number of miRNAs has been identified at specific stages of mouse embryonic 
development through massively parallel signature sequencing technology (Mineno et al. 
2006) and in bovine embryo through small RNAs library construction (Coutinho et al. 
2007). The coexistence of dynamic synthesis and degradation of miRNAs has been 
shown but overall quantity and stage-dependent miRNAs increases as the embryos 
develop during mouse preimplantation stage embryonic development (Yang et al. 
2008b). Even, during the preimplantation stage miRNAs are shown to participate in 
directing the highly regulated spatiotemporally expressed genetic network as well. The 
miRNAs profile observed in mouse embryos are provided with a clear insight into the 
embryonic stage-specific miRNA transcriptome, and facilitated the identification of the 
primary target for each miRNA and thereby the pathways regulated by embryonic 
specific mRNAs (Mineno et al. 2006). A dynamic change in miRNA expression during 
oogenesis in growing and mature mouse oocytes has observed and miRNA levels in 
mature mouse oocytes and early embryos fall precipitously in the two-cell embryo, but 
rise again at the four-cell stage, presumably as a result of new transcription from the 
embryonic genome (Tang et al. 2007). They are also engaged by playing important roles 
in diverse cellular processes as well. Examination of miRNAs expression in mouse 
through to the eight-cell stage revealed that dynamic changes of miRNAs during early 
embryonic development (Tang et al. 2007). Where, the total amount of miRNA was 
found to be downregulated by 60% between one- and two-cell-stage embryos and then 
increases, resulting in a 2.2-fold difference between two- and four-cell-stage embryos. 
Which suggests that a very significant proportion (>90%) of the maternally inherited 
miRNAs present in the zygote is probably actively degraded during the first cell 
division, although maternal mRNAs are globally degraded at this time (Hamatani et al. 
2004). So, miRNAs may be involved in the regulation of maternal transcripts in oocytes 
and embryos and whose degradation may be essential for successfully completing 
meiotic maturation and subsequent development. Study has been also suggested that 
sperm-borne miRNAs play a limited role, if any, in mammalian fertilization or early 
preimplantation development (Amanai et al. 2006).  
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Significant proportion of the maternally inherited miRNAs present in the Zygote is 
probably actively degraded during the first cell division. The total miRNA in a four-
cell-stage embryo has bund to be ~2.2 times higher than the levels in a two-cell stage 
embryo which suggested that there is de novo expression of miRNAs between the two- 
and four-cell stages of development (Tang et al. 2007). MicroRNAs belong to the let-7 
family are found to be abundant in mouse oocytes and shown dynamic regulation for 
the period of oogenesis and early embryonic development. In a four-cell-stage embryo 
the miR-290 clusters (Houbaviy et al. 2003) among the upregulated miRNAs were 
abundant. Compared with the two cell-stage embryos, they were up-regulated by 15-
fold and by 24-fold in four-cell and eight-cell-stage embryos, respectively. Thus, 
miRNAs from the miR-290 cluster are amongst the earliest to be expressed during early 
mouse embryonic development. Abundance of miR-17-92 cluster has been shown to be 
significantly increased during oogenesis and was inherited by the zygote and increased 
again after the two-cell embryo stage (Tang et al. 2007). 
 
2.4.3 miRNAs in embryonic stem cells development and maintenance 
 
Recent studies have identified a unique set of miRNAs expressed and its functional 
importance in embryonic stem cells (ES cells). Initial effort has identified that miR-290 
through miR-295 (miR-290 cluster) are ES cell-specific and there after suggested that 
they could potentially participate in early embryonic processes such as the maintenance 
of pluripotency in mouse (Houbaviy et al. 2003). Similar study in human has also 
identified some clustered miRNAs (miR-296, miR-301 and miR-302: homologous to 
the miRNAs reported by Houbaviy et al. in mouse) specifically expressed in human ES 
cells and not in differentiated embryonic cells or adult tissues (Suh et al. 2004). These 
clustered miRNA organization is presumably effective for coordinated regulation of 
their expression and regulation of common targets because a common seed is shared 
between some miR-290 cluster miRNAs, miR-302a-d and miR-93 (Houbaviy et al. 
2003, Houbaviy et al. 2005). The role of miR-290 cluster in embryogenesis has been 
evidenced in a study, in which the generation of a mouse mutant with a homozygous 
deletion of the miR-290 cluster resulted in the death of embryos (Ambros and Chen 
2007). By the loss- or gain-of-function studies of Dicer, DGCR8 and ES-related 
miRNA genes such as miR-290-295 cluster have strongly suggested that miRNAs play 
an important role in ES cell maintenance, differentiation (Benetti et al. 2008b, 
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Sinkkonen et al. 2008) and lineage determination (Ivey et al. 2008, Kanellopoulou et al. 
2005, Tay et al. 2008, Wang et al. 2007). Despite the fact that knowledge on the role of 
miRNAs in the embryonic development and stem cell maintenance, differentiation and 
lineage in mouse and human is increasingly building, it is yet to be elucidated for 
ruminants. 
 
2.5 miRNAs in the embryo produced by assisted reproductive technologies  
 
The advancement of manipulation of reproductive process and application through 
assisted technology is impressive in the last two decades. Since 1970, artificial 
insemination (AI) and the associated techniques such as semen cryopreservation and 
ovulation synchronization dominated the reproductive techniques. The female 
contribution to genetic progress was achieved with the advent of embryo transfer and 
the associated techniques such as non-surgical embryo collection, in vitro maturation, 
fertilization and culturing of bovine oocytes. ET can be accomplished by different 
approaches. Dams can be super-ovulated, artificially inseminated (AI) and later the 
resulted fertilized oocytes are collected by flushing. These fertilized oocytes are then 
cultured till blastocyst stage and are implanted in synchronized heifers. This technique 
is referred as multiple ovulation and embryo transfer (MOET). Oocytes can also be 
collected directly from mother's body through ultra-sonography, cultured for maturation 
and then fertilized with spermatocytes (IVF). If fertilization is successful, similar to 
MOET, the fertilized ovum after undergoing several cell divisions, is either transferred 
to the surrogated mother's for normal development in the uterus, or frozen for later 
implantation. In IVF and in vitro culture procedure, approximately 30 to 40% of the 
matured oocytes develop to transferable blastocysts (Hagemann et al. 1998, Keskintepe 
and Brackett 1996). However, IVP bovine embryos display a number of marked 
differences compared to in vivo one. These differences are evident in gross morphology 
(color, density, cell number and size), timing of development (Greve et al. 1995), in 
biochemical features such as buoyant density, chilling sensitivity, zona pellucida 
stability and resistance to freezing as well as in certain features of embryonic 
metabolism (Niemann et al. 1993). Another advance technique is somatic cell nuclear 
transfer (SCNT) with promising implication for the agricultural and biomedical 
research. Conventional SCNT or cloning involves fusion of a somatic donor cell into an 
enucleated metaphase II (MII) arrested oocyte. The resulting embryo is cultured to the 
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blastocyst stage before being transferred to a surrogate cow to produce live offspring. 
So, cloning procedures adopt to some extent the same procedure as in-vitro fertilization. 
Additional steps in cloning are enucleating the mature oocyte and thereafter transfer of 
the somatic nuclei in this enucleated oocyte. Later the cultivation and transfer to 
recipient heifers follows the same protocol as described for IVF derived foetuses. 
However, Cloning cattle using Somatic Cell Nuclear Transfer (SCNT) is an inefficient 
process, where the surviving offspring only represent approximately 5% of the embryos 
transferred into the surrogate cow (Oback and Wells 2003).  
 
The IVF and SCNT technology has opened the possibilities to manipulate and cultivate 
the embryo. However, it has also been linked to many abnormalities in embryo 
development. Well evident abnormalities in foetuses or calves following transfer of in 
vitro cultivated embryos includes lower pregnancy rate, increased abortion, oversized 
calves, musculoskeletal deformities and abnormalities of placental development, which 
are often described as “Large Offspring Syndrome” (LOS). LOS has been described for 
bovine (Farin et al. 2006), sheep (Sinclair et al. 1999) and mice (Eggan et al. 2001). The 
abnormalities associated to the IVF, SCNT and in vitro culture of embryo are in 
principle due to aberrant or alteration of transcriptional activity at sub-cellular level. 
Several lines of evidence in mouse and cattle indicate that expression patterns of genes 
from in vitro-produced embryos are not necessarily representative of those of in vivo 
embryos (as reviewed) (Niemann and Wrenzycki 2000). An important gene that has 
been found to be expressed by in vivo-derived bovine blastocysts, but not in their in 
vitro-produced counterparts, is the Connexin-43 that is crucial for maintenance of 
compaction. The bovine leukemia inhibitory factor (bLIF) and LIF-receptor-R (LR-8) 
genes were found to be expressed by in vitro produced embryos, but not in their in vivo 
counterparts. The heat shock protein gene 70.1 (Hsp70.1) has been found upregulated 
by blastocysts produced in vitro compared to in vivo embryos, while the glucose 
transporter-l mRNA (Glut-l) is downregulated by morulae produced in vitro as 
compared to in vivo-derived morulae (Niemann and Wrenzycki 2000). However, such 
abnormalities are found to be more pronounced in cloned animals. The clones have a 
high mortality rate due to suffering a number of developmental abnormalities such as 
higher birth weights, muscular-skeletal problems and incorrect placental formation 
(Wells et al. 2004). Candidate gene study reveals that the failure of implantation may be 
due to aberrant expression of genes in the preimplantation cloned embryo, which are 
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crucial for the early regulation and differentiation of the placenta (Hall et al. 2005). At 
the cellular level, a higher incidence of apoptosis (Park et al. 2004) and aberrant 
allocation of inner cell mass (ICM) (Koo et al. 2002) is evident. At the sub-cellular 
level, aberrant DNA methylation patterns (Bourc'his et al. 2001) and the dysregulation 
of genes occurs (Humpherys et al. 2002). These abnormalities are thought to mainly be 
due to epigenetic defects (changes in chromatin structure, not involving a change in 
DNA base sequence) which occur during cell reprogramming, where the donor cell 
DNA is reprogrammed by the oocyte cytoplasm to a embryonic state (Schurmann et al. 
2006). 
 
Recent global gene expression profiling study has also evidenced aberrant regulation of 
gene expression either by genetic or epigenetic modification due to manipulation and 
culture of preimplantation embryos (Aston et al. 2009, Zhou et al. 2008). According to 
the nature and extend of regulatory mechanisms it could be consider that miRNAs are 
playing pivotal roles in such aberrant transcriptional processes. Since, miRNA has been 
appeared as first and foremost epigenomic tool or modifier that regulate gene expression 
epigenetically at the post-transcriptional or transcriptional level and were found to play 
important roles during mammalian development (Ambros 2004, Bartel 2004, 
Kloosterman and Plasterk 2006). They were found to be targeted by epigenetic 
modification and eventually controlling epigenetics and some imprinted miRNAs found 
to undergo subsequent epigenetic reprogramming in mouse embryos (Cui et al. 2009, 
Kircher et al. 2008, Williams et al. 2007). Although few reports until now have been 
addressed the differential miRNAs regulation in the IVP and SCNT embryo compared 
to the artificial inseminated one with particular aspects of their function. Among them, 
one has revealed the disregulated expression of several micro RNAs (miRNAs) in 
bovine cloned elongated embryos using a heterologous microarray (Castro et al. 2010). 
miRNAs expression profiling in elongated cloned and in vitro-fertilized bovine embryos 
has suggested that the different state of reprogramming of miRNAs occurred in cloned 
bovine elongated embryos (Castro et al. 2010). Among the most notable downregulated 
miRNAs found in their study were miR-30d and miR-26a. Both of these miRNAs 
interacted with TKDP, which is involved in maternal recognition of pregnancy in cattle 
(Lagos-Quintana et al. 2001). However, status of reprogramming error in the extra 
embryonic tissues (or placenta) has not yet been separated which could be the main 
reason for the cloned pregnancy loss during the first trimester. Based on these 
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preliminary data, it can be inferred that aberrant trophoblast gene and miRNAs 
expression in cloned embryos contributed to pregnancy failures at and beyond 
implantation. At this moment, much and more information is remaining to elucidate the 
role of miRNAs in the alteration of important transcripts in the IVP and SCNT embryo 
and their association to the abnormal embryonic development.  
 
2.6 Maternal recognition of embryo, implantation and miRNAs 
 
A critical need arises early in gestation for the mother to "recognize" that she is 
pregnant in most species. More specifically, the concentration of progesterone in 
maternal blood must be sustained at a high level in order that the endometrium be 
maintained in a state conducive to embryonic survival. This means that the corpus 
luteum must not die and regress, as it normally does just prior to the onset of the next 
cycle. The early ruminant embryo secretes copious quantities of a protein called 
interferon tau. Exposure of the endometrium to this hormone dampens the secretion of 
PGF, thereby blocking the signal for luteolysis. As a result, the corpus luteum survives 
and progesterone levels are maintained. During post hatching stage, the mononuclear 
trophoblast cells of embryo begin to transcribe mRNA for interferon tau (trophoblastin 
or trophoblast protein-1) at day 12. Highest transcription of mRNA for IFNt occurs on 
days 15 to 17 and continues until approximately day 25 when the initial adhesion of the 
conceptus to the luminal epithelium of the uterus halts IFNt gene expression (Figure 
2.12) (Bartol et al. 1985, Farin et al. 1990). The expression of IFNt is limited to the 
trophectoderm and is not transcribed in the endoderm or yolk sac (Farin et al. 1990). 
The site specific production of IFNt by trophoblast cells may be due to exclusive 
expression of the blastocyst-specific transcription factor Cdx2 in trophoblast cells 
regulating IFNt gene transcription (Imakawa et al. 2006) and/or the absence of Oct-4 in 
these same cells (Ezashi et al. 2001). Uterine produced factors, such as granulocyte-
macrophage-colony stimulating factor (Ezashi and Roberts 2004), interleukin 3 and 
insulin-like growth factors -I and -II (Ko et al. 1991) appear to enhance IFNt secretion 
by the conceptus by acting via the Ets-2 enhancer region (Ezashi and Roberts 2004). 
Synthesis and secretion of IFNt by the developing conceptus blocks the luteolytic 
signal, maintaining the function of the corpus luteum and is thereby the signal for 
maternal recognition of pregnancy (MRP) in ruminants (Bazer et al. 1989, Bazer et al. 
1991, Bazer 1992). In addition to signaling MRP, IFNt is also responsible for inducing 
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or enhancing the expression of numerous genes referred to as IFNt-stimulated genes 
(ISGs). These ISGs contribute to the regulation of uterine receptivity and conceptus 
development at early gestation (Hansen 1998, Spencer et al. 2004).  
 
Figure 2.12: Maternal recognition of pregnancy and different phases of blastocyst 
implantation. (A) Maternal recognition and preattachment, which is 
involving shedding of the zona pellucida (phase 1) on day 8 and 
precontact and blastocyst orientation (phase 2) on day 9-11. (B) 
Apposition and transient attachment (phase 3) after day 11 (C) Adhesion 
(phase 4) between days 15 and 16 (adapted from Spencer et al. 2004). 
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Following MRP, the adhesion between trophoblastic cell membranes and the tips of the 
microvilli of uterine luminal eptithelial cells is evident by days 19 to 20 of gestation 
(Guillomot 1995). Maternal recognition of pregnancy and different phases of blastocyst 
implantation are shown in figure 2.12. To facilitate adhesion of the conceptus, 
remodeling of the uterine endometrial extracellular matrix (ECM) is necessary 
(MacIntyre et al., 2002; Yamada et al., 2002b). ECM proteins in the uterine 
endometrium includes several proteins namely types I and IV collagen, laminin and 
fibronectin (MacIntyre et al. 2002, Yamada et al. 2002). Coordinated production of 
matrix metalloproteinases (MMPs) by the conceptus and the production of tissue 
inhibitors of MMPs (TIMPs) by the endometrium are also reported (Salamonsen et al. 
1995). Among the several proteins those are involved with adhesion of the 
trophectoderm to the luminal epithelium of the uterus, the most important are integrins 
which play a dominant role in the interaction with the ECM to convey cellular signals 
between the conceptus trophectoderm and uterine epithelial cells (MacIntyre et al. 
2002). The adhesion stage is usually characterized by firm adhesion between the 
conceptus and luminal epithelium, which begins between days 21 to 22 of bovine 
gestation (Guillomot 1995) and is completed by day 27 (King et al. 1980). Once cellular 
contact is established between the trophectoderm and luminal epithelium, IFNt gene 
expression drops immediately down (Guillomot et al. 1990). This attachment is 
transient and it is replaced within a few days by a more robust adhesion in the glandular 
intercaruncular region between the trophoblast and luminal epithelium, called an areolae 
(Guillomot 1995, Spencer et al. 2004). These areolae are specialized areas within the 
intercaruncular placenta that form openings of gland ducts on the surface of the luminal 
epithelium (Guillomot 1995). Syncytial plaque formation in the uterine epithelium 
during implantation is facilitated by the migration and fusion of the trophoblastic 
binucleate cell (BNC) with uterine cells (Wooding 1983).  
 
Binucleate cells are responsible for the formation of the hybrid feto-maternal syncytia, 
allowing for successful implantation and subsequent cotyledonary growth of the 
placentome (Spencer et al. 2007). Binucleate cells- a specialized group of cells in 
ruminants that are produced by nuclear division of uninucleate trophoblast cell without 
cytoplasmic division. These cells are responsible for the simultaneous production and 
paracrine secretion of proteins and growth factors at the materno-fetal interface (Kessler 
and Schuler 1997). About 20 % of the surface of the trophectoderm comprises 
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binucleate cells (BNC) (Xie et al. 1997), which migrate through adjacent cell tight 
junctions and across the microvillar junction to reach the maternal luminal epithelium. 
They fuse with maternal epithelial cells forming a multicellular complex (Wooding 
1983). In the bovine, this migration is maximal at approximately d 24 of gestation, but 
remains functional throughout gestation (Wooding, 1983). The process of migration and 
attachment of the BNC is a relatively undefined process but appears to involve such 
factors as glycoprotein CD9 and fertilin (Xiang and MacLaren 2002). Secretion from 
BNC includes members of the growth hormone/prolactin family, including: chorionic 
somatomommotropin 1 (CSH1; also know as placental lactogen), several prolactin-
related proteins (PRP; -I, -VII, -VIII and -IX) and members of the aspartic proteinase 
family called pregnancy associated glycoproteins (PAGs; also known as pregnancy 
specific proteins B) (Spencer et al. 2007). These factors are placental specific hormones 
that are not synthesized or secreted by any other endocrine gland (Anthony et al. 1995). 
In the bovine, mRNA for CSH1 is detected between days 26 to 30 of gestation and 
increases throughout gestation, however PRP-1 mRNA expression begins between days 
20 to 25 of gestation, is of maximal concentration at day 60 of gestation and decreases 
thereafter (Yamada et al. 2002). Placental CSH1 binds to prolactin homodimer and 
prolactin/growth hormone heterodimer receptors in the glandular epithelium and 
stimulates uterine gland growth and/or differentiated functions during pregnancy 
(Spencer et al. 2007). 
 
Maternal recognition of pregnancy and subsequent implantation is largely dependent on 
steroidogenic balance and specific transcriptional activities. So there is a strong 
possibility for the miRNAs to be involved in such mechanism, since miRNAs 
dependent regulation of steroidogenesis and steroidogenic control of miRNAs 
biosynthesis has already been evidenced as discussed in the literature on ovary. The 
receptivity of uterus during blastocyst implantation is achieved through transition from 
elevated estrogen dependent highly proliferative state to progesterone dependent highly 
secretory state. miRNAs could also be involved in implantation process via uterine 
changes through regulating or interfering the post transcriptional and translational 
activity of vast number of genes. Supported studies suggest that miRNAs participate in 
regulating dynamic changes in uterine gene expression patterns that occur during the 
transition from the pre-receptive to the receptive phase and miRNAs mediated 
regulation of uterine gene expression in the context of implantation is evidenced 
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(Chakrabarty et al. 2007). Hence, it clear that miRNAs potentially regulate gene 
expression and participate in directing the highly regulated spatiotemporally expressed 
genetic network during implantation (Chakrabarty et al. 2007). In addition, several 
studies have already reported the regulation of miRNAs in the endometrium by the 
ovarian steroid (Macias et al. 2009, Pan et al. 2007, Toloubeydokhti et al. 2008b). 
Further, in vitro gain- and loss-of-function experiments showed that the expression of 
cyclooxygenase-2, a gene critical for implantation, is post-transcriptionally regulated by 
two miRNAs namely, mmu-miR-101a and mmu-miR-199a* (Chakrabarty et al. 2007). 
Another study has identified higher expression of miR-21 in the subluminal stromal 
cells at implantation sites on day 5 of pregnancy but not detected during pseudo-
pregnancy or even under delayed implantation (Hu et al. 2008). This revealed that the 
expression of mmu-miR-21 in the implantation sites regulated by the active blastocysts. 
Moreover, in the same study, the role of miR-21 in embryo implantation has been 
suggested due to targeted regulation of the Reck gene (Hu et al. 2008). The topic 
becomes interesting when it is identified that miRNAs could be released in the extra 
cellular environment and functioning (Chim et al. 2008, Luo et al. 2009). So, there is a 
possibility that miRNAs in regulating extra cellular signaling network as like as 
interferon tau and other associated molecules during the maternal recognition of 
pregnancy in the pre attachment period. However, relevant study to identify such 
involvement is still remaining to be elucidated. 
 
2.7 miRNAs in the development and physiology of placenta 
 
The development of the early embryos and placentas in bovine is markedly different 
from primates and rodents. Human blastocyst gets implanted to the uterus at day 5-7 
while in mouse implantation occurs at day 4 of gestation (Paria et al. 2001, Vigano et al. 
2003). The bovine placenta is characterized as chorioallantoic type and by structures or 
by developmental patterns it is different in comparison to human or mouse. 
Development of the bovine placenta is dependent on proper gastrulation during 
extended pre-attachment period, which gives rise to the development of the germ layers 
(endoderm, mesoderm and ectoderm), concomitant trophoblast elongation and the 
subsequent development and vascularization of the allantois (Maddox-Hyttel et al. 
2003). The hypoblast cells or primitive endoderms are formed from the ICM and 
confluent hypoblast cells are lining the inside of the trophoblast occurs around day-8 
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and day-10, respectively. Epiblast (ICM at day12) displaces the overlying trophoblast 
lining (Rauber’s layer) and develops the embryonic disk. Later on between days 14 and 
16 mesoderm formation is initiated (Maddox-Hyttel et al. 2003). Trophoblast cells 
together with the somatic mesoderm form the chorion successively. Folds of 
trophectoderm cells fuse with the somatic mesoderm and form the amnion that create a 
fluid-filled space and surrounds the embryo proper. During the progress of the embryo 
to develop into a fetus, an out pocketing of the hindgut extends from the fetus into the 
loose tissues of the splanchnic mesoderm forming the allantois at around day 20. The 
allantois is responsible for vascularizing the chorion and amnion. The allantois expands, 
becomes directly apposed to the chorion and the two tissues fuse to form the 
chorioallantois. Together with the amnion these tissues form the extra-embryonic fetal 
membranes, refereed to as the placenta (Schlafer et al. 2000). The early placenta when 
comes in contact with maternal caruncles, it induces villous processes undergo 
hypertrophy and hyperplasia and subsequently forms cotyledons. Small villi or papillae 
develop on the regions of the trophoblast that are apposed to the intercaruncular 
endometrium and project into the openings of the uterine glands (Wooding et al. 1982). 
These villi allow for a primary route for absorption of glandular secretions and provide 
an initial anchor for the conceptus as well. During this period in the luminal surface of 
the uterine caruncles are found to become wrinkled and concave to allow the ridged 
surface of the trophoblast to align with the undulated surface of the caruncle (Guillomot 
1995). This is the initial development of the placentome, which is the site of fusion of 
the placental cotyledons with the endometrial caruncles (Spencer et al. 2004). By day 42 
fused placental cotyledons with endometrial caruncles are progressed to form larger and 
complex placentomes (Noden and De Lahunta 1985). Placentomes with extensive 
villous formation are the primary site of transport for easily diffusible molecules such as 
amino acids, glucose, oxygen and carbon dioxide, while macromolecules are 
transported in the inter placentomal areas adjacent to uterine glands (Wooding and Flint 
1994).  
 
Regarding involvement of miRNAs in the process of placentogenesis is yet to be 
discovered in detail. However, complex physiological process and multitude of gene 
expression in the placentation and function indicates that miRNAs could be involved to 
play a pivotal role as they are found to be important regulator in many other cellular 
processes. Recently some sporadic attempts were taken to study miRNAs during 
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pregnancy, prostaglandin regulation and patho-physiological condition of women 
placenta. First demonstration was to study the existence of human placental miRNAs in 
maternal plasma and their  stability through out with physical nature by TaqMan 
MicroRNA Assays (Chim et al. 2008). Interestingly, 4 most abundant placental 
miRNAs (miR-141, miR-149, miR-299-5p and miR-135b) were detected in the maternal 
plasma during pregnancy and found to be reduced expression in post-delivery plasma. 
The plasma concentration of miR-141 has been found to increase as pregnancy 
progressed into the third trimester. Compared with mRNA encoded by CSH1 [chorionic 
somatomammotropin hormone 1 (placental lactogen)], miR-141 was stable in maternal 
plasma (Chim et al. 2008). This initial evidence indicates that miRNAs are involved in 
the regulation of placental functions and pregnancy. Another study was performed by 
small RNA library sequencing and miRNA histochemistry using human placental 
chorionic villi to identify miRNA expression profiles in the human placenta (Luo et al. 
2009). The miRNA cluster genes were observed to be differentially expressed in 
placental development and further revealed that villous trophoblasts express placenta-
specific miRNAs. In addition, analysis of small RNA libraries from the blood plasma 
showed that the placenta-specific miRNAs are abundant in the plasma of pregnant 
women and the rapid clearance of the placenta-specific miRNAs from the plasma after 
delivery. It has been also demonstrated that miRNAs are indeed extracellularly released 
via exosomes while studied trophoblast cell line cultured in vitro (Luo et al. 2009). The 
study has been suggested that miRNAs are exported from the human placental 
syncytiotrophoblast into maternal circulation, where they could target maternal tissues. 
This result interestingly coincides with the previous study (Chim et al. 2008) and 
placental miRNAs has been identified to enter into maternal circulation. These data 
provide initial evidence and important insights into miRNA biology of the human 
placenta. Growth and differentiation of the placenta are fundamental to mammalian 
reproduction, including humans and functional impairment of this organ by 
misregulation of miRNAs could lead to severely abnormal pregnancies as well as other 
associated diseases. For instance, miRNAs were found as differentially regulated in the 
placenta with severe pre-eclampsia when compared to normal one (Hu et al. 2009). Pre-
eclampsia (PE) is usually caused by poor placentation with impaired remodeling of the 
spiral arteries. It has been found that miR-16, miR-29b, miR-195, miR-26b, miR-181a, 
miR-335 and miR-222 were significantly increased in placenta from women with severe 
PE (Hu et al. 2009). This suggests that different miRNAs may play an important role in 
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pathogenesis of PE. Investigation to elucidate the importance of miRNAs in regulation 
of placental development and function is just at the beginning. Whatever involvement 
identified in human even though it is very few, in case of ruminants it is untouched and 
could be an interesting field of investigation.   
 
2.8 miRNAs and abnormal placentogenesis in the IVP and SCNT pregnancy 
 
There have been many problems associated with the effect that nuclear transfer has on 
the normal development of the cloned animal. By far, the most commonly reported 
theme of deformity is that of placental development. Following sections describe and 
highlight some commonly observed abnormalities, transcriptional aberration and 
abnormal epigenetic modification found to arise in the placenta from IVP and SCNT 
pregnancies together with probable involvement of miRNAs and problem statement. 
 
2.8.1 Abnormal placentogenesis in the SCNT pregnancy 
 
It has been well recognized that animals produced via SCNT method exhibit a wide 
range of placental abnormalities that result in a substantial loss of live births, the birth 
of deformed offspring and an inordinate amount of stress on the recipient animal. 
Abortion throughout gestation and perinatal death of cloned calves has been attributed 
to such placental abnormalities noted after nuclear transfer. Placental anomalies have 
been reported in many studies with some of the more common pathologies include, but 
are not limited to, lack of adventitial placentation, lower number of placentomes, thick 
and oversized placentomes, edematous membranes, edematous amnion, edematous 
chorioallantois, intercotyledonary edema (Hill et al. 1999), retarded allantoic growth 
(Wells et al. 1999), hydroallantois, decreased vascularization, decreased number of 
cotyledons and binucleate cells, enlarged umbilical vessels (Wells et al. 1999) and 
increased cotyledonary size and cell numbers (Batchelder et al. 2005, Chavatte-Palmer 
et al. 2002, Cibelli et al. 1998, Hashizume et al. 2002, Heyman et al. 2002, Hill et al. 
2000, Hill et al. 2001, Hoffert et al. 2005, Ravelich et al. 2004a, Stice et al. 1996, 
Zakhartchenko et al. 1999). Many of the failed pregnancies abort during the middle of 
the first trimester, around day 40 (Hill et al. 1999, Stice et al. 1996), even though the 
fetus appears to be developing in a normal manner (Wells et al. 1999). Major causes for 
the mentioned placental abnormalities are thought to be due to aberrant gene expression, 
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imprinting loses and defective epigenetic modification resulted from donor cell nuclear 
reprogramming error by the oocyte cytoplasm. Primary findings related to this field are 
discussed bellow. 
 
2.8.2 Aberrant gene expression in the placenta of different sources of pregnancies 
 
Abnormal gene expression has been noted in cloned mouse and bovine fetuses and 
placenta. Dysregulated gene expression has been identified in the placentas or 
placentomes of cloned bovine fetuses as early as day 25 and throughout gestation to 
term by several studies (Hashizume et al. 2002, Hill et al. 2002). At the protein level, 60 
proteins were found to be differentially expressed in term placentas of cloned calves 
compared with fertilized controls (Kim et al. 2005). Abnormal expression of over 200 
genes was noted in cloned mouse placentas (Humpherys et al. 2002). Further support 
for dysfunctional placental development in clones comes from the recent study (Jouneau 
et al. 2006), which showed that the majority of the cloned mouse embryos die before a 
functional placenta can develop. Elevated interferon tau expression was detected in one 
study from bovine cloned embryos (Wrenzycki et al. 2001). Major histocompatibility 
complex I expression has been detected abnormally early in cloned bovine embryos and 
fetuses and has indicated immunologic rejection by the recipient as a possible cause of 
early embryonic death (Hill et al. 2002, Pfister-Genskow et al. 2005). Insulin-like 
growth factor binding proteins 2 and 3 showed increased expression in the 
extraembryonic membranes of bovine nuclear transfer fetuses (Ravelich et al. 2004a). 
Examination of gene expression patterns in bovine placentomes collected from SCNT, 
IVF and AI pregnancies demonstrates gross abnormalities in gene expression associated 
with SCNT cloning (Everts et al. 2008, Oishi et al. 2006). Finally, when gene 
expression in cloned mice derived from nuclei of different cell types was examined 
(Humpherys et al. 2002), some cell type-specific effects were seen, but most of the 
abnormalities in cloned mice were independent of donor cell type and seemed to be a 
consequence of the nuclear transfer procedure. Moreover, a comparison of the effects in 
placenta and liver of cloned pups demonstrated that the placental effect is especially 
pronounced, with at least 4% of genes expressed in the placenta showing dysregulation. 
Aberrant placental lactogen, pregnancy-associated glycoprotein, leptin levels and 
heparanase levels were noted in the placental tissues derived from cloned bovine 
pregnancies (Hashizume et al. 2002, Ravelich et al. 2004b). These studies have 
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indicated widespread abnormalities in gene expression from both fetal and placental 
tissues of cloned offspring. The common occurrence of aberrant gene expression in 
early SCNT cotyledons compared to cotyledons from artificial insemination derived 
pregnancy (Aston et al. 2009). In particular, most aberrant expression was found for the 
imprinted transcripts in SCNT placenta compared to AI placenta. These issues are 
discussed detail in the following section. 
 
2.8.3 Aberrant epigenetic reprogramming and genomic imprinting in the placenta from 
SCNT pregnancies 
 
Epigenetic process is the heritable differences in gene function and expression leading 
to phenotypic differences which cannot be explained by the DNA sequence itself (Smith 
and Murphy 2004, Wolffe and Matzke 1999, Wu and Morris 2001). Cellular 
development and function may be affected by changes in epigenetic processes altering 
gene expression (Smith and Murphy 2004). Abnormal epigenetic mechanisms including 
aberrant DNA methylation, X-chromosome inactivation and histone modification have 
been shown to be associated with cloned placenta. It is obvious that gene expression 
patterns affected by epigenetic processes may not be correctly reestablished after 
nuclear transfer. After SCNT chromatin structure and transcriptional activity of donor 
nuclei must revert to that of an early one-cell embryo after nuclear transfer in order to 
direct embryonic development. This process is known as nuclear reprogramming and 
essentially involves both morphological and biochemical changes (Di Berardino 1997, 
Kikyo and Wolffe 2000, Sun and Moor 1995). In mammals, nuclear remodeling after 
nuclear transfer has been recognized as chromatin condensation, nuclear envelope 
breakdown and the formation of a pronuclear-like structure that undergoes swelling and 
transferred nucleus tends to behave more like that of early stage embryos (Adenot et al. 
1997, Baran et al. 2002, Collas and Robl 1991, Czolowska et al. 1984, Hyttel et al. 
2001, Kanka et al. 1991, Prather et al. 1990, Stice and Robl 1988, Szollosi et al. 1988). 
Transcription from the donor nucleus is normally ceased after nuclear transfer during 
nuclear remodeling, but reappeared later on during genomic activation at 8- to 16- cell 
stage (Kanka et al. 1991, Kim et al. 2002). Protein and lamin expression have been 
reported to change after nuclear transfer in mammalian studies (Kubiak et al. 1991, 
Prather et al. 1989, Prather et al. 1991, Prather and Rickords 1992). Nuclear transfer 
bovine embryos were found to be absent of immunoreactive somatic histone H1 after 
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nuclear transfer and then reappeared at the time of genomic activation in bovine 
embryos (Bordignon et al. 1999). Epigenetic alterations of the genome are found to be 
occurred primarily by histone modification and DNA methylation (Smith and Murphy 
2004) and affecting critical developmental processes, namely genomic imprinting, X-
chromosome inactivation and gene expression.  
 
DNA methylation involves the addition of a methyl group to the 5th position of the 
cytosine pyrimidine ring or the number 6 nitrogen of the adenine purine ring (cytosine 
and adenine are two of the four bases of DNA with the specific effect of reducing gene 
expression. Changes in embryo-wide DNA methylation patterns and global DNA 
methylation levels were also reported in association with adverse preimplantation 
development (Cezar et al. 2003, Hiendleder et al. 2004). In cloned mice, individual 
clones showed differing aberrant methylation patterns of CpG islands in placental 
tissues (Ohgane et al. 2001). Elevated methylation levels were found in cloned bovine 
embryos (Dean et al. 2001, Santos et al. 2003). It has been found that an initial 
demethylation of the donor nucleus takes place immediately after transfer but no further 
demethylation during early embryogenesis followed by precocious de novo methylation 
at the 8-cell stage (Dean et al. 2001). Demethylated euchromatin and hypermethylated 
heterochromatin in cloned bovine embryos has also been reported (Bourc'his et al. 
2001). The methylation of the ninth lysine residue on histone H3 has been shown to 
correlate with the pattern of DNA methylation in cloned bovine embryos with abnormal 
elevation and altered histone acetylation levels in many of the cloned embryos and 
placenta (Enright et al. 2003, Santos et al. 2003). 
 
X-inactivation is a process by which one of the two copies of the X chromosome 
present in female mammals is inactivated. The inactive X chromosome is silenced by 
packaging into transcriptionally inactive heterochromatin. X-inactivation occurs so that 
the female, with two X chromosomes, does not have twice as many X chromosome 
gene products as the male, which only possess a single copy of the X chromosome. In 
cattle, X-chromosome inactivation was found to be abnormal (Xue et al. 2002). Random 
X-inactivation in the placental tissues cloned calves and abnormal methylation as well 
as altered expression patterns of X-linked genes were observed (Gutierrez-Adan et al. 
2000, Niemann et al. 2002, Wrenzycki and Niemann 2003, Wrenzycki et al. 2005). In 
contrast, surviving cloned calves were found to have normal X-linked gene expression 
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patterns (Xue et al. 2002). Just as X-chromosome dosage compensation can be impaired 
in cloned offspring, histone modification patterns may be abnormal in cloned embryos. 
Genomic imprinting is a genetic phenomenon by which certain genes are expressed in a 
parent-of-origin-specific manner. It is an inheritance process independent of the 
classical Mendelian inheritance. Imprinted genes are either expressed only from the 
allele inherited from the mother (e.g. H19 or CDKN1C), or in other instances from the 
allele inherited from the father (e.g. IGF-2) through DNA methylation and histone 
modifications in order to achieve monoallelic gene expression without altering the 
genetic sequence. Nuclear transfer and inadequate in vitro culture conditions leading to 
improper genetic reprogramming which results in improper establishment of imprinting 
at the regulatory imprinting centers during the critical period of pre implantation and 
later on, such errors are affecting placental development. Sequences associated to the 
control of the imprinted genes H19 and Snprn have been found to be demethylated in 
cloned mouse embryos (Mann et al. 2003). Investigations on imprinted gene expression 
in bovine and ovine fetuses derived from IVP and SCNT have been suggested that 
improper genomic imprinting. Examination of gene expression patterns in the placentas 
of cattle, sheep and mice produced using in vitro culture procedures demonstrated 
altered expression of imprinted (Bertolini et al. 2002, Blondin et al. 2000, Doherty et al. 
2000, Wrenzycki et al. 2004, Young et al. 2001) and autosomal non-imprinted genes 
(Ravelich et al. 2004a, Ravelich et al. 2006, Wrenzycki et al. 2004). Adult cloned 
animals were generally considered to be normal when analyzed for epigenetic changes, 
suggesting that perhaps only the most epigenetically normal embryos survive to 
adulthood (Cezar et al. 2003, Ohgane et al. 2001). These studies all indicate that 
widespread chromatin remodeling, modification of DNA methylation and histone 
modification occurs during nuclear reprogramming which could be the primary reason 
for abnormal placentogenesis leading to the loss of cloned embryos. 
 
2.8.4 miRNAs in the placenta from SCNT pregnancy in relation to its aberrant genetic 
and epigenetic modification 
 
According to the aforesaid reviews, it is completely evident that the placental 
deformities are a major hindrance in the production of nuclear transfer animals. So, 
studying the important factor which is involved in regulating aberrant genetic and 
epigenetic gene regulation, reprogramming errors, aberrant genomic imprinting and in a 
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word the genetic or epigenetic modification associated to the abnormal placentogenesis 
in somatic cell nuclear transfer pregnancies is paramount important. As mentioned, key 
mechanisms underlying this epigenetic reprogramming are DNA methylation, histone 
remodeling and telomere maintenance, which are involved in the control of gene 
expression, X chromosome inactivation and genomic imprinting (Holmes and Soloway 
2006, Li et al. 1993, Perecin et al. 2009). Interestingly, all mechanisms are not 
contributing equally to the embryonic and extra-embryonic lineage (McGrath and Solter 
1984, Oudejans et al. 1997, Surani et al. 1984, Wagschal and Feil 2006). Specially, 
genomic imprinting has been shown to be less or not dependent on DNA methylation in 
the placenta for its somatic maintenance than in the embryo. Rather, placenta-specific 
imprinting involves repressive histone modifications and non-coding RNAs (Brockdorff 
2002, Higashimoto et al. 2002, Lewis et al. 2004, Li et al. 1993, Sado et al. 2000, Sado 
and Ferguson-Smith 2005, Yatsuki et al. 2004). When considering non-coding RNAs, 
then miRNAs a recently discovered class of small RNAs appeared as first and foremost 
epigenomic tool or modifier that regulate gene expression epigenetically at the post-
transcriptional or transcriptional level and were found to play important roles including, 
but not restricted to, cell proliferation, apoptosis, diseases and differentiation during 
mammalian development (Ambros 2004, Bartel 2004, Kloosterman and Plasterk 2006). 
So, miRNA could be consider as an important regulatory factor directly link to 
mentioned aberrant molecular mechanisms for genetic and epigenetic modification. 
They were found to be targeted by epigenetic modification and eventually controlling 
epigenetics and some imprinted miRNAs found to undergo subsequent epigenetic 
reprogramming in mouse embryos (Cui et al. 2009, Kircher et al. 2008, Williams et al. 
2007). Many of the miRNAs have been predicted and found to have pivotal roles in 
controlling DNA methylation, regulating chromatin structure and controlling telomere 
recombination (Benetti et al. 2008a, Benetti et al. 2008b, Fabbri et al. 2007, Guil and 
Esteller 2009, Lewis et al. 2005, Lujambio and Esteller 2007, Ting et al. 2008, Valeri et 
al. 2009). Interestingly, they could be imprinted like genes and many of X-linked 
microRNAs escape meiotic sex chromosome inactivation (Kanellopoulou et al. 2009, 
Song et al. 2009).   
 
Recent epigenetic regulation by the miRNAs has opened up a new dimension of mode 
of regulation from translational suppression and classic RNAi degradation. In addition 
to regulation of gene expression at the posttranscriptional level in the cytoplasm, recent 
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findings suggest additional roles for miRNAs in the nucleus. MiRNAs which are 
encoded within the promoter region of genes could be involved in silencing such genes 
at transcription level epigenetically. Such cis-regulatory roles of miRNAs have been 
observed in transcriptional silencing of POLR3D expression and endothelial nitric oxide 
synthase (eNOS) promoter activity (Kim et al. 2008, Zhang et al. 2005). Recently, 
aberrant epigenetic reprogramming of imprinted miR-127 in cloned murine embryos 
has been reported in relation to the aberrant epigenetic reprogramming of the mouse 
retrotransposon-like gene Rtl1 (a key gene in placental formation) (Cui et al. 2009). 
Moreover, the miRNA has been recognized as an important regulator of genetic and 
epigenetic modifier but study on their role in the well recognized aberrant genetic and 
epigenetic mechanism associated to malformation or abnormal development of placenta 
in somatic cell nuclear transfer pregnancies is missing. Thereby, very little or no 
information are available about the specific miRNA and their targets to regulate 
epigenetic machinery or epigenetic regulation of specific miRNAs that are required for 
normal physiological condition or for any phenotypic effects of placenta derived from 
SCNT pregnancies. Considering this important facts, part of the present study has been 
conducted to identify the expression, regulation or deregulation if there is, in the 
placenta derived from in vitro, SCNT pregnancies compared to that in vivo pregnancies 
as well other associated molecular mechanisms.  
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3 Part I: miRNAs in the bovine ovary 
 
Follicular development begins with the establishment of a finite pool of primordial 
follicles, which culminates in either by the atretic degradation or release of a mature 
oocyte from the follicle. Entire process is governed by numerous intra-ovarian factors 
through complex mechanisms including transcriptional regulation which could be 
regulated by recently identified new class of non-coding small RNAs of ~22nt i.e. 
miRNAs. Most miRNAs in animals are thought to function through the inhibition of 
effective mRNA translation of target genes through base pairing with the 3´-untranslated 
region. They are already proved as one of the key transcriptional regulators in different 
biological processes for disease, development and fertility. But their presence & 
expression in bovine ovary has not yet determined. The present study was conducted 
with a view to discover distinct miRNAs in bovine ovary as well as to find out their 
pattern of expression and characteristics. 
 
To identify miRNAs in bovine ovary, small RNA-cDNA library was constructed. For 
this purpose, total RNA enriched with small RNA was isolated from ovary and size 
fractionated (18-24 nt) by denaturing PAGE using 21nt size marker. Once the enriched 
small RNA fraction has been recovered from the acrylamide gel slice, the small RNAs 
were ligated with a 3´ linker and containing a Ban-I restriction site, which upon 
purification from dPAGE again, were subjected to reverse transcription. At this point an 
exonuclease digestion was carried out and then a second 3´ ligation was done using a 
different linker sequence. Linkered product (60 nt) was purified from dPAGE and 
subsequently, the amplification of the RT product was done. Then the amplicon was 
subjected to Ban I digestion, concatemerization, end filling and non-templated 
adenosine addition for serially ligated fragments. Concatemers were later on cloned in 
to PCR cloning vector and transformed into TOP 10 chemically competent cells. 
Colonies were picked and sequenced. Bioinformatic analysis was done according to the 
published criteria’s for the small RNAs by means of publicly available web tools. In 
addition, bioinformatic characteristics, target prediction, molecular mechanisms 
including different pathways and functions of the predicted targets and expression 
patterns of the identified miRNAs in other reproductive tissues and cells were studied. 
Detail materials and methods used for this study and the findings obtained thereafter in 
the study are presented below. 
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3.1 Material and methods 
 
3.1.1 Materials and tools 
 
3.1.1.1 List of chemicals, kits, biological and other materials 
 
List of Chemicals, kits and other 
materials 
Manufacturer/Supplier 
1-STEP NBT/BCIP Thermo Fisher Scientific Inc. IL, USA 
2- Propanol Roth, Karlsruhe, Germany 
5-Bromo-4-chloro-3-inolyl-
phosphate (BCIP) 
AppliChem GmbH, Darmstadt, Germany 
Acetic acid Roth, Karlsruhe, Germany 
Agar-Agar Roth, Karlsruhe, Germany 
Agarose Sigma-Aldrich Chemie GmbH, Munich, Germany 
Ammonium acetate Sigma-Aldrich Chemie GmbH, Munich, Germany 
Ammonium peroxide sulphate Roth, Karlsruhe, Germany 
Ampicillin Roth, Karlsruhe, Germany 
Anti-Digoxigenin-AP Roche Diagnostics GmbH, Mannheim, Germany 
Ban I restriction endonuclease New England Biolabs, MA, USA 
BioThermD™ Taq DNA Pol Ares Bioscience GmbH, Cologne, Germany 
Bovine serum ablbumin (BSA) Promega, Mannheim, Germany 
Bromophenol blue Roth, Karlsruhe, Germany 
Chloroform Roth, Karlsruhe, Germany 
dNTPs Roth, Karlsruhe, Germany 
Dye terminator cycle sequencing Beckman Coulter, Krefeld, Germany 
Ethidium bromide Roth, Karlsruhe, Germany 
Ethylenediaminetetraacetic acid Roth, Karlsruhe, Germany 
ExoSAP-IT USB, Ohio, USA 
Fast Red Substrate System Dako Deutschland GmbH, Hamburg, Germany 
Fish sperm DNA Roche Diagnostics GmbH, Mannheim, Germany 
Formaldehyde Sigma-Aldrich Chemie GmbH, Munich, Germany 
GelStar® Nucleic Acid Stain Lonza Bioscience, Köln, Germany 
GenEluteTM plasmid Miniprep kit Sigma-Aldrich Chemie GmbH, Munich, Germany 
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Glycogen MBI Fermentas GmbH, Leon-Rot, Germany 
Glycogen for sequencing Beckman Coulter, Krefeld, Germany 
Heparin Sigma-Aldrich Chemie GmbH, Munich, Germany
Isopropyl β-D-thiogalactoside IPTG Roth, Karlsruhe, Germany 
Levamisol Sigma-Aldrich Chemie GmbH, Munich, Germany
Methylsalicylate Sigma-Aldrich Chemie GmbH, Munich, Germany
MiniEluteTM reaction cleanup kit Qiagen, Hiden, Germany 
miRCat-33TM Conversion Oligo  Integrated DNA Technologies, Munich, Germany 
miRCatTM Small RNA Cloning Kit Integrated DNA Technologies, Munich, Germany 
miRCURY™ LNA Detection probe Exiqon, Vedbaek, Denmark 
mirVana miRNA isolation kit Applied Biosystems, Foster City, CA, USA 
miSPIKE internal RNA control Integrated DNA Technologies, Munich, Germany 
Oligonucleotide primers Eurofins MWG Operon, Ebersberg, Germany 
One Shot® TOP10 E. coli Invitrogen, Carlsbad, CA,USA 
Penicillin Sigma-Aldrich Chemie GmbH, Munich, Germany
Performa® DTR Gel Filtration Edge BioSystems, Maryland, USA 
Permount* Mounting Medium Fisher Scientific GmbH, Schwerte, Germany 
Phenol:Chl:Isoamyl Alcohol Invitrogen, Carlsbad, CA, USA  
Poly(A) Tailing Kit Ambion Inc, Austin, TX, USA 
QIAquick Gel Extraction Kit Qiagen, Hiden, Germany 
QIAquick PCR purification kit Qiagen, Hiden, Germany 
Ribo-nuclease inhibitor (RNasin) Promega, Mannheim, Germany 
RNA later Sigma-Aldrich, MI, USA 
RNAse-OUTTM Invitrogen, Carlsbad, CA, USA 
RNeasy mini kit Qiagen, Hiden, Germany 
Sample loading solution (SLS) Beckman Coulter, Krefeld, Germany 
Sequagel XR Sequencing Gel Beckman Coulter, Krefeld, Germany 
Sheep serum Sigma-Aldrich Chemie GmbH, Munich, Germany
Sodium acetate Roth , Karlsruhe, Germany 
Sodium pyruvate Sigma-Aldrich Chemie GmbH, Munich, Germany
SuperScript™ III RT  Invitrogen, Carlsbad, CA, USA  
T4 DNA ligase Promega, Mannheim, Germany 
TOPO TA Cloning® vector Invitrogen, Carlsbad, CA, USA 
Tris Roth , Karlsruhe, Germany 
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Triton X-100 Roche Diagnostics GmbH, Mannheim, Germany 
Vectashield Mounting Medium  Vector Laboratories, Inc. Burlingame, CA USA 
Vector Methyl green nuclear  Vector Laboratories, Inc. Burlingame, CA USA 
X-Gal (5-bromo-4-chloro-3-
indolylbeta-D-galactopyranoside) 
Roth, Karlsruhe, Germany 
Yeast tRNA Invitrogen, Carlsbad, CA, USA  
 
3.1.1.2 List of equipments 
 
ABI PRISM® 7000 SDS Applied Biosystems, Foster City, CA, USA
Agilent 2100 bioanalyzer Agilent Technologies , CA, USA 
ApoTome microscope Carl Zeiss MicroImaging, Germany 
Centrifuge Hermel, Wehing 
CEQ 8000 genetic analysis apparatus Beckman Coulter, Brea, CA, USA 
Confocal laser scanning microscope-510 Carl Zeiss, Germany 
Electrofusion machine, CFA 400 Kruess, Hamburg, Germany 
Electrophoresis unit (for agarose gels) BioRad, Munich, Germany 
Fluorescence microscope (DM-IRB) Leica, Bensheim, Germany 
Inverted fluorescence microscope DM IRB Leica, Bensheim, Germany 
Millipore apparatus Millipore Corporation, USA 
My Cycler Thermal cycler Bio-RadLaboratories, CA, USA 
NanoDrop 8000 spectrophotometer NanoDrop, Wilmington, Delaware, USA 
Power supply PAC 3000 Biorad, Munich, Germany 
PTC-100 thermal cyclers BioRad, Munich, Germany 
Savant SpeedVac GMI, Inc. Minnesota, USA 
SHKE6000-8CE refrigerated Shaker Thermoscinentific, IWA, USA 
Spectrophotometer, Ultrospec™ 2100 pro  Amersham Bioscience, Munich, Germany 
Stereomicroscope SMZ 645 Nikon, Japan 
Tuttnauer autoclave Conn. unlimited, Wettenberg, Germany 
Ultra low freezer (-85 °C) Labotect GmbH, Gottingen, Germany 
UV Transilluminator (Uvi-tec) Uni Equip, Martinsried, Germany 
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3.1.1.3 List of softwares 
 
BLAST cow sequences  http://www.ncbi.nlm.nih.gov/genome/seq/BlastGen/ 
Blast ncRNA database  http://ncrnadb.trna.ibch.poznan.pl/blast.html  
ENSEMBL genome browser http://www.ensembl.org/index.html 
Entrez Gene  www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene 
Gene Ontology http://www.geneontology.org 
Genomic tRNA database  http://lowelab.ucsc.edu/GtRNAdb/ 
Mfold web server v 3.2 http://frontend.bioinfo.rpi.edu/applications/mfold/  
miRBase Targets Version 5 http://microrna.sanger.ac.uk/targets/v5/ 
miRBase_12.0 http://microrna.sanger.ac.uk/sequences/  
Multiple Sequence Alignment http://searchlauncher.bcm.tmc.edu/ 
Primer Express 2.0  Applied Biosystems, Foster City, CA, USA 
Ribosomal RNA BLAST  http://bioinformatics.psb.ugent.be/webtools/rRNA/  
RNAdb  http://research.imb.uq.edu.au/rnadb/default.aspx  
tRNAscan-SE  http://lowelab.ucsc.edu/tRNAscan-SE  
 
3.1.1.4 Reagents and media preparation 
 
All solutions used in this investigation were prepared with deionised and demineralised 
(Millipore) and where necessary the pH was adjusted with Sodium hydroxide or 
hydrochloric acid. In addition, the solutions or buffers were subsequently filtered 
through 0.2 µ filter and autoclaved at 120°C for 20 minutes where it is necessary. 
Prepared solutions were aliquot in to small volume and stores at desired temperature 
according to the recommendation of suppliers.  
 
Name of the medium/buffer Constituents Amount/
volume
10X PBS                                            : NaCl 8.77 g
 Na2HPO4 1.50g
 NaH2PO4 2.04g
 Water upto 1000.0 ml
1X PBS                                              : 10X PBS 100.0 ml
 DEPC upto 900.0 ml
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10x TBE buffer                                 : Tris base 218.0 g 
 Boric Acid 105.0 g 
 EDTA solution (pH.8.0) 80.0 ml 
 Water upto 2000.0 ml 
Ammonium Persulfate (APS) 10%   : APS 0.12 g 
 H2O 1.2 ml 
40% acrylamide                                : Acrylamide 76.0 g 
 bis-acrylamide 4.0 g 
 Water to final volume of  200.0 ml 
SDS (10%)                                        : Sodium dodecil sulphate 5.0 g 
 Water  100.0 ml 
LB-agar                                             : Sodium chloride 8.0 g 
 Peptone 8.0 g 
 Yeast extract 4.0 g 
 Agar-Agar 12.0 g 
 Sodium hydroxide (40 mg/ml) 480.0 µl 
 ddH2O upto 800.0 ml 
LB-broth                                            : Sodium chloride 8.0 g 
 Peptone 8.0 g 
 Yeast extract 4.0 g 
 Sodium hydroxide (40 mg/ml) 480.0 µl 
 ddH2O upto 800.0 ml 
DEPC-treated water (1000 ml)         : DEPC 1.0 ml 
 Water upto 1000.0 ml 
Lysis buffer (100 μl)                         : Igepal (0.8%) 0.8 μl 
 RNasin 5.0 μl 
 DTT 5.0 μl 
 Water upto 100.0 μl 
TAE (50x) buffer, pH 8.0                 : Tris  242.0 mg 
 Acetic acid   57.1 ml 
 EDTA (0.5 M) 100.0 ml 
 ddH2O upto 1000.0 ml 
TE (1x) buffer                                   : Tris (1 M) 10.0 ml 
 EDTA (0.5 M) 2.0 ml 
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X-gal                                                 : ddH2O upto 1000.0 ml
 X-gal 50.0 mg
PBS + PVA (50 ml)                          : Polyvinyl alcohol (PVA) 
PBS upto 
300.0 mg
50.0 ml
Physiological saline solution            : Sodium chloride 9.0 g
 Water upto 1000.0 ml
Agarose loading buffer                     : Bromophenol blue 0.0625 g
 Xylencyanol 0.0625 g
 Glycerol 7.5 ml
 ddH2O upto 25.0 ml
dNTP solution                                   : dATP (100 mM) 10.0 l
 dCTP (100 mM) 10.0 l
 dGTP (100 mM) 10.0 l
 dTTP (100 mM) 10.0 l
 ddH2O upto 400.0 l
IPTG solution                                    : IPTG 1.2 g
 ddH2O upto 10.0 ml
3M Sodium Acetate, pH 5.2             : Sodium Acetate  123.1 g
 ddH2O upto 500.0 ml
1M EDTA, pH 8.0                            : EDTA 37.3 g
 ddH2O upto 1000.0 ml
1x PBS-Tween (PBST)                     : 1x PBS 999.50 ml
 Tween®20 0.50 ml
SSC (20x)                                          : NaCl 87.65 g
 Sodium citrate 44.1 g
 Water upto 500.0 ml
4% paraformaldehyde (pH7.3)          : Paraformaldehyde 4.0 g
 1X PBS 100.0  ml
0.5M Sucrose/PBS (30% sucrose)    : Sucrose 85.57 gm
 1X PBS upto 500.0 ml
Acetylation solution                          : triethanolamine  2.33 ml
 acetic anhydride  500.0 µl
 DEPC water  upto 200.0 ml
Yeast tRNA (10 mg/ml)                    : Yeast tRNA 25.0 mg
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 DEPC-treated H2O 2.50 ml 
Hybridization solution                      : Formamide -65% 32.25 ml 
 20X SSC -5X 12.5 ml 
 Tn-20- 0.1% 50.0 µl 
 1M citric acid 460.0 µl 
 Heparin 50 µg/ml 2.5 mg 
 10mg/ml tRNA-500µg/ml 2.5 ml 
 DEPC water upto 50.0 ml 
Hybridization wash solution             : Formamide -65% 65.0 ml 
 20X SSC -5X 25.0 ml 
 Tn-20- 0.1% 100.0 µl 
 1M citric acid 1.2 µl 
 DEPC water upto 100.0 ml 
50% Formamide/SSC                       : Formamide 1000.0 ml 
 1X SSC 1000.0 ml 
50% formamide/Tn-20/SSC             : Formamide,  50% 500.0 ml 
 Tween-20, 0.1% 1.0 ml 
 1X SSC 499.0 ml 
5X SSC                                             : 20X SSC 250.0 ml 
 DEPC water 750.0 ml 
2X SSC                                             : 20X SSC 100.0 ml 
 DEPC water 900.0 ml 
1X SSC                                             : 20X SSC 100.0 ml 
 DEPC water 1900.0 ml 
0.2X SSC                                          : 20X SSC 10.0 ml 
 DEPC water 990.0 ml 
1X PBST                                           : 1X PBS 999.0 ml 
 Tween-20 1.0 ml 
Blocking solution                              : 0.5% blocking powder 0.2 g 
 10% inac. Sheep serum 4.0 ml 
 0.1% tween-20 40.0 µl 
 1X PBS upto 40.0 ml 
 dd H2O up to 1000.0 ml 
Stop solution                                     : EDTA 1mM 14.61 mg 
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 PBS pH 5.5 upto 50.0 ml
10N NaOH                                        : NaOH 40 gm
 dd H2O upto 100.0 ml
 
3.1.2 Methods 
 
3.1.2.1 Isolation of Small RNAs and subsequent miRNAs fractionation 
 
Bovine ovaries were obtained from a cyclic heifer with the age of 30 months at a stage 
of mid cycle with a visible mature corpus luteum including normally distributed 
different types of follicles. Small RNA samples from different bovine tissues and cells 
were isolated using mirVana miRNA isolation kit (Applied Biosystems Inc, Foster City, 
CA) according to the manufacturer’s instructions. For cloning, 10 µg of the ovarian 
small RNA was loaded into 12% denaturing poly acrylamide gel electrophoresis with 
size markers miSPIKE (Integrated DNA Technologies, Inc., Iowa, USA) and fractions 
of 18-26 nt were recovered using DTR gel filtration cartridge (Edge BioSystems, 
Maryland, USA). 
 
3.1.2.2 Cloning of small RNAs 
 
For cloning the small RNAs, “5´ Ligation independent Cloning” was followed to ensure 
complete recovery of conventional small RNAs as well as small RNAs with 5´ 
modifications or non-standard 5´ ends. All the linkers and primers were obtained from 
Integrated DNA Technologies, Inc., Iowa, USA. List and sequence of linkers and 
primers are given in table 3.1. Briefly, once the enriched small RNA fraction has been 
recovered from the acrylamide gel slice, the small RNAs were ligated with a 3´ linker - 
adenylated oligos, modified with a 3´-terminal dideoxy-C (ddC) containing Ban-I 
restriction site (Lau et al. 2001). The ligated products were loaded on dPAGE for 
purification and reverse transcription was performed. An exonuclease digestion was 
carried out after first strand cDNA synthesis and then a second 3´ ligation was done 
using a different linker sequences. The second 3´ linkered product (60nt) was purified 
from dPAGE to remove free linkers. Subsequently, the amplification of the RT-PCR 
product was done using linker specific primer set with the thermocycler program of 
95.0ºC for 10 minutes, 35 cycles of (95.0 ºC for 30 seconds, 52.0 ºC for 30 seconds 72.0 
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ºC for 30 seconds) and followed by incubation at 72.0ºC for 5 minutes. Then, the 
amplicon was subjected to Ban I digestion, concatemerization and end filling with non-
template adenosine followed by cloning into TOPO TA Cloning® vector (Invitrogen, 
Carlsbad, CA). Concatemer clones were picked up, cultured and colony PCR was 
performed for screening the insert size. Plasmid DNA preparation and DNA sequencing 
was performed for screened clones and small RNAs which were separated by well 
defined linker units with the reconstituted Ban I site. 
 
3.1.2.3 Bioinformatic analysis of small RNA sequences 
 
The small RNA sequences were first compared with the sequences in miRBase 
(Ambros et al. 2003a, Griffiths-Jones 2004, Griffiths-Jones et al. 2006, Luciano et al. 
2005). Small RNAs completely or partially matched by less than two mismatches to any 
registered miRNA in miRBase were considered putative bovine miRNA. The remaining 
sequences were compared to the bovine nucleotide collection (nr/nt) and the expressed 
sequence tags (EST) database in NCBI (Bettegowda et al. 2008) and different 
noncoding RNA databases (Babiarz et al. 2008, Gonzalez and Behringer 2009, 
Toloubeydokhti et al. 2008a, Watanabe et al. 2005, Yang et al. 2008b). Sequences, 
which were matched 100% to any mRNA, rRNA or tRNA were excluded from further 
evaluation to generate novel miRNA candidates. All the remaining sequences and the 
putative bovine miRNA sequences were submitted to BLAST-search in the Ensembl 52: 
bovine genome assembly (Btau_4.0) (De La Fuente and Eppig 2001) and the 75 bp 
genomic flanking sequence upstream from the 3´ end or downstream from the 5´ end of 
the miRNA was considered putative precursor of the matching miRNA.  
All the putative precursor sequences were analyzed for hairpin structure using the mfold 
Web server (version 3.2) (Goud et al. 1998) to evaluate the ability to form 
thermodynamically stable hairpin structures (Zuker 2003) based on other criteria 
described elsewhere (Ambros et al. 2003a). Chromosome locations, orientation and 
genomic features of the predicted miRNA precursors as well as other small RNAs 
sequences (not meeting miRNAs criteria) and whether they were located in intragenic or 
intergenic genomic regions were determined using ensembl. Other small RNAs were 
categorized according to published research articles (Ambros et al. 2003b, Aravin et al. 
2003, Aravin and Tuschl 2005). 
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3.1.2.4 Detection of miRNAs expression by semi-quantitative RT-PCR  
 
Small RNA samples isolated from the 11 different tissues and cells, such as ovarian 
cortex, fetal ovary at about six month of pregnancy, cumulus cells, matured corpus 
luteum, oviduct (entire), uterus (horn), placenta, heart, liver, lung and spleen were used 
for the detection of miRNAs by PCR method according to Ro et al (Ro et al. 2006) with 
some modifications. In this, the poly (A)-tailed small RNA was purified by acid phenol: 
chloroform: iso-amyl alcohol and ethanol precipitation method. All small RNA-cDNA 
samples were diluted to the same concentration of 6 ng/μl (which was the lowest 
amount obtained from cumulus cells). Three microliters of cDNA was used as template 
for conventional PCR and the products were analyzed on a 2% agarose gel. List of 
primers and oligos used are shown in the table 3.1. Some representative RT-PCR 
products were cloned into PGEM-T easy vector (Promega Corporation, Wisconsin, 
USA) and transformed to E. coli and sequenced to verify the specificity of PCR 
amplification. 
 
Table 3.1: List of oligos and primers used for cloning and detection of miRNAs 
NameA Sequence (5´-3´) Usage 
3´ Linker rAppCTGTAGGCACCATCAAT/3ddC Library 
RT Primer GATTGATGGTGCCTACAG Library 
2nd 3´Linker rAppTGGAATTCTCGGGTGCCAAGGT/ddC Library 
PCR Primer CCTTGGCACCCGAGAATT Library 
M13 Forward GTAAAACGACGGCCAG Sequencing
M13 reverse CAGGAAACAGCTATGAC Sequencing
RTQ1 CGAATTCTAGAGCTCGAGGCAGGCGACATGGCT
GGCTAGTTAAGCTTGGTACCGAGCTCGGATCCAC
TAGTCC(T)25VN 
RT PCR 
RTQ2  GAATTCTAGAGCTCGAGGCAGGCGACATG(T)25VN RT PCR 
RTQ-UNI CGAATTCTAGAGCTCGAGGCAGG RT PCR 
Bta-Let7b TGAGGTAGTAGGTTGTGTGGTT RT PCR 
Bta-miR-15b GTAAACCATGATGTGCTGCTA RT PCR 
Bta-miR-18a ATCTGCACTAGATGCACCT RT PCR 
Bta-miR-29a AACCGATTTCAGATGGTGCTA RT PCR 
Bta-miR-101 TTCAGTTATCACAGTACTGTA RT PCR 
Bta-miR-125b TCACAAGTTAGGGTCTCAGGGA RT PCR 
Bta-miR-126 CGCATTATTACTCACGGTACG RT PCR 
Bta-miR-145 GTCCAGTTTTCCCAGGAATCC RT PCR 
Bta-miR-199a TAACCAATGTGCAGACTACTGT RT PCR 
Bta-miR-222 ACCCAGTAGCCAGATGTAGCT RT PCR 
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Bomir-22/22* ACAGTTCTTCAACTGGCAGCTT RT PCR 
Bomir-140/140* CAGTGGTTTTACCCTATGGTAG RT PCR 
Bomir-143: TGAGATGAAGCACTGTAGCTC RT PCR 
Bomir-152 CCAAGTTCTGTCATGCACTGA RT PCR 
Bomir-193a GGGACTTTGTAGGCCAGTT RT PCR 
Bomir-378 CTGGACTTGGAGTCAGAAGGC RT PCR 
Bomir-382 GAATCCACCACGAACAACTTC RT PCR 
Bomir-409 AGGGGTTCACCGAGCAACAT RT PCR 
Bomir-424 CAAAACGTGAGGCGCTGCTA RT PCR 
Bomir-503 TGCAGTACTGTTCCCGCTGCTA RT PCR 
Bomir-542 TCTCGTGACATGATGATCCCCGA RT PCR 
Bomir-578 TGTGGGTGTGTGCATGTGCGTG RT PCR 
Bomir-652 CACAACCCTAGTGGCGCCATT RT PCR 
Bomir-940 GCAGGGCCCCCGCTCCCC RT PCR 
Bomir-A4052 GGGAGCCTCGGTTGGCCTCGG RT PCR 
Bomir-A3341 GTGGCTGTCCCTGGAGGTGGG RT PCR 
Bomir-C2841 GCCCCGGCCGCTCCCGGCC RT PCR 
Bomir-E2664 AGGGCGGGCGGCGACTGGAA RT PCR 
Bomir-G2511 AGGCGGGCCGGGGTTGGAAGG RT PCR 
Bomir-F2531 TGGTGGAGATGCCGGGGACGT RT PCR 
Bomir-A2143 CGGCAGATGAAGTCCATCGG RT PCR 
Bomir-C1931 CCTGCTGATCTCACATTAATT RT PCR 
Bomir-F1821 AGCCCTGGCCCTGCCATCGTG RT PCR 
Bomir-C1511 GTGGAGGAGAATGCCCGGGG RT PCR 
Bomir-D1431 GGCGACGGAGGCGCGACCCCC RT PCR 
Bomir-F1353 ATCTTTGGGCTAGGTTAGTTC RT PCR 
Bomir-F1351 GCCCCGGCCGCTCCCGGCCTT RT PCR 
Bomir-A3711 TTCCGCGCTCTACGCCAGC RT PCR 
Bomir-F0131 GGGGCGGGGGGGCGGGTG RT PCR 
Bomir-F0132 AGCCCGGGCCCCTCCCCTG RT PCR 
Bomir-H0121 ACTTCCCGTGTGTTGAGCC RT PCR 
Bomir-F0244 GCTACTACCGATTGGATGG RT PCR 
Bomir-H0222 CGGCGGCAGCGCCGGGGC RT PCR 
Bomir-A0321 AGCGCCGCCGGCCGCACC RT PCR 
Bomir-C0533 CGGGACCGGGGTCCGGTGC RT PCR 
Bomir-F0522 GGTGGGGTGGGGGGGTTGG RT PCR 
Bomir-B0821 GTCCCCGGGGCTCCCGCC RT PCR 
Bomir-F2422 GGTGGGAGGGTCCCACCGAG RT PCR 
Bomir-D3011 CCGAGTGCTCCCGCGAGCGCT RT PCR 
VN: Two variable nucleotides, where V is A, G, or C; N is A, G, C, or T 
A: Name started with Bta and Bomir denotes annotated and new miRNAs bovine 
miRNAs, respectively. 
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3.1.2.5 In situ hybridization of miRNAs in ovarian cryo-sections and whole mount 
cumulus oocyte complexes 
 
For in-situ hybridization of miRNAs, bovine ovary (21/0) days of estrus cycle was fixed 
in 4% PFA overnight at 4°C followed by overnight incubation in PBS with 30% sucrose 
at 4°C and frozen in Tissue-Tek OCT reagent (Sakura Finetek, Zoeterwoude, NL). 
Cryo-sections (10 µm) preparation, post-fixation, acetylation and proteinase K treatment 
was done as described previously (Obernosterer et al. 2007). Two hours of pre-
hybridization was performed at 52°C in hybridization solution (50% formamide, 5 × 
sodium chloride/sodium citrate [SSC; pH 6.0], 0.1% Tween-20, 50 μg/ml heparin, and 
500 mg/ml yeast tRNA). Ovarian sections were incubated overnight at 52°C with 3'-
Digoxigenin (DIG) labeled LNA-modified oligonucleotide probes (1pM) for miR-29a, 
U6 RNA and scrambled miR (Exiqon, Vedbaek, Denmark) in hybridization buffer in a 
humidified chamber. Blocking, incubation with anti-DIG-AP antibody, washing and 
color development using Fast Red reaction was performed as described previously 
(Obernosterer et al. 2007). The slides were mounted with VectaShield containing DAPI 
(Vector laboratories, Burlingame, CA) and analyzed by confocal laser scanning 
microscope (CLSM LSM-510, Carl Zeiss, Germany). For whole mount in-situ 
hybridization, cumulus oocyte complexes were aspirated from more than 8 mm of 
ovarian follicles. Pre-fixation, processing, digestion with Proteinase K, pre-
hybridization, hybridization, post-hybridization washing was performed in 4-well 
embryo culture dishes according to the high-resolution whole mount in situ 
hybridization protocol from Exiqon. The rest of the procedures were similar to cryo-
section hybridization protocol.  
 
3.1.2.6 Prediction and analysis of ovarian miRNA targets  
 
For this purpose, initially a raw list of all genes found to be targeted by cloned miRNA 
was generated using MIRANDA algorithm, miRBase target version 5 (Hong et al. 
2008). Subsequently, about 800 distinct important genes related to mammalian 
reproductive system development, function and disorders were extracted from Ingenuity 
knowledge base (IPA 7.0) by key word search. Then, two filtration steps were applied 
to generate a comprehensive list of target genes. Firstly, raw target set and genes set 
extracted from database were cross matched and common genes were extracted. 
Secondly, the condition of multiple genes targeted by multiple miRNAs from the 
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common target list was cosidered. From these screened target sets, 11 miRNAs having 
the highest number as well as overlapping target genes were enlisted. Then, the Gene 
Ontology (GO) analysis of the screened and sub sets of miRNAs target genes were 
performed in order to predict the possible biological processes and functions that were 
most likely to be affected by miRNAs using web delivered tools of Ingenuity Pathway 
Analysis (Redwood City, California). Top significant GO categories, biological 
functions and different canonical pathways were analyzed for miRNA specific targets as 
well as for all screened targets based on significant over-representation of genes using a 
selected threshold for p-values ≤ 0.05 of hypergeometric distribution (Delfour et al. 
2007). 
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3.2 Results 
 
3.2.1 Description of the bovine ovarian small RNA library 
 
To identify miRNAs in the ovary, RNAs of 18 to 26 nt in length from bovine ovarian 
small RNAs (~ 200 nt) were purified, cloned, sequenced and analyzed. About 233 
concatemer clones were sequenced to generate 479 sequences (after discarding non-
quality and self ligated linker sequences). Of these 80 small RNA-cDNA sequences 
were beyond the expected range of nucleotides (18-26nt) in length. Only sequences of 
18 nt or more in length were subjected to detail analysis. Distribution of different 
lengths of nucleotide sequences found in this library is presented in figure 3.1. All 
identified sequences were categorized according to their properties as determined by in-
silico analysis based on the criteria reported elsewhere for different types of small 
RNAs (Ambros et al. 2003a, Ambros et al. 2003b, Aravin et al. 2003, Aravin and 
Tuschl 2005). The 479 sequences identified in the library represented 41% miRNAs, 
12% mRNA, 12% rRNA, 6.3% tRNA, 6.0% repeat associated siRNA, 2.7% small 
antisense RNA, 3.5% tiny noncoding RNA, 1% small nuclear RNA and 15.2% 
sequences that did not match to bovine genome (Figure 3.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Size distribution of 479 small RNAs sequences cloned from the bovine 
ovary 
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Figure 3.2: Frequency (%) of different types of RNA represented in the library 
 
3.2.2 Distinct miRNAs identified in the bovine ovary 
 
In cDNA library a total of 196 sequences were found to be miRNA like molecules, of 
which 74 revealed distinct miRNAs (Table 3.2). Out of these 74 miRNAs, 36 were 
found to be reported in miRBase 12.0 for different species including bovine, 14 are 
registered only for other species and 24 were completely new. Of these 38 new bovine 
miRNAs, 15 miRNAs were identical or differed by only one or two nucleotides from 
known mammalian miRNAs. All the new miRNAs were denoted as starting with prefix 
‘bomir’ followed by their homologue miRNA number or by clone name in case of no 
sequence homology. Already annotated miRNAs were named as they were stated in 
miRBase.  
 
Two miRNAs, namely: mir-22/22* and 140/140* which are cloned from 5´ fold back 
arm of the hairpin precursor, have shown exact match to human miRNAs but not to 
bovine as annotated in miRBase. So, previously annotated bta-miR-22 and 140 seem to 
be miR-22* and miR-140*, respectively. The number of times that each miRNA cloned 
in the library ranged from 28 clones for let-7b to a single clone (singleton) for 39 of the 
73 miRNAs. All in all, 22 of the 73 miRNAs were cloned for three or more times 
(Figure 3.3).  
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Figure 3.3: Frequency (%) of cloned miRNAs along with their copy number 
 
The corresponding bovine genomic sequences and their locations were identified for 
each miRNA. The 5´ or 3´ flanking genomic sequences were then tested for the ability 
to fold into canonical ~70-nt miRNA precursor hairpin structures by using the MFOLD 
web server (Eppig 1991). Small RNA clones with proper positioning within an arm of 
the hairpin suggest that they have been excised during dicer processing in the cells. 
Nearly in all of those cases, sequences were found to be conserved in different species 
including the predicted precursors (Table 3.2 and Table 3.3). The Bomir-652, which 
could not be located in bovine genome, was found to be cloned for five times in the 
library and share sequence homology with already identified miRNA in other species.  
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Table 3.2: List of new miRNAs cloned from bovine ovary 
 
miR ID L Homolog C S Sequence Genomic Location e T  
bomir-22*/22-5p a 22 hsa-miR-22 3  +/- ACAGUUCUUCAACUGGCAGCUU 19:22901905:22901926:1f mt
bomir140*/140-5pb 22 hsa-miR-140 1  + CAGUGGUUUUACCCUAUGGUAG 18:35987052:35987073:1f mt
bomir-143-3p 22 ggo-miR-143 11  +/- UGAGAUGAAGCACUGUAGCUCG 7:60268857:60268878:1f Ie 
bomir-152-5p 21 hsa-miR-152 1  - CCAAGUUCUGUCAUGCACUGA 19:39650399:39650419:-1f It 
bomir-193a-2-3pc 19 bta-miR193a 1  - GGGACUUUGUAGGCCAGUU 14:889828:889846:-1f In 
bomir-378-1-3p 21 hsa-miR-378 1  + CUGGACUUGGAGUCAGAAGGC 7:60536513:60536533:1f In 
bomir-378-2-5p 21 hsa-miR-378  -   + CUGGACUUGGAGUCAGAAGGC 4:11116898:11116918:1h In 
bomir-382-3p 22 hsa-miR-382 1  - GAAUCCACCACGAACAACUUC 21:66031757:66031777:-1f In 
bomir-409-5p 22 hsa-miR-409 2  - GGGGUUCACCGAGCAACAUUC 21:66042162:66042182:-1f In 
bomir-424-3p 22 hsa-miR-424* 1  -  CAAAACGUGAGGCGCUGCUAU Un.04.53:446874:446894:-1f In 
bomir-503-3p 23 mmu-miR-503 1  + UGCAGUACUGUUCCCGCUGCUA Un.004.53:446563:446584:1f Ie 
bomir-542-3p 23 hsa-miR-542 1  + UCUCGUGACAUGAUGAUCCCCGA Un.004.53:441604:441626:1f Ie 
bomir-574-5p 22 hsa-miR-574 1  - UGUGGGUGUGUGCAUGUGCGUG 16:59370677:59370698:-1f Ie 
bomir-652-3pd 21 hsa-miR-652 5  + CACAACCCTAGTGGCGCCATT (from H. sap.)   --
bomir-940-5p 18 hsa-miR-940 1  - GCAGGGCCCCCGCUCCCC 20:75274475:75274492:-1h Ie 
bomir-F0131-5p 18 mmu-miR-667 1  + GGGGCGGGGGGGCGGGUG 7:10905965:10905982:1h Ie 
bomir-F0132-5p 19 hsa-miR-1469 1  + AGCCCGGGCCCCUCCCCUG 7:13891718:13891736:1h It 
bomir-H0121-3p 19 hsa-miR-1471 1  + CUUCCCGUGUGUUGAGCC 18:7202610:7202627:1h Ie 
bomir-F0244-5p 19 osa-miR1423 1  - GCUACUACCGAUUGGAUGG 12:45758300:45758318:-1g Ie 
bomir-H0222-3p 22 cre-miR1172.1 1  - GGACGGCGGCAGCGCCGGGGCG 29:41706141:41706159:-1f Ie 
bomir-A0321-3p 18 mml-miR-638 1  + AGCGCCGCCGGCCGCACC 19:39110507:39110524:1g In 
bomir-C0533-5p 20 oan-miR-1418* 1  + CGGGACCGGGGUCCGGUGCG 18:59928733:59928752:1f Ie 
      21:52041918:52041937:-1f Ie 
bomir-F0522-1-3p 19 hsa-miR-1234 1  + GGUGGGGUGGGGGGGUUGG 21:35870379:35870397:1h Ie 
      22:59347395:59347413:1h In 
bomir-B0821-5p 21 oan-miR-1394 1  - GUCCCCGGGGCUCCCGCCGGC 20:19373746:19373766:-1h Ie 
bomir-F1351-3p 20 gga-miR-1607 3  + GCCCCGGCCGCUCCCGGCCU 25:41129497:41129516:1h Ie 
bomir-F1353-5p 20 dre-miR-430c 1  + AUCUUUGGGCUAGGUUAGUU 28:27885036:27885055:1h In 
bomir-D1431-5p 22 pta-miR1310 2  - GGCGACGGAGGCGCGACCCCCC 12:75102030:75102051:-1g Ie 
bomir-C1511-5p 20 hsa-miR-877 1  + GUGGAGGAGAAUGCCCGGGG Un.04.1059:20639:20658:1h In 
bomir-F1821-3p 21 hsa-miR-631 1  + AGCCCUGGCCCUGCCAUCGUG Un.04.152:123191:123211:1h In 
bomir-C1931-5p 23 gma-miR1523 1  + CCUGCUGAUCUCACAUUAAUUCA 26:12405838:12405860:1h Ie 
bomir-A2143-3p 18 oan-miR-181c* 1  + CGGCAGAUGAAGUCCAUC 16:47801336:47801353:1h In 
bomir-F2422-5p 20 hsa-miR-659 1  + GGUGGGAGGGUCCCACCGAG 18:53584142:53584161:1h It 
bomir-F2531-3p 18 ppt-miR1030i 3  + UGGUGGAGAUGCCGGGGA 8:77307661:77307678:1g Ie 
bomir-G2511-3p 18 bmo-miR-92 1  + AGGCGGGCCGGGGUUGGA 18:41190536:41190553:1h Ie 
bomir-E2664-3p 20 mml-miR-638 1  - AGGGCGGGCGGCGACUGGAA 18:64361001:64361020:-1h It 
bomir-D3011-3p 21 mml-miR-650b 1  + CCGAGUGCUCCCGCGAGCGCU 18:39424938:39424958:1g It 
bomir-A3341-1-3p 22 bta-miR-487a 1  + GUGGCUGUCCCUGGAGGUGGG 3:124988008:124988028:1h Ie 
      Un.04.4799:1335:1355:1h Ie 
bomir-A3711-5p 19 hsa-miR-937 2  + UUCCGCGCUCUACGCCAGC 9:63475804:63475822:1g Ie 
bomir-A4052-1-5p 19 hsa-miR-615 1  + GGGAGCCUCGGUUGGCCUC 18:59928630:59928648:1f Ie 
      21:52042022:52042040:-1f It 
      Un.04.2732:16069:16087:-1f Ie 
 
L:length, C: copy number, S: strand, In: intronic, It: intragenic, Ie: intergenic, mt: 
miR transcript, a: Cloned sequence is homolog to has-miR 22 but not to bta-miR-22, 
may bta-miR-22 presented in miRBase v. 12 is bta-miR-22*, b: Cloned sequence is 
homologue to has-miR-140 but not to bta-miR-140, may bta-miR-140 presented in 
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miRBase v. 12 is bta-miR-140*, c: Sequence is smaller than bta-miR-193a and has 
different genomic locus. d: Sequence does not match to bovine genome, e: Genomic 
location presenting chromosome number with start and end position along with 
sense/antisense orientation by 1/-1 of cloned mature sequence. Conservation pattern 
of the predicted precursor sequences from flanking bovine genome sequence is 
indicated by- f: found in more than 6 mammalian species, g: present at least in 2 
species, h: only in bovine. 
 
3.2.3 Genomic distribution, properties and clustering of new miRNAs 
 
Genomic locations and properties of the new miRNAs are shown in table 3.2. All newly 
identified bovine miRNAs (except bomir-652) are corresponded to 43 distinct loci. 
Putative precursor hairpin structures have been predicted for all these 43 loci using 
genomic sequences flanked from candidate miRNAs (Table 3.3). Thirty three of these 
are found to be encoded by single copy miRNA genes, whereas the other five (bomir-
378, bomir-C0533-5p, bomir-F0522-3p, bomir-A3341-3p and bomir-A4052-5p) have 
multiple loci in the bovine genome (Table 3.2). The analysis of the genomic positions of 
61 sequences corresponding to 38 distinct new miRNA genes showed that the majority 
(23 out of 44 loci) are localized to intergenic regions and the rest corresponded to the 
intragenic regions in either sense or antisense orientation (Table 3.2). However, 11 
sequences are found to be exclusively from known intronic region.  
 
Table 3.3: Predicted secondary structure of new miRNAs 
 
1. >bomir-22*/22-5p:Btau_4.0:19:22901896:22901976:1(10-31) dG = -31.40 kcal/mol 
CAGAGGGCAacaguucuucaacuggcagcuuUAGCUGGGUCAGGACAuaaagcuugccacugaagaacuACUGCGGCUCAG 
     CA   G-   ac         ac     -      GC  GGU  
       GAG  GCA  aguucuuca  uggca gcuuUA  UG   C 
       |||  |||  |||||||||  ||||| ||||||  ||   | 
       CUC  CGU  ucaagaagu  accgu cgaaau  AC   A 
     GA   GG   CA         c-     u      --  AGG  
2. >bomir-140*/140-5p:Btau_4.0:18:35987036:35987127:1(17-38) dG = -51.10 kcal/mol 
UCUCUCUGUGUCCUGCcagugguuuuacccuaugguagGUUACGUCAUGCUGUUCuaccacaggguagaaccacggACAGG 
AUACCGGGGCA 
     UC    U        -  a             a       UU   UC  
       UCUC GUGUCCUG Cc gugguuuuacccu ugguagG  ACG  A 
       |||| |||||||| || ||||||||||||| |||||||  |||  | 
       GGGG CAUAGGAC gg caccaagauggga accauCU  UGU  U 
     AC    C        A  -             c       --   CG 
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3. >bomir-143-3p:Btau_4.0:7:60268810:60268888:1(57-78) dG = -48.50 kcal/mol 
UCUCCCAGCCUGAGGUGCAGUGCUGCAUCUCUGGUCAGUUGGGAGUCugagaugaagcacuguagcucgGGAAGGGAGA 
           AG      G         G      U  -  AG  
     UCUCCC  CCUGAG UGCAGUGCU CAUCUC GG UC  U 
     ||||||  |||||| ||||||||| |||||| || ||  | 
     AGAGgg  gggcuc augucacga guagag CU AG  U 
           aa      g         a      u  G  GG  
4. >bomir-152-5p:Btau_4.0:19:39650354:39650424:-1(6-26) dG = -38.00 kcal/mol 
CGGGCccaaguucugucaugcacugaCUGCUCCAGAGCCCGAGUCGGAGUGUAUCACAGAACCUGGGCCGG 
     CG      a       c       --    ---   C  
       GGCcca guucugu augcacu  gaCU   GCU C 
       |||||| ||||||| |||||||  ||||   ||| | 
       CCGGGU CAAGACA UAUGUGA  CUGA   CGA A 
     GG      C       C       GG    GCC   G  
5. >bomir-193a-2-3p:Btau_4.0:14:889826:889878:-1(32-50) dG = -17.80 kcal/mol 
AUGGCUGCCUCACAAGGUUUGGAGCUGUGCCUgggacuuuguaggccaguuCA 
     AU    -    C       - UG A  U  
       GGCU GCCU ACAAGGU U  G GC \ 
       |||| |||| ||||||| |  | ||  G 
       uuga cgga uguuuca g  C CG / 
     AC    c    -       g gU -  U  
6. >bomir-378-1-3p:Btau_4.0:7:60536464:60536541:1(49-69) dG = -47.70 kcal/mol 
CCACCCAGGGCUCCUGACUCCAGGUCCUGUGUGUUACCUCGAAAUAGCAcuggacuuggagucagaaggcCUGAGUGG 
         C    G  C              UGU      CCU  
     CCAC CAGG CU CUGACUCCAGGUCC   GUGUUA   C 
     |||| |||| || ||||||||||||||   ||||||   | 
     GGUG GUCc ga gacugagguucagg   cACGAU   G 
         A    g  a              u--      AAA  
7. > bomir-378-2-5p:Btau_4.0:4:11116890:11116965:1(9-29) dG = -14.80 kcal/mol 
GGAGAGCAcuggacuuggagucagaaggcUGGAGCUUACAGGGCAGCACCGUCAUCUACUGGUGGAGAACUACGCC 
       AG-  CA  gg   ugg   c   a   U  A   UAC  
     GG   AG  cu  acu   agu aga ggc GG GCU   A 
     ||   ||  ||  |||   ||| ||| ||| || |||   | 
     CC   UC  GA  UGG   UCA UCU CUG CC CGA   G 
       GCA  AA  GG   ---   -   A   -  A   CGG 
8. >bomir-382-3p:Btau_4.0:21:66031742:66031827:-1 (51-71)dG = -28.30 kcal/mol 
UUUGGUACUGAAAAAAGUGUUGUCCGUGAAUGAUUCGUCAUAAGUAAAGCgaauccaccacgaacaacuucUCUUCAAGUA 
CCACA 
     UU      -    AAAAGU     C    AAU       CAUA  
       UGGUAC UGAA      GUUGU CGUG   GAUUCGU    A 
       |||||| ||||      ||||| ||||   |||||||    | 
       ACCAUG ACUU      caaca gcac   cuaagCG    G 
     AC      A    CUcuu-     a    cac       AAAU 
9. >bomir-409-5p:Btau_4.0:21:66042116:66042194:-1(13-33) dG = -33.60 kcal/mol 
UGAUACCGAAAAgggguucaccgagcaacauucGUCGUCCAGAUGCAAAGUUGCUCGGGUAACCUCUCCCCGCGUACCA 
     U A   -  AAA       ca         a  -    GU  
      G UAC CG   Agggguu  ccgagcaac uu cGUC  \ 
      | ||| ||   |||||||  ||||||||| || ||||  C 
      C AUG GC   UCUCCAA  GGCUCGUUG AA GUAG  / 
     A C   C  CCC       UG         A  C    AC 
10. >bomir-424-3p:Btau_4.0:Un.004.53:446853:446952:-1(59-79) dG = -46.20 kcal/mol 
UUCGUUGACUCCGAGGGGAUGCAGCAGCAAUUCAUGUUUUGAAGUGCUUUAAACGGUUcaaaacgugaggcgcugcuauACCC 
CCUUGCGAGGAAGUAGG 
     U CG  GA   -       A  C      AA             G  CUU  
      U  UU  CUC CGAGGGG UG AGCAGC  UUCAUGUUUUGAA UG   \ 
      |  ||  ||| ||||||| || ||||||  ||||||||||||| ||   U 
      G  GA  GAG GUUCCCC Au ucgucg  gagugcaaaacUU GC   / 
     G AU  AG   C       C  a      cg             G  AAA  
12. >bomir-542-3p:Btau_4.0:Un.004.53:441560:441637:1(45-67) dG = -25.80 kcal/mol 
CCCAGACCUUUCAGUUAUCAAUCUGUCACAAGUGCACAGUGGUAucucgugacaugaugauccccgaGAUGUCUGAGG 
       -     C    A---       AUC      A  -   AC  
     CC CAGAC UUUC    GUUAUCA   UGUCAC AG UGC  A 
     || ||||| ||||    |||||||   |||||| || |||  | 
     GG GUCUG AGag    uaguagu   acagug uc AUG  G 
       A     U    cccc       ---      c  u   GU  
13. >bomir-574-5p:Btau_4.0:16:59370641:59370704:-1(7-28) dG = -25.20 kcal/mol 
AGAGUGugugggugugugcaugugcgugUGUGCACAUGCAUAUGUGUGUGGCUAUCUUAGCUGU 
     AG   Gu--    g  ug             G  
       AGU    gugg ug  ugcaugugcgugU U 
       |||    |||| ||  ||||||||||||  | 
       UCG    UAUC GU  GUGUAUACGUACA G 
     UG   AUUC    G  GU             C  
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14. >bomir-652-3p: hsa:X:109185213-109185310:-1, dG = -50.10 kcal/mol 
CACAUCCAACACGUGACguguugggaucaccgcgguaaGUUAAUAUCAGAUACACUUACCGUGGGAGAGGAUCCCAACACGUC 
ACGUAUCGGUAAGCA       
   CACAU-  AAC                  a----           UAAUAU  
         CC   ACGUGACguguugggauc     ccgcgguaaGU      \ 
         ||   ||||||||||||||||||     |||||||||||      C 
         GG   UGCACUGCACAACCCUAG     GGUGCCAUUCA      / 
   ACGAAU  CUA                  GAGAG           CAUAGA  
15. >bomir-940-5p:Btau_4.0:20:75274429:75274494:-1(3-20) dG = -39.80 kcal/mol 
CCgcagggcccccgcuccccGUGGCCACCAGAGUGCCCUGUGGGGAGGCGGGGGAGCCACCUGGGG 
       g    g----      -       UG C-   C  
     CC cagg     cccccg cuccccG  G  CAC A 
     || ||||     |||||| |||||||  |  ||| | 
     GG GUCC     GGGGGC GAGGGGU  C  GUG G 
       G    ACCGA      G       GU CC   A 
16. >bomir-F0131-5p:Btau_4.0:7:10905950:10906020:1(16-33) dG = -29.40 kcal/mol 
UGUGUUUGGGAGUUGggggcgggggggcgggugGAUUCCAGCUGUCUUCCCCUCGUGGACACUGUGACAUA 
           UG  A   Gg-   c          g   A  
     UGUGUU  GG GUU   ggg gggggggcgg ugG \ 
     ||||||  || |||   ||| |||||||||| ||| U 
     AUACAG  UC CAG   CUC CCCUUCUGUC ACC / 
           UG  A   GUG   -          G   U  
17. >bomir_F0132-5p:Btau_4.0:7:13891717:13891774:1(2-20) dG = -23.40 kcal/mol 
CagcccgggccccuccccugGCUCCGCCCACAGCAUCAUGGGACCCAGCCCAGGGCCU 
     Ca    -    ccc-    c  --   CCG  
       gccc gggc    uccc ug  GCU   C 
       |||| ||||    |||| ||  |||   | 
       CGGG CCCG    AGGG AC  CGA   C 
     UC    A    ACCC    U  UA   CAC  
18 >bomir-H0121-3p:Btau_4.0:18:7202568:7202632:1(43-60) dG = -27.60 kcal/mol 
GAGGCGGCCAGACCAGCAGGGCGCAGGGGACCAUGUGUCCUCcuucccguguguugagccGCGUG 
     GAG     CA   CA   -   CGC   -    CA  
        GCGGC  GAC  GCA GGG   AGG GGAC  \ 
        |||||  |||  ||| |||   ||| ||||  U 
        CGccg  uug  ugu ccc   ucC CCUG  / 
     GUG     ag   --   g   u--   U    UG  
 
19. >bomir-F0244-5p:Btau_4.0:12:45758242:45758332:-1(15-33) dG = -20.10 kcal/mol 
GCCACUGCCCCAUUgcuacuaccgauuggauggUUUAGUGUUGCCCUUGGAUAAUCCAAUAAGUAGAAUUAAUAGGUGAAAA 
GUUGUGAGC 
       -   U  ------  C    cua    cg       g      UGU  
     GC CAC GC      CC AUUg   cuac  auuggau gUUUAG   U 
     || ||| ||      || ||||   ||||  ||||||| ||||||   |  
     CG GUG UG      GG UAAU   GAUG  UAACCUA UAGGUU   G 
       A   U  AAAAGU  A    UAA    AA       A      CCC  
20 >bomir-H0222-3p:Btau_4.0:29:41706131:41706188:-1(30-48) dG = -31.50 kcal/mol 
UCUGGGGCGCCCCGCACCGGCGGGCAGGAcggcggcagcgccggggcgCCGUCUCGGA 
          ---        -  A---   G  GGC  
     UCUGG   GGCGCCCC GC    CCG CG   \ 
     |||||   |||||||| ||    ||| ||    A 
     AGGCU   CCgcgggg cg    ggc gc   / 
          CUG        c  cgac   g  AGG  
21. >bomir-A0321-3p:Btau_4.0:19:39110468:39110542:1(40-57) dG = -20.40 kcal/mol 
CCGGCCUACUUGGGGCUCCGAGCCGCUGCCGCAUACAUUagcgccgccggccgcaccGCCGUCACCUUCAGCGCU 
     CC   -  ACU--   -   UC--  A    C  C   AUA  
       GGC CU     UGG GGC    CG GCCG UG CGC   C 
       ||| ||     ||| |||    || |||| || |||   | 
       UCG GA     ACU CCG    gc cggc gc gcg   A 
     --   C  CUUCC   G   ccac  -    c  c   aUU 
22. >bomir-C0533-1-5p:Btau_4.0:18:59928730:59928786:1(4-23) dG = -26.70 kcal/mol 
CGUcgggaccgggguccggugcgGAGAGCCCUUCGUCCCGGGACACGGGGCGCGGCC 
     C    gga-   ggg     ug     A  
      GUcg    ccg   uccgg  cgGAG G 
      ||||    |||   |||||  ||||| | 
      CGGC    GGC   GGGCC  GCUUC C 
     C    GCGG   ACA     CU     C  
23. >bomir-C0533-2-5p:Btau_4.0:21:52041884:52041940:-1(4-23) dG = -26.70 kcal/mol 
CGUcgggaccgggguccggugcgGAGAGCCCUUCGUCCCGGGACACGGGGCGCGGCC 
     C    gga-   ggg     ug     A  
      GUcg    ccg   uccgg  cgGAG G 
      ||||    |||   |||||  ||||| | 
      CGGC    GGC   GGGCC  GCUUC C 
     C    GCGG   ACA     CU     C 
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24. >bomir-F0522-1-3p:Btau_4.0:21:35870333:35870398:1(47-65) dG = -27.40 kcal/mol 
CCUCUCUCCCUGCAGCAUCUCAGGGCACUGUGUGACUUGGGUCGGGggugggguggggggguuggU 
     -  UC      UG AG      AG   A   UGU  
      CC  UCUCCC  C  CAUCUC  GGC CUG   \ 
      ||  ||||||  |  ||||||  ||| |||   G 
      gg  gggggg  g  guggGG  CUG GGU   / 
     U  uu      gu gg      G-   -   UCA  
25. >bomir-F0522-2-3p:Btau_4.0:22:59347353:59347420:1(43-61) dG = -34.40 kcal/mol 
GGAGGGUGCCUCUAAGCCUCACUUGUCCUGCCUGUCAAAUGGggugggguggggggguuggCCUUUCC 
           U   UCUA      A  UG   UG   GUC  
     GGAGGG GCC    AGCCUC CU  UCC  CCU   A 
     |||||| |||    |||||| ||  |||  |||   | 
     CCUUUC Cgg    uugggg gg  ggg  ggG   A 
           -   ----      -  gu   gu   GUA  
26. >bomir-B0821-5p:Btau_4.0:20:19373708:19373768:-1(3-23) dG = -32.60 kcal/mol 
GCguccccggggcucccgccggcGGAGUUCGGUUUGCACCGGGGAGGGGGCCGGGGAUCGG 
     G  -     gg       g  gg   A  UCG  
      Cg ucccc  ggcuccc cc  cGG GU   \ 
      || |||||  ||||||| ||  ||| ||   G 
      GC AGGGG  CCGGGGG GG  GCC CG   / 
     G  U     --       A  G-   A  UUU  
27. >bomir-F1351-3p:Btau_4.0:25:41129445:41129520:1(53-72) dG = -44.20 kcal/mol 
CGGCGGCCGGGAAAGGUGGGCUGGGCUCCGGGGCCCCUCCCCGCCCGGUGCUgccccggccgcucccggccuUGUG 
     CGGC-        AA   --    UG   U     G CCC  
          GGCCGGGA  GGU  GGGC  GGC CCGGG C   U 
          ||||||||  |||  ||||  ||| ||||| |   |      
          ccggcccu  ccg  cccg  UCG GGCCC G   C 
     GUGUu        cg   gc    --   U     - CCC  
28. >bomir-F1353-5p:Btau_4.0:28:27885032:27885119:1(5-24) dG = -18.30 kcal/mol 
AAAAaucuuugggcuagguuaguuCUAUUUUAUGAUCUGUUAUGAAAUGGGUUAAGGAAAAGGAUCCAUGUGGAAGA 
AAGAUCAGAGA 
     AAAAA-      ggg   g  ua     A   UA         A  
           aucuuu   cua gu  guuCU UUU  UGAUCUGUU U 
           ||||||   ||| ||  ||||| |||  ||||||||| | 
           UAGAAA   GGU UA  UAGGA AAG  AUUGGGUAA G 
     AGAGAC      GAA   G  CC     A   GA         A  
29. >bomir-D1431-5p:Btau_4.0:12:75101950:75102053:-1(3-24) dG = -44.60 kcal/mol 
GUggcgacggaggcgcgaccccccCCCCCCCCCCCCCCCCCCGCCCCGGUCCGACGGUGCGACCCGCCAGGGGCGCUC 
UGGGGACAGUCCGCCCCGCCCCGCCC 
     GU    a--   a    c   cc-    CCCC--    CCCCCCCC   C   GU  
       ggcg   cgg ggcg gac   cccC      CCCC        CGC CCG  C 
       ||||   ||| |||| |||   ||||      ||||        ||| |||  | 
       CCGC   GCC CCGC CUG   GGGG      GGGG        GCG GGC  C 
     C-    CCC   -    -   ACA    UCUCGC    ACCGCCCA   U   AG  
30. >bomir-C1511-5p:Btau_4.0:Un.004.1059:20638:20698:1(2-21) dG = -32.00 kcal/mol 
CguggaggagaaugcccggggCGUGCUGGGCGGUGCGGGCUGGGCUGGCAGCUCCUCCCUC 
     Cgu       aau---      gg  UG  G  
        ggaggag      gcccgg  CG  CU G 
        |||||||      ||||||  ||  || | 
        CCUCCUC      CGGGUC  GC  GG G 
     CUC       GACGGU      GG  GU  C  
31. >bomir-F1821-3p:Btau_4.0:Un.004.152:123132:123213:1(60-80) dG = -31.60 kcal/mol 
CGCAACGAGGGCUCGGGACACAGCCCUGCUUCCUGGCCCACGUCACCCGUCGUGGCCAGagcccuggcccugccaucgugUC 
     C  A    G   UC   ACA   CCCU   UC      C   UCA  
      GC ACGA GGC  GGG   CAG    GCU  CUGGCC ACG   C 
      || |||| |||  |||   |||    |||  |||||| |||   | 
      Ug ugcu ccg  ccc   guc    cga  GACCGG UGC   C 
     C  -    a   u-   g--   c---   --      -   UGC  
32. >bomir-C1931-5p:Btau_4.0:26:12405822:12405907:1(17-39) dG = -11.60 kcal/mol 
CCCUGAGUUGCAAUUCccugcugaucucacauuaauucaUCUUUGCUAGAGAAAUAUCUGAGUGUCUGUUUUGGUUCAAU 
AAAGCC 
     CC  GA    C    Cccu  u   -    cau  a   a   UU  
       CU  GUUG AAUU    gc gau cuca   ua uuc UCU  \ 
       ||  |||| ||||    || ||| ||||   || ||| |||  G      
       GA  UAAC UUGG    UG CUG GAGU   AU AAG AGA  / 
     CC  AA    -    UUU-  U   U    CU-  A   -   UC 
33. >bomir-A2143-3p:Btau_4.0:16:47801303:47801359:1(34-51) dG = -18.50 kcal/mol 
ACACCCGGCUGGCGUCAACUCUGAACAGAUUCUcggcagaugaaguccaucGGGAAG 
     ACA     C   - G   A  -    ACA  
        CCCGG UGG C UCA CU CUGA   G 
        ||||| ||| | ||| || ||||   | 
        GGGcu acc g agu ga ggcU   A 
     GAA     -   u a   a  c    CUU  
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34. >bomir-F2422-5p:Btau_4.0:18:53584142:53584210:1(1-20) dG = -35.50 kcal/mol 
ggugggagggucccaccgagCACCCUGUCGGCUGGCAGCCCCGGCCCAGGUAGUGGGUGCUCUGCCACA 
     g    g     -     cgagCAC    UC      CA  
      gugg agggu cccac       CCUG  GGCUGG  \ 
      |||| ||||| |||||       ||||  ||||||  G 
      CACC UCUCG GGGUG       GGAC  CCGGCC  / 
     A    G     U     AU-----    --      CC  
35. >bomir-F2531-3p:Btau_4.0:8:77307612:77307688:1(50-67) dG = -13.80 kcal/mol 
GGUUUAAUGCUCUGCUGUCAGCGCUUUGAAAUUCUUACUAAUCUUUUUUugguggagaugccggggaCGUAAUAAUU 
     GGUUUA-   -     CU   AG    UU    UUCUUA  
            AUG CUCUG  GUC  CGCU  GAAA      \ 
            ||| |||||  |||  ||||  ||||      C 
            UGC ggggc  uag  gugg  UUUU      / 
     UUAAUAA   a     cg   ag    uU    UCUAAU  
36. >bomir-G2511-3p:Btau_4.0:18:41190497:41190564:1(40-57) dG = -21.10 kcal/mol 
AGGGGGAGAGUUGCGGCUCAUGAACUGGGUCCAGGUGGAaggcgggccgggguuggaAGGUUCCAGCU 
     AGGG    AG  G      A  AA   GG-   A  
         GGAG  UU CGGCUC UG  CUG   UCC G 
         ||||  || |||||| ||  |||   ||| | 
         CCUU  Aa guuggg gc  ggc   AGG G 
     UCGA    GG  g      -  cg   gga   U  
37. >bomir-E2664-3p:Btau_4.0:18:64360999:64361052:-1(33-52) dG = -21.10 kcal/mol 
AGUCAAGUGAGCGGCCGCACCGGCUCUCCCGGagggcgggcggcgacuggaaAG 
     AG-  A   GAGCG     A   G     C  
        UC AGU     GCCGC CCG CUCUC \ 
        || |||     ||||| ||| |||||  C 
        ag uca     cggcg ggc gggaG / 
     GAa  g   g----     -   -     G  
38. >bomir-D3011-3p:Btau_4.0:18:39424877:39424959:1(62-82) dG = -47.50 kcal/mol 
ACGCGCUUCUCGGCGCUCACUCGGCGGCACCACUGCCGCAAAUGCGGCUUCGUGGUCUGCGccgagugcucccgcgagcgcuU 
     AC    U  U   CGCU         GC-     U--     A  
       GCGC UC CGG    CACUCGGCG   ACCAC   GCCGC A 
       |||| || |||    |||||||||   |||||   ||||| | 
       cgcg ag gcc    gugagccGC   UGGUG   CGGCG A 
     Uu    -  c   cuc-         GUC     CUU     U  
39. >bomir-A3341-1-3p:Btau_4.0:3:124987968:124988032:1(41-61) dG = -28.00 kcal/mol 
UCACCCCAGUCUCUAGUGAGAGAGCCAUGGCGGCAGGGGCguggcugucccuggaggugggACUG 
     UCAC    G       UGA  G       G GGC  
         CCCA UCUCUAG   GA AGCCAUG C   \ 
         |||| |||||||   || ||||||| |    A      
         gggu ggagguc   cu ucggugC G   / 
     GUCA    -       c--  g       - GGG  
40. >bomir-A3341-2-3p:Btau_4.0:Un.004.4799:1295:1359:1(41-61) dG = -28.00 kcal/mol 
UCACCCCAGUCUCUAGUGAGAGAGCCAUGGCGGCAGGGGCguggcugucccuggaggugggACUG 
     UCAC    G       UGA  G       G GGC  
         CCCA UCUCUAG   GA AGCCAUG C   \ 
         |||| |||||||   || ||||||| |    A 
         gggu ggagguc   cu ucggugC G   / 
     GUCA    -       c--  g       - GGG  
41. >bomir-A3711-5p:Btau_4.0:9:63475787:63475874:1(18-36) dG = -64.40 kcal/mol 
CGCCGCUCCGCUCCCGGuuccgcgcucuacgccagcCCGCUGCCUGCCGGGCUGGUGCAGGCCGCGGAGCCGGGCGGCCCGG 
CAGGCA 
     C   -   CC   -            cu  a         -  UG  
      GCC GCU  GCU CCCGGuuccgcg  cu cgccagcCC GC  \ 
      ||| |||  ||| ||||||||||||  || ||||||||| ||   C 
      CGG CGG  CGG GGGCCGAGGCGC  GA GUGGUCGGG CG  / 
     A   A   CC   C            CG  C         C  UC  
42. >bomir-A4052-1-5p:Btau_4.0:18:59928617:59928686:1(14-32) dG = -38.20 kcal/mol 
ACGGCAGCGCCGCgggagccucgguuggccucGGAUAGCCGGUCCCCCGCCGUCCCCGCCGGCGGGCCGU 
          AG     -    ag cu   uu  cc    A  
     ACGGC  CGCCG Cggg  c  cgg  gg  ucGG U 
     |||||  ||||| ||||  |  |||  ||  |||| | 
     UGCCG  GCGGC GCCC  G  GCC  CC  GGCC A 
          G-     C    CU CC   --  CU    G  
43. >bomir-A4052-2-5p:Btau_4.0:21:52041984:52042053:-1(14-32) dG = -38.20 kcal/mol 
ACGGCAGCGCCGCgggagccucgguuggccucGGAUAGCCGGUCCCCCGCCGUCCCCGCCGGCGGGCCGU 
          AG     -    ag cu   uu  cc    A  
     ACGGC  CGCCG Cggg  c  cgg  gg  ucGG U 
     |||||  ||||| ||||  |  |||  ||  |||| | 
     UGCCG  GCGGC GCCC  G  GCC  CC  GGCC A 
          G-     C    CU CC   --  CU    G 
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44. >bomir-A4052-3-5p:Btau_4.0:Un.004.2732:16031:16100:-1(14-32) dG = -38.20 kcal/mol 
ACGGCAGCGCCGCgggagccucgguuggccucGGAUAGCCGGUCCCCCGCCGUCCCCGCCGGCGGGCCGU 
          AG     -    ag cu   uu  cc    A  
     ACGGC  CGCCG Cggg  c  cgg  gg  ucGG U 
     |||||  ||||| ||||  |  |||  ||  |||| | 
     UGCCG  GCGGC GCCC  G  GCC  CC  GGCC A 
          G-     C    CU CC   --  CU    G  
 
45. > bomir-106-2-5p:Btau_4.0:Un.004.53:181658:181738:-1(14-34) dG = -30.10 kcal/mol 
CCUUGGCCAUGUAaaagugcuuacagugcagguaGCUUUUUGAGAUCUACUGCAAUGCAAGCACUUCUUACAUUACCAUGG 
       U   CC      -        a  g     g   C  UU  
     CC UGG  AUGUAa aagugcuu ca ugcag uaG UU  \ 
     || |||  |||||| |||||||| || ||||| ||| ||   U      
     GG ACC  UACAUU UUCACGAA GU ACGUC AUC AG  / 
       U   AU      C        C  A     -   U  AG  
 
46. >bomir-24-3-3p:Btau_4.0:8:85962803:85962876:1(47-71) dG = -27.20 kcal/mol 
GCCCUCCGGUGCCUACUGAGCUGAUAUCAGUUCUCAUUUUACACACuggcucaguucagcaggaacaggagUCG 
     GCC    G  G   A         UA     UCUCAU  
        CUCC GU CCU CUGAGCUGA  UCAGU      \ 
        |||| || ||| |||||||||  |||||       U 
        gagg ca gga gacuugacu  gguCA      / 
     GCU    a  a   c         c-     CACAUU  
47. >bomir-26-2-3p:Btau_4.0:22:11464097:11464186:-1(54-75) dG = -34.00 kcal/mol 
CAGGCCCGCGUCCGCGUGCAAGUAACCGAGAAUAGGCCCCUUGGGACCUGCACagccuauccuggauuacuugaaCGAGGCC 
ACGGCCUU 
     C     CGC U  G   G       -  G  A      ---------  C  
      AGGCC   G CC CGU CAAGUAA CC AG AUAGGC         CC U 
      |||||   | || ||| ||||||| || || ||||||         || | 
      UCCGG   C GG GCa guucauu gg uc uauccg         GG U 
     U     CAC -  A   a       a  -  c      aCACGUCCA  G  
48. >bomir-199a-2-5p:Btau_4.0:7:13733556:13733633:1(8-29) dG = -33.50 kcal/mol 
CCCAGCCuaaccaaugugcagacuacuguACACAUUCAGAGCCCCCUGAACAGGUAGUCUGAACACUGGGUUGGCGGG 
        A   uaa   a   g         guACACA     AG  
     CCC GCC   cca ugu cagacuacu       UUCAG  C 
     ||| |||   ||| ||| |||||||||       |||||  | 
     GGG CGG   GGU ACA GUCUGAUGG       AAGUC  C 
        -   UUG   C   A         AC-----     CC  
49. >bomir-199a-3-5p:Btau_4.0:11:102419020:102419092:1(6-27) dG = -21.00 kcal/mol 
CAGCCuaaccaaugugcagacuacuguACAAUUUGGGAGUCCUGAACAGAUAGUCUAAACACUGGGUAGACGG 
     CAGC   a   a   gc      -    ACAAU UG  A  
         Cua cca ugu  agacua cugu     U  GG \ 
         ||| ||| |||  |||||| ||||     |  ||  G      
         GAU GGU ACA  UCUGAU GACA     A  CC / 
     GGCA   G   C   AA      A    ----- GU  U  
50. >bta-let-7b-2-3p:Btau_4.0:5:123308015:123308097:-1(60-81) dG = -22.90 kcal/mol 
CUCGAGGAAGGCAGUAGGUUGUAUAGUUAUCUUCCGAGGGGGCAACAUCACUACCCUGAaaccacacaaccuacuaccucaCC 
     GAC    AAGGC          AUA   A  UUCCG  G  GC  
        GAGG     AGUAGGUUGU   GUU UC     AG GG  A 
        ||||     ||||||||||   ||| ||     || ||  |      
        cucc     ucauccaaca   caa AG     UC CU  A 
     CCa    a----          cac   -  UCCCA  A  AC  
 
Secondary structure for new miRNAs and new loci of annoated miRNAs predicted 
by mfold web server. First line started with the name of the miRNA followed by 
database (Ensemble 52; Btau_4.0), genomic location (chromosome number: start: 
end: sense or antisense orientationand orientation, (position of the mature sequence 
in the precursor) and minimum free energy. Position of the mature sequence in the 
hairpin precursor is indicated as lower case and by the red color. 
 
Characterization of miRNAs was done based on the annotation in the bovine genome 
data base Ensembl 52: Btau_4.0 (De La Fuente and Eppig 2001). Bomir-F0522-3p and 
bomir-A4052-5p were mapped to both intergenic and intronic locations. Bomir-F0132-
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5p (sense), bomir-E2664-3p (antisense) and bomir-A4052-5p (antisense) are originated 
from the exons of protein-coding genes. While searching the genomic location for all 
miRNAs, six new genomic locations for annotated miRNAs like bta-mir-106, 24, 26, 
199a and let-7b were found.  
 
All the 50 new genomic loci were found to be distributed in 19 chromosomes (Chr.) 
namely: Chr. 3, 4, 5, 7, 8, 9, 11, 12, 14, 16, 18, 19, 20, 21, 22, 25, 26, 28 and 29. 
However, eight loci were found to be mapped to unknown chromosome in the Ensembl 
52: Btau_4.0 (end note). Among all newly identified loci, eight miRNA genes were 
found to be located on Chr. 18 and five miRNAs found on Chr. 7 and 21. Further 
analysis of the already annotated miRNAs and the newly predicted loci has revealed six 
miRNAs gene clusters which were mapped within < 10 kb. This clusters are i) bta-miR-
10a and bomiR-A0321 on Chr. 19; ii) bta-miR-23b, bta-miR-27b and bta-miR-24-3 on 
Chr. 8; iii) bta-let-7a-3 and let 7b-2-3P on Chr. 5; iv) bomiR-A4052-1 and bomiR-
C0533 on Chr. 18; v) bta-miR-487a, bta-miR-487-b, bomiR-382 and bomiR-409 on 
Chr. 21; vi) bomiR-C0533-2 and bomiR-A4052-2 on Chr. 21.  
 
To determine whether new miRNAs are conserved among closely related species, 
homology for precursor sequence in the ENSEMBL genome databases have been 
searched. Results revealed that 17 precursor loci (out of 43 loci for 38 new bovine 
miRNAs) were found to be conserved in at least six species. While five miRNAs 
(bomiR-F0244, bomiR-A0321, bomiR-F2531, bomiR-D3011 and bomiR-A3711) were 
found to be conserved in at least two species, 21 miRNA loci were specific to bovine. 
All of the newly cloned miRNAs were found to be conserved as mature sequences in 
the genome of different species. Thermo-dynamically stable hairpin structures have 
been found for those conserved and new miRNAs as shown in table 3.3.  
 
3.2.4 Other small RNAs and their genomic properties found in the library 
 
Analysis of small RNA library in the present study has enabled us to identify 57 
different endogenous siRNAs. They were categorized broadly into two groups, namely: 
29 sequences composed of 27 distinct RNAs derived from genomic repetitive region as 
repeat associated small interfering RNAs (rasiRNAs) and other 30 RNAs associated to 
non repetitive regions as non-repeat associated small interfering RNAs (nasiRNAs). 
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According to their sequence properties 13 out of 30 nasiRNAs were found to be natural 
antisense transcripts with ~20 nt in length. Therefore, since they seem to be endogenous 
siRNAs, they were denoted as small antisense RNAs (santRNAs) and the rest 17 as tiny 
non-coding RNAs (tncRNAs). Size ranges for rasiRNAs were 18-28 nt with mean ± SD 
21.5 ± 3.1 nt, which do not reveal a sharp size distribution characteristic. However, for 
the santRNAs and tncRNAs the size distribution was 19.6 ± 1.9 and 19.5 ± 1.1 nt, 
respectively. Cloned rasiRNAs were found to be distributed on various chromosomes 
and mapped to repeat sequences mostly corresponding to retrotransposons in both sense 
and antisense orientation. Total numbers of hits for 27 rasiRNAs were 581 (ranging 
from 4 to100). Seventy five percent of the rasiRNAs were found to have preference for 
uridine and adenine residues in either 3´ or 5´ end position. While seven of the 
santRNAs were precisely mapped to intergenic region, six fitted to intronic region. All 
the 13 santRNAs were cloned as antisense orientation to the genome or intron of the 
protein coding genes on 12 different chromosomes.  
 
Secondary structure analysis of all santRNAs revealed no characteristic hairpin as found 
for the miRNAs. While eleven tncRNAs were mapped to intergenic region, five were 
mapped to intronic and two to exonic regions. Two of the seventeen tncRNAs are 
predicted to form potential fold back structures like the miRNAs. However, these 
putative tncRNA precursor structures deviate significantly from the miRNA hairpins in 
key features and they were found to be poorly conserved in closely related species.  
 
3.2.5 Detection and expression of miRNAs in the ovary and other bovine tissues 
 
The expression of all new miRNAs including nine annotated miRNAs (let-7b, mir-15b, 
mir-18a, mir-29a, mir-125b, mir-126, mir-145, mir-199a and mir-222) in 11 different 
bovine tissues were analyzed using semi-quantitative RT-PCR (details in figure 3.4, 
table 3.4). As small RNAs cloned in the library derived from all compartments of the 
ovary, samples from ovarian cortex, cumulus cells and matured corpus luteum were 
used to determine the sub-cellular expression profile of the new miRNA using RT-PCR 
(Table 3.4). This is because of two facts: firstly, the bovine ovary is continuously 
changing throughout the process of folliculogenesis and secondly, the distinct nature of 
function of intra-ovarian cells and tissues compartments in the ovary.  
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Figure 3.4: Detection and expression analysis of selected miRNAs in multiple tissues. 
Expression profiles of some representative miRNAs (out of detected 44 
miRNAs) in multiple tissues by PCR approach. The expressions for all 
miRNAs are summarized in the table 3.4. Amplicons were analyzed on 2% 
agarose gel. 5S rRNAs and U6 RNA were used as a loading control. A 
DNA ladder (M) indicating the size of the fragments (50-100-150 nt) on 
each side. Ovary denotes only the ovarian cortex without corpus luteum. 
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Table 3.4: Detection and expression of selected miRNAs in multiple tissues 
miRNAs 
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5s rRNA +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ 
U6 RNA +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ 
bta-let7b ++ +++ +++ +++ ++ + +++ ++ + ++ +++ 
bta-mir-15b + +++ +++ +++ +++ +++ +++ +++ +++ + +++ 
bta-mir-18a +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ 
bomir-22*/22-5p + + + - - - - + - + + 
bta-mir-29a +++ - +++ - - - +++ +++ + ++ ++ 
bta-mir-125b - ++ +++ ++ ++ + ++ ++ - +++ + 
bta-mir-126 ++ +++ ++ +++ +++ +++ +++ +++ +++ +++ +++ 
bomir140*/140-5p +++ +++ +++ ++ ++ ++ ++ ++ ++ - ++ 
bomir-143-3p ++ +++ + ++ + + +++ ++ + + ++ 
bta-mir-145 ++ +++ - ++ - - +++ ++ ++ - +++ 
bomir-152-5p ++ ++ - ++ +++ +++ ++ ++ +++ +++ +++ 
bomir-193a-2-3p + ++ ++ - ++ ++ ++ + + ++ ++ 
Bta-mir-199 +++ ++ +++ ++ ++ ++ +++ +++ ++ +++ +++ 
bta-mir-222 - - +++ - - ++ - - + + + 
bomir-378-3p +++ +++ - - ++ +++ + ++ + + - 
bomir-382-3p + - - - +++ +++ +++ +++ - - +++ 
bomir-409-5p + +++ +++ ++ +++ +++ +++ +++ +++ +++ ++ 
bomir-424-3p ++ - - - + ++ - - ++ - + 
bomir-503-3p ++ +++ +++ ++ + + ++ ++ + ++ ++ 
bomir-542-3p - ++ ++ ++ +++ ++ +++ ++ ++ + + 
bomir-574-5p + + - + + ++ ++ ++ ++ ++ ++ 
bomir-652-3p + +++ - +++ ++ +++ - - ++ - - 
bomir-940-5p + - - - +++ + - + +++ ++ - 
bomir-F0132-5p +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ 
bomir-F0244-5p + ++ +++ ++ + ++ ++ + ++ + + 
bomir-H0222-3p - ++ - +++ + + ++ ++ - + + 
bomir-A0321-3p ++ ++ ++ ++ ++ ++ ++ ++ ++ + ++ 
bomir-C0533-5p + +++ ++ + - + + + - - - 
bomir-F0522-3p - - ++ ++ - - - + - - - 
bomir-F1351-3p ++ - - +++ ++ +++ + +++ +++ ++ +++ 
bomir-F1353-5p ++ ++ - ++ + +++ +++ + +++ - + 
bomir-D1431-5p ++ +++ ++ +++ ++ + ++ +++ - + - 
bomir-C1511-5p + + - + ++ ++ + ++ ++ + + 
bomir-F1821-3p ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ 
bomir-C1931-5p + ++ - +++ +++ +++ +++ +++ +++ - +++ 
bomir-A2143-3p - ++ - +++ +++ +++ ++ ++ ++ ++ +++ 
bomir-F2422-5p +++ - - + + +++ - - ++ - + 
bomir-F2531-3p + - - + ++ ++ + +++ ++ + - 
bomir-G2511-3p + - - + + +++ + +++ ++ ++ - 
bomir-E2664-3p ++ ++ ++ ++ + ++ ++ + ++ + ++ 
bomir-D3011-3p + + ++ + + + + + + ++ + 
bomir-A3341-3p + + + + + + + + + + + 
bomir-A3711-5p + + - + + + +++ + + + + 
bomir-A4052-5p + + - ++ ++ ++ ++ ++ +++ ++ ++ 
 
Expression profiles of 44 miRNAs including all new miRNAs in multiple tissues 
by PCR approach. Amplicons were analyzed on 2% agarose gel. 5S rRNAs and 
U6 RNA were used as a loading control. Relative band intensity was categorized 
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into four groups like ‘+++’ for Strong signal, ‘++’ for Medium signal, ‘+’ for 
Weak signal or smear like product and ‘-’ for not detected by comparing the 
expression signal of each miRNA to the expression level of 5S rRNA and U6 
RNA.  a: Ovarian cortex with no visible corpus luteum, b: Ovary from fetus at 
about 5th  month of pregnancy, c: Mature corpus luteum from the same Ovary. 
 
Of all 47 miRNAs (38 new and 9 already annotated miRNAs) 44 were detected in both 
ovarian cells and multiple tissues. Five miRNAs (bta-mir-126, bomir-F0132, bomir-
A0321 and bomir-F1821) were found to be expressed at similar level in all experimental 
tissues. Seven miRNAs (bta-mir-18a, bta-mir-29a, bomir-140, bta-mir-199, bomir-378, 
bomir-F0132 and bomir-F2422) were found to be expressed at relatively higher levels 
in ovarian cortical portion (Table 2). On the other hand, all undetected or less expressed 
miRNAs in ovarian cortex have been shown to be highly expressed in cumulus cells or 
corpus luteum. Most of the miRNAs were found to be differentially expressed between 
adult ovarian tissues and fetal ovary. Among them bta-mir-15b, bomir-409, bomir-652, 
bomir-C0533 and bomir-D1431 were highly expressed in the fetal ovary compared to 
that of adult ovarian cortex. However, bta-mir-29a, bta-mir-199 and bomir-F2422 were 
found to be expressed at higher level in the adult ovarian cortex than that of the fetal 
ovary (Table 2). Bta-mir-125b, bta-mir-222, bomir-542, bomir-652, bomir-H0222, 
bomir-F0522, bomir-C1931 and bomir-A2143 were found to be expressed at very low 
level or not detected at all in the ovarian cortex. However, their abundance was higher 
in the cumulus cells and matured corpus luteum. The expression of bta-mir-222 was 
detected exclusively in the cumulus cells. In addition, higher expression of bta-mir-
125b, bomir-409, bomir-503 and bomir-F0244 was also observed in the cumulus cells. 
The expression of bomir-652, bomir-H0222, bomir-C1931 and bomir-A2143 was 
higher in the corpus luteum.  
Moreover, higher expression level of different miRNAs in various reproductive tissues 
was also observed. This includes bomir-940 in the oviduct; bta-mir-222, bomir-F2422 
and bomir-G2511 in the uterus; and bta-mir-29a, bomir-143, bta-mir-145, bta-mir-199, 
bomir-542 in the placenta. All these investigated miRNAs were detected at least in one 
of the non-ovarian somatic tissues including heart, liver, lung and spleen (Table 3.4). 
The RT-PCR analysis did not confirm the expression of three novel miRNAs (bomir-
F0131, bomir-H0121 and bomir-B0821) in any of the tissues under investigation (image 
not shown). 
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In order to elucidate the cellular localization of one miRNA, bta-miR-29a was selected 
due to its differential expression between adult and fetal ovary, which are distinct in 
their functional activity.  
 
Accordingly, in-situ localization of this miRNA in the sections of bovine ovarian 
follicle revealed its expression in the different intra-ovarian cells (theca, mural 
granulosa, cumulus granulosa and oocyte) of different stages of development including 
primordial, primary, growing and matured/tertiary follicles (Figure 3.5). Stable 
expression was detected in the whole mount cumulus-oocyte-complexes derived from 
the follicles of more than 8 mm in diameter. In the semi-quantitative RT-PCR data, 
expression of this miRNA was found in the cortex region of the adult ovary where 
follicles with cumulus cells are residing. Moreover, the expression of this miRNA was 
detected further until early stage of corpus luteum (Figure 3.5), but very low or no 
expression in the matured corpus luteum (Figure 3.4).    
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Figure 3.5: In-situ detection of mir-29a in the ovarian sections and whole mount COCs. 
Bovine ovarian cryo-sections and whole mount cumulus-oocyte complexes 
were in situ hybridized with 3'-digoxigenin labeled locked nucleic acid 
(LNA) microRNA probes for miR-29a (1), U6 RNA (2) and scrambled 
miRNA (3). BL- Basement Laminae, TI- Theca Interna, TE- Theca Externa, 
GR- Multiple layers of Granulosa, ZP-Zona Pellucida, OO-Oocyte, CR- 
Corona Radiata, AN-Antrum of the follicle, PT- Presumptive theca in the 
growing follicle. 
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3.2.6 Prediction and functional categorization of cloned miRNA targets  
 
The goal of this prediction and analysis was to find the major biological processes and 
signaling pathways in the ovary that are most likely affected by a group of miRNAs. 
Even though there were many potential target genes predicted for the cloned miRNAs, 
several filtering and screening procedures (see materials and methods) have enabled us 
to generate a comprehensive target list consisting of 115 potential genes from all the 
predicted targets. From this screened target set, let-7b, mir-15b, mir-18a, mir-29a, mir-
101, mir-125b, mir-126, mir-143, mir-145, mir-199a and mir-222 found to have the 
highest number and overlapping targets (Figure 3.6). Interestingly, all of these targeting 
miRNAs were represented at higher frequency in the constructed library.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Eleven miRNAs with highest number of screened target genes (sub-set 
miRNAs targets). Each circle representing one miRNAs and the 
surrounding genes are targeted by that miRNA. Genes shared by the 
different circles highlighted as blue (overlapping genes between miRNAs), 
which are commonly targeted by the corresponding miRNAs. 
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Table 3.5: Ingenuity analysis of the genes targeted by top eleven screened miRNAs  
 
miRNAs Functions and disease categories enriched with 
the selected miRNA targets 
Canonical Pathways enriched with the 
selected miRNA targets 
Let-7b Tissue morphology, cellular growth and 
proliferation, endocrine system disorders 
IGF-1 signaling, hepatic 
fibrosis/hepatic stellate cell activation 
mir-15b cell death, connective tissue development and 
function, cell cycle 
p53 signaling, PPARα/RXR activation 
 
mir-18a Cell cycles, cellular function, endocrine system 
development 
Cell cycle: G1/S checkpoint 
regulation, TGF-β signaling 
mir-29a Reproductive system development and 
function, organ development, endocrine system 
development 
Ephrin receptor signaling 
Aminophosphonate metabolism 
mir-101 Endocrine system development, lipid 
metabolism, small molecule biochemistry 
C21-steroid hormone metabolism, 
Androgen and estrogen metabolism 
mir-125b Inflammatory response, cell cycle, cellular 
function and maintenance 
LPS/IL-1 Mediated inhibition of RXR 
function, LXR/RXR activation 
mir-126 Cellular movement, Endocrine system 
disorders, cell mediated immune response 
Pro-apoptosis, PXR/PXR activation 
 
mir-143 Cellular growth and proliferation, DNA 
replication, recombination and repair, gene 
expression 
G1/S transition of the cell cycle, p53 
signaling 
mir-145 Reproductive system diseases, reproductive 
system development and function, cell death 
BMP signaling pathway, VEGF 
signaling 
mir-199a Cellular development, cell death, cellular 
growth and proliferation 
Cell cycle: G2/M DNA damage 
checkpoint regulation, p38 MAPK 
signaling 
mir-222 Cellular development, reproductive system 
development and function, cell death 
IGF-1 signaling, Axonal guidance 
signaling 
 
Eleven top miRNAs targeting highest number of genes from the screened and 
filtered all predicted targets and their top Gene Ontology categories and pathways 
based on Fisher' Exact P-value (<0.05) are presented in the table.  
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Figure 3.7: Top biological function, disease categories and pathways enriched with 
predicted and screened miRNA target genes. A. Top biological functions 
and disease categories and B. pathways enriched with predicted and 
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screened miRNA target genes. Ratio is the number of affected genes to 
total number of genes in the pathway. Threshold p < 0.05 is shown as 
yellow line. Bars that are above the line indicate significant enrichment of 
a functional category or pathway. 
 
Detailed Gene Ontology (GO) analysis of the screened and sub-sets of miRNAs target 
genes were found to be associated with reproductive system development, function and 
disorders. These include cell cycle, morphology, cell death, cell to cell signaling, 
cellular growth, development and proliferation, DNA replication, recombination & 
repair, endocrine system disorder and different pathways underlying the ovarian 
functions. To further elucidate the specific functions of these genes, a detailed pathway 
analysis was performed using Ingenuity Pathway Analysis (Redwood City, California) 
for all target sets (Figure 3.7) as well as for the sub-set of genes (Table 3.5). 
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3.3 Discussion 
 
3.3.1 Identification of small RNAs 
 
MicroRNAs play an integral part of animal gene regulatory networks as one of the most 
abundant classes of gene regulators. They are estimated to comprise 1–5% of animal 
genes (Bartel 2004, Bentwich et al. 2005, Berezikov et al. 2005) or a given genome 
could encode nearly thousands of miRNAs (Bentwich et al. 2005). Moreover, a typical 
miRNA regulates hundreds of target genes (Brennecke et al. 2005, Krek et al. 2005, 
Lewis et al. 2005, Xie et al. 2005) and altogether they could target a large proportion of 
genes up to 30% of the genome (Lim et al. 2005). Changes in the expression of even a 
single miRNA could have a significant impact on the outcome of diverse cellular 
activities regulated by the product of these genes. Beyond the strict conservation of 
miRNAs across different species, some miRNAs appears to be species specific (Ambros 
et al. 2003a, Bentwich et al. 2005, Stark et al. 2007). Compared with computational or 
heterologus approaches, direct cloning has the advantage of identifying non-conserved 
and new miRNAs.  
 
Cloning and expression analysis led to the identification of 74 miRNAs out of which 38 
are new in bovine. Mature sequences were found to be conserved in closely related 
species, but when considering precursor sequence only 51% was found to be conserved 
in human, mouse, rat, dog, horse and also in other non-mammalian vertebrates. 
However, in the present study 17 miRNA precursors corresponding to 21 genomic loci 
were found to be not conserved (Table 1). This could be either due to the lack of 
sequences in draft genome assembly or these miRNAs are bovine specific. The genomic 
properties of identified new miRNAs showed that they are derived from exon, intron 
and intergenic region. This may suggest that these miRNAs can be transcribed in 
parallel with their host transcripts. In addition, two different transcription classes of 
miRNAs (‘exonic’ and ‘intronic’) recognized here may require somewhat different 
mechanisms of bio-genesis as stated previously (Rodriguez et al. 2004). Discovery of 
six clusters composed of 15 miRNA genes on six chromosomes showed that these 
closely located host genes may share the same cis-regulatory elements and the miRNAs 
within the clusters might be expressed in the same tissues or at the same developmental 
or physiological stage. 
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The representation of many known and novel miRNAs in this single library indicates 
the presence of potential miRNAs, which are not yet discovered. Both in-depth analysis 
of the existing library and cell-type-specific analysis of individual miRNAs will give 
insight into the functional mechanisms and pathways involved in ovarian 
folliculogenesis in particular and female fertility in general. All the sequences for new 
and known miRNAs were submitted to the miRBase for official annotation and 
recognition. The accession number and annotated name for all novel miRNAs were 
assigned by the miRBase in version 15.0 according to the universal criteria specific to 
the miRNAs, which are presented in table 3.6. 
 
Table 3.6: Annotated novel miRNAs with their accession number provided by the 
miRBase organization   
 
 Original clone ID Sequence (5´-3´) Annotated  
new name 
Assigned 
accession 
 bomir-424-3p CAAAACGUGAGGCGCUGCUAU bta-mir-424* MI0012212
 bomir-193a-2-3p GGGACUUUGUAGGCCAGUU bta-mir-193a-2 MI0013051
 bomir-378-1-3p ACUGGACUUGGAGUCAGAAGGC bta-mir-378-2 MI0013052
 bomir-574-5p UGUGGGUGUGUGCAUGUGCGUG bta-mir-669 MI0013053
 bomir-F0131-5p GGGGCGGGGGGGCGGGUG bta-mir-2881 MI0013054
 Bomir-F0132-5p AGCCCGGGCCCCUCCCCUG bta-mir-2882 MI0013055
 bomir-H0121-3p CUUCCCGUGUGUUGAGCC bta-mir-2883 MI0013056
 bomir-F0244-5p GCUACUACCGAUUGGAUGG bta-mir-2884 MI0013057
 bomir-H0222-3p CGGCGGCAGCGCCGGGGCG bta-mir-2885 MI0013058
 bomir-A0321-3p AGCGCCGCCGGCCGCACC bta-mir-2886 MI0013059
 bomir-C0533-1-5p CGGGACCGGGGUCCGGUGCG bta-mir-2887-1 MI0013060
 bomir-C0533-2-5p CGGGACCGGGGUCCGGUGCG bta-mir-2887-2 MI0013061
 bomir-F0522-1-3p GGUGGGGUGGGGGGGUUGG bta-mir-2888-1 MI0013062
 bomir-F0522-2-3p GGUGGGGUGGGGGGGUUGG bta-mir-2888-2 MI0013063
 bomir-B0821-5p GUCCCCGGGGCUCCCGCCGGC bta-mir-2889 MI0013064
 bomir-F1351-3p GCCCCGGCCGCUCCCGGCCU bta-mir-2890 MI0013065
 bomir-F1353-5p AUCUUUGGGCUAGGUUAGUU bta-mir-2891 MI0013066
 bomir-D1431-5p GGCGACGGAGGCGCGACCCCCC bta-mir-2892 MI0013067
 bomir-C1511-5p GUGGAGGAGAAUGCCCGGGG bta-mir-2893 MI0013068
 bomir-F1821-3p AGCCCUGGCCCUGCCAUCGUG bta-mir-2894 MI0013069
 bomir-C1931-5p CCUGCUGAUCUCACAUUAAUUCA bta-mir-2895 MI0013070
 bomir-A2143-3p CGGCAGAUGAAGUCCAUC bta-mir-2896 MI0013071
 bomir-F2422-5p GGUGGGAGGGUCCCACCGAG bta-mir-2897 MI0013072
 bomir-F2531-3p UGGUGGAGAUGCCGGGGA bta-mir-2898 MI0013073
 bomir-G2511-3p AGGCGGGCCGGGGUUGGA bta-mir-2899 MI0013074
 bomir-E2664-3p AGGGCGGGCGGCGACUGGAA bta-mir-2900 MI0013075
 bomir-D3011-3p CCGAGUGCUCCCGCGAGCGCU bta-mir-2901 MI0013076
 bomir-A3341-1-3p GUGGCUGUCCCUGGAGGUGGG bta-mir-2902-1 MI0013077
 bomir-A3341-1-3p GUGGCUGUCCCUGGAGGUGGG bta-mir-2902-2 MI0013078
 bomir-A3711-5p UUCCGCGCUCUACGCCAGC bta-mir-2903 MI0013079
 bomir-A4052-1-5p GGGAGCCUCGGUUGGCCUC bta-mir-2904-1 MI0013080
 bomir-A4052-1-5p GGGAGCCUCGGUUGGCCUC bta-mir-2904-2 MI0013081
 bomir-A4052-1-5p GGGAGCCUCGGUUGGCCUC bta-mir-2904-3 MI0013082
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 bomir-22*/22-5p ACAGUUCUUCAACUGGCAGCUU bta-mir-3600 MI0015943
 bomir-152-5p CCAAGUUCUGUCAUGCACUGA bta-mir-2957 MI0015944
 bomir-382-3p GAAUCCACCACGAACAACUUC bta-mir-3578 MI0015945
 bomir-409-5p GGGGUUCACCGAGCAACAUUC bta-mir-3581 MI0015946
 bomir-542-3p UCUCGUGACAUGAUGAUCCCCGA bta-mir-3601 MI0015947
 bomir-652-3p GUGUUGGGAUCACCGCGGUAA bta-mir-3602 MI0015948
 bomir-26-2-3p AGCCUAUCCUGGAUUACUUGAA bta-mir-3603 MI0015949
 bomir-199a-2-5p UAACCAAUGUGCAGACUACUGU bta-mir-3604-1 MI0015950
 bomir-199a-2-5p UAACCAAUGUGCAGACUACUGU bta-mir-3604-2 MI0015951
 bta-let-7b-2-3p AACCACACAACCUACUACCUCA bta-mir-3596 MI0015952
 
In the present study several types of endogenous small interfering RNAs were identified 
along with the miRNAs. Among them, 27 distinct rasiRNAs represented the frequent 
class of small RNAs. Thirteen RNAs were classified as small antisense RNAs, while 17 
small RNAs were tiny non-coding RNAs. The small RNA cloning and profiling from 
another study revealed less representation of that group of rasiRNAs compared to the 
miRNAs (Aravin and Tuschl 2005). The properties identified for rasiRNAs here support 
the notion that they are presumably emerged from dsRNA produced by annealing of 
sense and antisense transcripts that contain repeat sequences related to transposable 
elements (Aravin et al. 2003). These rasiRNAs are known to repress the repeat 
sequences at the transcriptional or post-transcriptional level and maintain a centromeric 
heterochromatic structure (Lippman and Martienssen 2004). Identity and properties of 
new types of small RNAs in the present study showed the presence of diverse modes of 
small RNA-mediated gene regulation in bovine ovary, as reported in other species 
(Ambros et al. 2003b). Therefore, identification and characterization of other small 
RNAs and their expression patterns are important for elucidating detailed gene 
regulatory networks involved in the ovary. So, all these endogenous small interfering 
RNAs need to be further characterized to elucidate their cellular functions.  
 
3.3.2 Expression of miRNAs in diverse tissue types 
 
Expression analysis of 44 miRNAs in different ovarian cells and tissues types has 
enabled us to determine their site of action in terms of tissue specific abundance as well 
as functional regulation (Table 2). Nearly all of these miRNAs in at least one part of the 
entire ovary and other somatic tissues have been detected. In the present study, some 
miRNAs appear to be extremely tissue specific. For example; bomir-C0533 and bomir-
F0522 were found to be exclusively expressed in ovarian tissues suggesting their 
potential role in ovary-specific miRNA-dependent regulatory processes. Five miRNAs 
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(miR-29a, miR-125b, bomir-409, bomir-503 and bomir-F0244) were found to be highly 
abundant in the cumulus cells and four (bomir-652, bomir-H0222, bomir-C1931 and 
bomir-A2143) in corpus luteum. These cumulus enriched miRNAs in the present study 
may represent those miRNAs with potential association with the regulation of cumulus 
secreted factors, which are important for cumulus-oocyte communication and 
subsequent oocyte development. Similar study in mouse showed hormonal regulation of 
miRNAs expression in preovulatory mural granulosa cell (Fiedler et al. 2008). 
 
The expression of various ovary related genes was reported to be differentially regulated 
between ovaries from fetal, new born and adult animals (Baillet et al. 2008, Herrera et 
al. 2005, Olesen et al. 2007, Vaskivuo et al. 2001). Furthermore, alteration in expression 
of small RNAs has been addressed at different stages of mouse ovary (Ro et al. 2007b). 
Similarly, in the present study, differential expression of mir-29a, bomir-140, mir-199, 
mir-378, bomir-F0132 and bomir-F2422 in the ovarian cortical portion between fetal 
and adult cows. This may indicate their possible involvement in regulating follicular 
development in the adult cyclic ovarian function. This notion was further supported by 
higher detection of miR-29a in different follicular cells (theca, cumulus-granulosa, and 
oocyte) of adult ovary by in situ hybridization (Figure 5) and higher expression in 
cumulus cells by RT-PCR but no detection in the fetal ovary. The expression of 
miRNAs in ovarian cells is reported to be regulated by FSH and LH / hCG (Fiedler et 
al. 2008, Yao et al. 2009) which functions in the cyclic ovary but not in fetal ovary 
(Abel et al. 2000). Moreover, most of the targets predicted for this miRNA (Figure 6) 
are known to be involved in various cyclic adult ovarian functions.  
 
Noticeable expression level of miR-29a was found in different phases of corpus luteum 
(CL) development. According to RT-PCR and in situ hybridization results, expression 
of miR-29a was detected in the early phase CL but not in mid phase (matured) CL. 
These two phases of CL development are known to vary in multiple aspects of luteal 
physiology, angiogenesis and sensitivity to luteolytic actions, which are accompanied 
by differential expression of multiple genes (Copelin et al. 1988, Goravanahally et al. 
2009, Watts and Fuquay 1985, Wiltbank et al. 1995). Bovine corpus luteum is reported 
to be resistant to luteolysis by exogenous PGF2α in early stage of CL (before Day 5) 
due to differential expression of genes associated with the PGF2α receptor 
(Goravanahally et al. 2009). Considering these facts and restricted expression of miR-
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29a in early phase of CL in the present study, it is possible to suggest that miR-29a is 
involved in gene regulatory action during early phase of CL. All in all, present results 
on miR-29a may elucidate the potential involvement of this regulatory miRNA in 
growth and differentiation of cumulus cells, endocrine regulation of theca cells and 
early luteinisation in cyclic ovary. 
 
Cloning, determining potential secondary structures and expression analysis of all new 
miRNAs in multiple tissues indicate their tissue specific existence and regulation of 
gene expression. Only 7.8% of the new miRNAs could not be detected by the RT-PCR 
procedure in various reproductive tissues. This may be due to the fact that these 
transcripts were cloned at lower frequency (only once) showing their lower abundance 
and subsequent difficulty to detect them (Gu et al. 2007). In general, the expression 
profiling analysis in the present study revealed that cloned miRNAs were either 
ubiquitously expressed in multiple tissues or preferentially expressed in a few tissues 
including the intra-ovarian cells and tissues. 
 
3.3.3 Features of predicted target genes 
 
Multiple genes contributing to mammalian folliculogenesis have been identified in 
mouse knockout study (Matzuk and Lamb 2002). Primarily, oocyte-specific 
transcriptional regulators like Figla, Nobox, Sohlh1 and Lhx8, oocyte-secreted factors 
such as Gdf9 and Bmp15, as well as genes expressed in the granulosa and cumulus cells 
(FSHR and PTX3) were found to initiate and control follicular growth (Dumesic and 
Abbott 2008, Matzuk and Lamb 2002). Among the key intra-ovarian factors, the 
transforming growth factor b (TGFb) family members, of which bone morphogenetic 
protein-4 have been identified as regulators of primordial germ cell generation (van den 
Hurk and Zhao 2005).  
 
In response to FSH, the granulosa cell–derived factors such as kit ligand, transforming 
growth factor alfa (TGF-α) and epidermal growth factor (EGF) activate the resting 
follicular growth. The interactions between ovarian germ and somatic cells (granulosa 
cells and the oocytes) and expression of several intra-ovarian autocrine/paracrine 
regulators (FSH, estrogen and androgen receptors) are the major contributing factors in 
the ovary leading to preantral and antral follicles development (Filicori et al. 2003).  
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During follicle growth, IGF system works in synergy with gonadotrophins (follicle-
stimulating hormone and luteinising hormone) to regulate proliferation and 
differentiation of granulosa and theca cells (Campbell et al. 1998, Gutierrez et al. 1997). 
In addition, it has been shown that the processes of follicular dynamics (Recruitment, 
selection, dominance and ovulation) are associated with temporal changes of peripheral 
gonadotropins concentration and IGF system (Austin et al. 2001, Fortune et al. 2001, 
Ginther et al. 2002, Ireland et al. 2000, Mihm and Evans 2008, Quintal-Franco et al. 
1999, Schams et al. 1999). All the above-mentioned genes are represented in the 
predicted and analyzed targets. Altogether 115 genes were among potential target genes 
of identified miRNA. These target genes are already experimentally validated for 
potential ovary related functions in different mammalian species. Interestingly, several 
well-known target genes including IRS1, IGFBP3, DNMT3A, HOXA9, TNF, etc. 
which are identified by new screening approach, are already validated in wet lab 
experiments and reported as targets of multiple miRNAs (miR-145, miR-125b, miR-126 
and miR-29) (Fabbri et al. 2007, Shen et al. 2008, Shi et al. 2007a, Shi et al. 2007b, Tili 
et al. 2007). Accordingly these studies have elucidated the potential involvement of 
these miRNAs in broad class of functions related to apoptosis, differentiation signal, 
cell differentiation, tumorogenesis, DNA methylation and innate immune responses.  
 
Gonadotropins, intra-ovarian mediators and their receptors which are identified as target 
genes for identified miRNAs might mediate important intracellular actions necessary 
for normal follicular development and other ovarian functions. Alterations in the 
expression of these mediators by miRNAs will result in various ovarian dysfunctions 
causing infertility, polycystic ovary syndrome and tumorigenesis. Recent evidences also 
support the hypothesis, where at least six of 11 top ranked ovarian miRNAs were found 
to be related to cancer or tumors in the ovary. For example, miR-199a, miR-145, miR-
125b and let-7 clusters were found to be the most differentially regulated miRNAs in 
human ovarian cancer (Iorio et al. 2007, Yang et al. 2008a). While miR-145 (Iorio et al. 
2005) and mir-199a (Murakami et al. 2006) have recently been shown to be down-
modulated in the tumor cells, the miR-222 is reported to be down-regulated in ovarian 
epithelial carcinomas (Iorio et al. 2007). Furthermore, higher expression of miR-18a 
and lower expression of let-7b and miR-199a were shown to be correlated with serous 
ovarian carcinoma (Nam et al. 2008). In another study, miR17-5p and let-7b were found 
to be involved in the regulation of development and function of the ovarian corpus 
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luteum specially angiogenesis of corpus luteum (Otsuka et al. 2008). Interestingly, 
nearly all of these 11 selected miRNAs (Figure 6) in the present study are reported to be 
differentially regulated in endometrium of women with and without endometriosis (Pan 
et al. 2007). Altogether present findings and other evidences support the relevance of 
these 11 miRNAs to ovarian physiology and may be the most important regulatory 
miRNA group in ovary, as their predicted and analyzed target genes are involved in a 
broad range of signaling cascades and pathways of the ovarian function. 
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4 Part II: miRNAs in the placentas derived from in vivo, in vitro and somatic cell 
nuclear transfer pregnancies 
 
Somatic Cell Nuclear Transfer is a break-through technology but it is hindered by very 
low rates of live birth due to high incidence of placental abnormalities. The major 
source of these abnormalities is thought to be due to genetic and epigenetic 
modifications arise from improper reprogramming of the donor cell after nuclear 
transfer, which leads to post-implantation lethality to embryo with ultimate placental 
defects. miRNAs have been evidenced as an important modifier that regulates gene 
expression. However, the role of miRNAs in placenta derived from SCNT is unknown. 
The study aimed to elucidate the difference in expression profile of miRNAs in the 
placenta (at day 50) derived from artificial insemination (AI), in vitro production (IVP), 
SCNT pregnancy and in the donor cells (fibroblast from the same bull used to generate 
AI & IVP derived pregnancies) by quantifying 377 miRNAs. For this purpose, in vitro 
fertilization and SCNT was performed using semen and fibroblast, respectively from the 
same bull to generate embryo in vitro. Then the both group of embryos were cultured in 
vitro up to day-7. Some blastocysts were fixed and freezed for in situ hybridization and 
expression profiling, respectively. The rest of the embryos were transferred to the 
synchronized recipients to maintain pregnancy. On the other hand artificial insemination 
was performed to generate control embryos which were recovered at day 7 by flushing 
and the rest of the heifers were used to maintain pregnancy up to slaughter stage to 
recover control placentas. Animals were slaughtered gradually at day 16, day 50 and 
day 225 of pregnancy from all three groups (AI, IVP and NT) to recover elongated 
embryos, placenta and placentomes, respectively. Total RNAs from the frozen placenta 
(20 mg) of different sources and fibroblast cells were isolated and real time qRT PCR of 
miRNAs was performed using 384-well miRNAs arrays comprised of 377 individual 
miRNAs. Furthermore, cell specific expression of some selected miRNAs in the 
expanded blastocysts of different sources by whole mount in situ hybridization was 
performed. Temporal expression of selected miRNAs in fibroblast, blastocyst, expanded 
blastocyst, day-16 elongated embryo, day-50 placenta and day 225 placenta (AI, IVP 
and SCNT pregnancies) by real time qRT-PCR. In addition, global DNA methylation in 
the day 16 elongated embryos and day 50 placenta of different sources of pregnancies 
were performed. The detail materials and method followed and the obtained findings are 
presented in the following sections. 
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4.1 Materials and methods 
 
Following sections describe the detail materials which were utilized and brief methods 
followed in this experiment to study the pattern of miRNA expression and their 
regulation in the placenta and embryos from the pregnancy derived by nuclear transfer 
and in vitro produced embryo comapared to that from artificial insemination pregnancy. 
List of some materials which have also been used in the part I and mentioned in the 
related previous section are not listed here.     
 
4.1.1 Materials and tools 
 
4.1.1.1 List of chemicals, kits, biological and other materials 
 
List of Chemicals Manufacturer/Supplier 
2-Mercaptoethanol Sigma-Aldrich Chemie GmbH, Munich, Germany
5 α DH E. coli competent cells Stratagene, Amsterdam, The Neatherlands 
6-dimethylaminopyridine Sigma-Aldrich Chemie GmbH, Munich, Germany
Agar-Agar Roth, Karlsruhe, Germany 
Digoxigenin-AP Roche Diagnostics GmbH, Mannheim, Germany 
BioThermD™ Taq DNA Pol Ares Bioscience GmbH, Cologne, Germany 
Bovine serum ablbumin (BSA) Promega, Mannheim, Germany 
Dimethyl sulfoxide (DMSO) Roth, Karlsruhe, Germany 
DNA/RNA/Protein purification kit Norgen Biotek corporation, Thorold, Canada 
dNTPs Roth, Karlsruhe, Germany 
DMEM-F12 Ham Sigma-Aldrich Chemie GmbH, Munich, Germany
Dulbecco’s phos buff saline D-PBS Sigma-Aldrich Chemie GmbH, Munich, Germany
Epinephrine Sigma-Aldrich Chemie GmbH, Munich, Germany
Essential amino acids (BME) Gibco BRL, life technologies, Karlsruhe 
EZ DNA Methylation direct Kit Zymo Research, Orange, CA, USA 
Fast Red Substrate System Dako Deutschland GmbH, Hamburg, Germany 
Fast Red Substrate System Dako Deutschland GmbH, Hamburg, Germany 
Fertal Bovine Serum (FBS) Sigma-Aldrich Chemie GmbH, Munich, Germany
Fetal calf serum (FCS) Gibco, Karlsruhe, Germany 
FSH Sigma-Aldrich Chemie GmbH, Munich, Germany
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GenEluteTM plasmid Miniprep kit Sigma-Aldrich Chemie GmbH, Munich, Germany
Goat anti-EIF2C2 antibody Santa Cruz Biotechnology, Santa Cruz, CA, USA 
Goat anti-GAPDH antibody Santa Cruz Biotechnology, Santa Cruz, CA, USA 
Heparin sodium salt Sigma-Aldrich Chemie GmbH, Munich, Germany
Hepes Sigma-Aldrich Chemie GmbH, Munich, Germany
Penicillin G sodium salt Sigma-Aldrich Chemie GmbH, Munich, Germany
Streptomycin sulfate salt Sigma-Aldrich Chemie GmbH, Munich, Germany
Hoechst 33342 Invitrogen, Carlsbad, CA, USA 
Ionomycin Sigma-Aldrich Chemie GmbH, Munich, Germany
iTaq SYBR Green Supermix  Bio-Rad laboratories, Munich, Germany 
ROX Reference Dye Roche Diagnostics GmbH, Mannheim, Germany 
L-Glutamine Sigma-Aldrich Chemie GmbH, Munich, Germany
LNA™ PCR primer set, UniRT Exiqon, Vedbaek, Denmark 
Medium 199 Sigma-Aldrich Chemie GmbH, Munich, Germany
Methylamp Global DNA Meth kit Epigentek, Brooklyn, NY, USA 
Mineral oil Sigma-Aldrich Chemie GmbH, Munich, Germany
miRCURY™ LNA Detection probe Exiqon, Vedbaek, Denmark 
miRNeasy mini kit QIAGEN GmbH, Hilden, Germany 
Mouse anti-goat IgG-HRP Santa Cruz Biotechnology, Santa Cruz, CA, USA 
Nitrocellulose membrane Protran®, Schleicher & Schuell Bioscience 
Penicillin Sigma-Aldrich Chemie GmbH, Munich, Germany
pGEM-T vector and related reagents Promega, Mannheim, Germany 
pGEM-T vector and related reagents Promega, Mannheim, Germany 
Phenol red solution (5% in D-PBS) Sigma-Aldrich Chemie GmbH, Munich, Germany
QIAquick Gel Extraction Kit Qiagen, Hiden, Germany 
QIAquick PCR purification kit QIAGEN GmbH, Hilden, Germany 
Random primer Promega, Mannheim, Germany 
Ribo-nuclease inhibitor (RNasin) Promega, Mannheim, Germany 
Rigid thinwall 96X0.2ml microplate STARLAB GmbH (Ahrensburg) 
RNA later Ambion Inc, Austin, TX, USA 
RT2 miRNA first strand kit SABioscienecs, Frederick, MD, USA 
RT2 qPCR-Grade miRNA isolation SABioscienecs, Frederick, MD, USA 
RT2 Sybr green master mix SABioscienecs, Frederick, MD, USA 
Sodium dodecyl sulfate (SDS) Sigma-Aldrich Chemie GmbH, Munich, Germany
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Streptomycin Sigma-Aldrich Chemie GmbH, Munich, Germany
Streptomycin sulfate Sigma-Aldrich Chemie GmbH, Munich, Germany
SuperScriptTM II cDNA syn kit Invitrogen, Carlsbad, CA, USA 
SYBR Green master mix, Uni-RT Exiqon, Vedbaek, Denmark 
Trypsin-EDTA Sigma-Aldrich Chemie GmbH, Munich, Germany
Universal cDNA synthesis kit Exiqon, Vedbaek, Denmark 
 
4.1.1.2 List of equipments 
 
ABI 7900 HT real time PCR system Applied Biosystems, CA, USA 
ABI PRISM® 7000 sequence detection sys Applied Biosystems, CA, USA 
Agilent 2100 bioanalyzer Agilent Technologies , CA, USA 
Biomek® NXP, Multichannel laboratory 
automation workstation 
Beckman Coulter, Krefeld, Germany 
Centrifuge Hermel, Wehing 
CEQ 8000 genetic analysis apparatus Beckman Coulter, Brea, CA, USA 
CO2-incubator (MCO-17AI) Sanyo, Japan 
Confocal laser scanning microscope-510 Carl Zeiss, Germany 
ECL plus western blotting detection system GE Healthcare, Freiburg, Germany 
Electrofusion machine, CFA 400 Kruess, Hamburg, Germany 
Electrophoresis unit (for agarose gels) BioRad, Munich, Germany 
Embryo flushing catheter CH15, Wörrlein, Ansbach, Germany 
Embryo transfer syringe and sheath IMV, L’Aigle, France 
Fluorescence microscope (DM-IRB) Leica, Bensheim, Germany 
Four well dishes Thermo Fisher Sc, Roskilde, Denmark 
Four-well culture dishes Nunc, Roskilde, Denmark 
Inverted fluorescence microscope DM IRB Leica, Bensheim, Germany 
Memmert CO2 incubator  Fisher Scientific, Leicestershire, UK 
Millipore apparatus Millipore Corporation, USA 
My Cycler Thermal cycler Bio-RadLaboratories, CA, USA 
NanoDrop 8000 spectrophotometer NanoDrop, Wilmington, Delaware, USA 
PTC-100 thermal cyclers BioRad, Munich, Germany 
SHKE6000-8CE refrigerated Shaker Thermoscinentific, IWA, USA 
Stereomicroscope SMZ 645 Nikon, Japan 
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ThermoMax microplate reader Molecular Devices, CA, USA 
Ultra low freezer (-85 °C) Labotect GmbH, Gottingen, Germany 
UV Transilluminator (Uvi-tec) Uni Equip, Martinsried, Germany 
 
4.1.1.3 List of softwares 
 
BDGP Search tools http://www.fruitfly.org/seq_tools/promoter.html 
BLAST cow sequences  http://www.ncbi.nlm.nih.gov/genome/seq/BlastGen/ 
ENSEMBL genome browser http://www.ensembl.org/index.html 
Entrez Gene  www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene 
Gene Ontology http://www.geneontology.org 
Genomatix software suite 2.0 http://www.genomatix.de 
MethPrimer http://www.urogene.org 
Methyl Primer Express® v1.0 Applied biosystem, Foster City, CA 
miRBase_12.0 http://microrna.sanger.ac.uk/sequences/  
PCR array data analysis portal http://www.sabiosciences.com/pcr/arrayanalysis.php
Primer Express 2.0  Applied Biosystems, Foster City, CA, USA 
Promoter 2.0 Prediction Server http://www.cbs.dtu.dk 
SAS (version 8.02) SAS Institute Inc., NC, USA 
 
4.1.1.4 Reagents and media preparation 
 
All solutions used in this investigation were prepared with deionised and demineralised 
(Millipore) and where necessary the pH was adjusted with Sodium hydroxide or 
hydrochloric acid. In addition, the solutions or buffers were subsequently filtered 
through 0.2 µ filter and autoclaved at 120°C for 20 minutes where it is necessary. 
Prepared solutions were aliquot in to small volume and stores at desired temperature 
according to the recommendation of suppliers.  
 
Name of the medium/buffer Constituents Amount/
volume
10X PBS                                        : NaCl 8.77 g
 Na2HPO4 1.50g
 NaH2PO4 2.04g
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 Water upto 1000.0 ml 
1X PBS                                          : 10X PBS 100.0 ml 
 DEPC upto 900.0 ml 
10x TBE buffer                             : Tris base 218.0 g 
 Boric Acid 105.0 g 
 EDTA solution (pH.8.0) 80.0 ml 
 Water upto 2000.0 ml 
Capacitation medium (50 ml)        : Sodium chloride 0.2900 g 
 Potassium chloride 0.0115 g 
 Sodium hydrogen carbonate 0.1050 g 
 Sodium dihydrogen phosphate 0.0017 g 
 Hepes 0.1190 g 
 Magnesium chloride hexahydrate 0.0155 g 
 Calcium chloride dihydrate 0.0145 g 
 Sodium lactate solution 60% 184 μl 
 Phenol red solution (5% in D-
PBS) 
100.0 μl 
 Water upto 50.0 ml 
CR1-aa culture medium (50 ml)   :  Hemi-calcium lactate 0.0273 g 
 Streptomycin sulphate 0.0039 g 
 Penicillin G 0.0019 g 
 Sodium chloride 0.3156 g 
 Potassium chloride 0.0112 g 
 Sodium hydrogen carbonate 0.1050 g 
 Sodium pyruvate 0.0022 g 
 L-Glutamine 0.0073 g 
 Phenol red solution 100.0 μl 
 Sodium hydrogen carbonate 0.080 g 
Epinephrine solution                     : Sodium hydrogen sulfite 0.04 g 
 Sodium lactate solution (60%) 100.0 μl 
 Epinephrine 0.00183 g 
Fertilization medium                     : Sodium chloride 0.3300 g 
 Potassium chloride 0.0117 g 
 Sodium hydrogen carbonate 0.1050 g 
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 Sodium dihydrogen phosphate 0.0021 g
 Penicillin 0.0032 g
 Magnesium chloride hexahydrate 0.0050 g
 Calcium chloride dihydrate 0.0150 g
 Sodium lactate solution (60%) 93.0 μl
 Phenol red solution (5% in D-
PBS) 
100.0 μl
 Water upto 50.0 ml
Modified parker medium               : HEPES 0.140 g
 Sodium pyruvate 0.025 g
 L-Glutamin 0.010 g
 Gentamicin 500.0 μl
 Medium 199 99.0 ml
 Hemi calcium lactate 0.06 g
 Water upto 110.0 ml
Ammonium Persulfate (APS)10%: APS 0.12 g 
 H2O 1.2 ml
40% acrylamide                             : Acrylamide 76.0 g
 bis-acrylamide 4.0 g
 Water to final volume of  200.0 ml
SDS (10%)                                    : Sodium dodecil sulphate 5.0 g
 Water  100.0 ml
LB-agar                                         : Sodium chloride 8.0 g
 Peptone 8.0 g
 Yeast extract 4.0 g
 Agar-Agar 12.0 g
 Sodium hydroxide (40 mg/ml) 480.0 µl
 ddH2O upto 800.0 ml
LB-broth                                        : Sodium chloride 8.0 g
 Peptone 8.0 g
 Yeast extract 4.0 g
 Sodium hydroxide (40 mg/ml) 480.0 µl
 ddH2O upto 800.0 ml
DEPC-treated water (1000 ml)      : DEPC 1.0 ml
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 Water upto 1000.0 ml 
Lysis buffer (100 μl)                     : Igepal (0.8%) 0.8 μl 
 RNasin 5.0 μl 
 DTT 5.0 μl 
 Water upto 100.0 μl 
TAE (50x) buffer, pH 8.0              : Tris  242.0 mg 
 Acetic acid   57.1 ml 
 EDTA (0.5 M) 100.0 ml 
 ddH2O upto 1000.0 ml 
TE (1x) buffer                               : Tris (1 M) 10.0 ml 
 EDTA (0.5 M) 2.0 ml 
X-gal                                              : ddH2O upto 1000.0 ml 
 X-gal 50.0 mg 
PBS + PVA (50 ml)                       : Polyvinyl alcohol (PVA) 
PBS upto 
300.0 mg 
50.0 ml 
Permeabilizing solution (10 ml)    : Triton X-100 5.0 μl 
 Glycine + PBS added  10.0 ml 
Physiological saline solution         : Sodium chloride 9.0 g 
 Water upto 1000.0 ml 
Agarose loading buffer                  : Bromophenol blue 0.0625 g 
 Xylencyanol 0.0625 g 
 Glycerol 7.5 ml 
 ddH2O upto 25.0 ml 
dNTP solution                               : dATP (100 mM) 10.0 l 
 dCTP (100 mM) 10.0 l 
 dGTP (100 mM) 10.0 l 
 dTTP (100 mM) 10.0 l 
 ddH2O upto 400.0 l 
IPTG solution                                : IPTG 1.2 g 
 ddH2O upto 10.0 ml 
3M Sodium Acetate, pH 5.2          : Sodium Acetate  123.1 g 
 ddH2O upto 500.0 ml 
1M EDTA, pH 8.0                         : EDTA 37.3 g 
 ddH2O upto 1000.0 ml 
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0.2% Triton-X100                         : Triton 2.0 ml
 10x PBS upto 1000.0ml
0.3% BSA in PBS                         : BSA 3.0 g
 10x PBS upto 1000.0 ml
3% BSA in PBS                            : BSA 30.0 g
 10x PBS upto 1000.0 ml
1x PBS-Tween (PBST)                 : 1x PBS 999.50 ml
 Tween®20 0.50 ml
SSC (20x)                                      : NaCl 87.65 g
 Sodium citrate 44.1 g
 Water upto 500.0 ml
4% paraformaldehyde (pH7.3)      : Paraformaldehyde 4.0 g
 1X PBS 100.0  ml
0.5M Sucrose/PBS (30% sucrose): Sucrose 85.57 gm
 1X PBS upto 500.0 ml
Acetylation solution                      : triethanolamine  2.33 ml
 acetic anhydride  500.0 µl
 DEPC water  upto 200.0 ml
Yeast tRNA (10 mg/ml)                : Yeast tRNA 25.0 mg
 DEPC-treated H2O 2.50 ml
Hybridization solution                   : Formamide -65% 32.25 ml
 20X SSC -5X 12.5 ml
 Tn-20- 0.1% 50.0 µl
 1M citric acid 460.0 µl
 Heparin 50 µg/ml 2.5 mg
 10mg/ml tRNA-500µg/ml 2.5 ml
 DEPC water upto 50.0 ml
Hybridization wash solution         : Formamide -65% 65.0 ml
 20X SSC -5X 25.0 ml
 Tn-20- 0.1% 100.0 µl
 1M citric acid 1.2 µl
 DEPC water upto 100.0 ml
50% Formamide/SSC                    : Formamide 1000.0 ml
 1X SSC 1000.0 ml
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50% formamide/Tn-20/SSC          : Formamide,  50% 500.0 ml 
 Tween-20, 0.1% 1.0 ml 
 1X SSC 499.0 ml 
5X SSC                                          : 20X SSC 250.0 ml 
 DEPC water 750.0 ml 
2X SSC                                          : 20X SSC 100.0 ml 
 DEPC water 900.0 ml 
1X SSC                                          : 20X SSC 100.0 ml 
 DEPC water 1900.0 ml 
0.2X SSC                                       : 20X SSC 10.0 ml 
 DEPC water 990.0 ml 
1X PBST                                       : 1X PBS 999.0 ml 
 Tween-20 1.0 ml 
Blocking Solution                          : FCS 2.0 ml 
 B1 solution 18.0 ml 
B1 solution                                    : 1 M Tris pH 7.5 100.0 ml 
 5 M NaCL 30.0 ml 
 dd H2O up to 1000.0 ml 
Stop solution                                  : EDTA 1mM 14.61 mg 
 PBS pH 5.5 upto 50.0 ml 
10N NaOH                                    : NaOH 40 gm 
 dd H2O upto 100.0 ml 
 
4.1.2 Methods 
 
This section describes the detail material used and methods followed to carried out the 
present study. All experimental animals were heifers of the same breed (Simmental), 
age (15-20 months) and body weight (380-500 kg) and were housed within one farm 
under identical conditions. All experiments have been carried out according to the 
existing animal protection law of Germany. Semen for artificial insemination, in vitro 
insemination and donor cells for nuclear transfer were originated from the same sire. 
The detail materials and methods are outlined below.    
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4.1.2.1 In vitro production (IVP) and processing of blastocysts 
 
Bovine ovaries were collected from local abattoir and transported to the laboratory in a 
thermosflask (35°C) containing physiological NaCl solution (0.9% NaCl supplemented 
with 50 μl/100 ml Streptocombin (Albrecht GmbH, Germany). Cumulus-oocyte 
complexes (COCs) were aspirated from 2- to 8-mm-diameter follicles using a 10-ml 
syringe loaded with an 18- gauge needle upon washing the ovaries once with 70% 
ethanol and twice with physiological saline. Quality of COCs has been assessed under 
stereomicroscope and those with multiple cumulus layers including evenly granulated 
cytoplasm were selected, washed three times in pre-warmed maturation (MPM 
supplemented with 12 % heat-inactivated estrous cow serum, 10 μg/ml FSH, 0.73 
mg/ml of sodium bicarbonate, 50 μg/ml of gentamicin, 0.23 mg/ml of sodium pyruvate, 
1.27 mg/ml HEPES and 0.55 mg/ml calcium lactate). Selected COCs were subsequently 
transferred in groups of 50 to each well of four-well dishes (Nunc, Roskilde, Denmark) 
containing 400 μ1 maturation medium without being covered with mineral oil. 
Maturation was carried out at 39°C in a humidified atmosphere with 5% CO2 for 22 h. 
Sperm cells were separated by ‘‘swim up’’ technique for in vitro fertilization (IVF) 
according to (Parrish et al. 1988), where 50 matured oocytes in a well were co-cultured 
for 18 hours with 1 X 106 spermatozoa/ml at the same condition followed for 
maturation step. Following IVF, presumed zygotes were gently vortexed to separate 
them from the surrounding cumulus cells and attached or dead spermatozoa. Cumulus 
free zygotes were washed three times in CR-1aa culture medium (Rosenkrans & First 
1994) supplemented with 10% oestrus cow serum, 10 μl/ml basal medium Eagle (BME-
essential amino acids) and 10 μl/ml minimum essential medium (MEM-non essential 
amino acids) and were transferred into the well containing 400 μl culture medium 
covered with mineral oil. Embryos were cultured in vitro for 8 days. At day 7 
(blastocyst) and day 8 (fully expanded blastocyst) of culture, 5-8 embryos (washed in 
PBS) were freezed in liquid nitrogen in triplicates with 2 μl of lysis buffer [(5mM DTT, 
Promega, P1171), 0.8% Igepal (Sigma, I 3021), 1U/ μl RNasin (Promega, N 2511)]. A 
group of 20 embryos from each developmental stage were fixed in 4% parafomaldehyde 
overnight at 4°C for whole mount in situ hybridization. In addition, in vitro derived day-
7 blastocysts (n=20) were transferred singly to the recipients by nonsurgical standard 
procedures to generate day-16, day-50 and day-225 pregnancies. 
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4.1.2.2 In vivo embryo production and establishing control (artificial insemination) 
pregnancy  
 
To collect in vivo derived blastocysts, six Simmental heifers were synchronized by intra 
muscular injection of cloprostenol (PGF2α, Estrumate; Essex Tierarznei, Munich, 
Germany) twice within 11 days and subsequently superovulation was performed by 
injection of FSH (Stimufol, Ulg FMV, Belgium) starting at day 11 after onset of estrus. 
Frozen–thawed semen was used to inseminate all heifers. The blastocysts were flushed 
out with 500 ml D-PBS at day 7.5 post inseminations by embryo flushing catheter 
(CH15, Wörrlein, Ansbach, Germany) fixed in the uterine horn. All flushed blastocysts 
were assessed under stereo microscope for their quality and stages. Only 
morphologically good-quality early blastocyst and expended blastocysts (5 embryos per 
pool in triplicate for both stages) were snap frozen for the isolation of RNA as 
mentioned before. Another group of 20 expanded blastocysts were fixed overnight in 
4% paraformaldehyde at 4°C for whole mount in situ hybridization. Heifers (n=15) 
synchronized with a single dose of PGF2α followed by estrus check were artificially 
inseminated (AI) using frozen semen of the same sire (except the sire used to generate 
day 225 pregnancies) after 10 hours of standing estrus and pregnancy were maintained 
to provide control placenta tissue at day-50 (n=3) and day-225 (n=4). 
 
4.1.2.3 Donor cell preparation and nuclear transfer 
 
Preparation of donor cells, nuclear transfer and culture of reconstructed embryos has 
been performed according to the protocol described elsewhere with some modification 
(Hölker et al. 2005). Briefly, a primary cell line was established from ear skin biopsy of 
the bull used also production of in vivo and in vitro derived embryos and placentas. The 
biopsy was minced, washed, dispersed in T25 cell culture flask and cultured in 
Dulbecco’s Modified Eagles Medium (DMEM) supplemented with 2 mM glutamine, 
1% non-essential amino acids, 0.1 mM β-mercaptoethanol, 100 U/ml penicillin, 100 
µg/ml streptomycin (all from Sigma, Deisenhofen, Germany) containing 10% fetal calf 
serum (FCS) (Gibco, Karlsruhe, Germany) in a humidified atmosphere of 95% air and 
5% CO2 at 37°C. Outgrowing cells were trypsinized (0.05% Trypsin/0.53 mM EDTA; 
Gibco) and replated to allow proliferation to 90% confluence. The harvested cells were 
reconstituted at a concentration of 1x 106 cells/ml and then either frozen in 10% 
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dimethyl sulfoxide (Sigma, Deisenhofen, Germany) in DMEM until later use or 
returned to culture. The fibroblasts used for nuclear transfer were from passages 4-5 and 
were induced to enter a period of quiescence (presumptive G0) by serum starvation for 
7 days (0.5% fetal calf serum).  
 
Oocytes were placed in hepes-buffered TCM-199 (25mM Hepes, 5mM NaHCO3) 
medium containing 1 µg/ml Hoechst 33342 (Sigma, B-2261) and 7.5 µg/ml 
cytochalasin B (Sigma, C-6762) for ~ 10 min prior to enucleation. Metaphase II oocytes 
were enucleated by removal of the polar body and the attached cytoplasm with the 
metaphase plate utilizing a 25 µm beveled glass pipette under the microscope. The 
absence of the metaphase plate or enucleation was confirmed by a brief exposure of the 
karyoplast to ultraviolet light. Successful enucleation was also indicated by the typical 
blue fluorescence of Hoechst 33342 within the pipette. Cytoplasts derived from 
enucleated oocytes were maintained in TCM-air for up to 2 h and nuclear transfer was 
conducted in the same medium as enucleation, but without Hoechst 33342 stain.. 
Immediately before donor cell transfer, a suspension of the donor cells was prepared by 
standard trypsinization. The cells were pelleted and resuspended in TCM-air and 
remained in this medium until injection. A single cell was sucked into a 30-µm (outer 
diameter) bevelled glass pipette and carefully transferred into the perivitelline space of 
the recipient oocyte in close contact with the oocyte membrane. Reconstructed embryos 
were electrically fused at 26 h after onset of maturation. Fusion of donor cell and oocyte 
was induced with a single electrical pulse of 25 V DC for 45 µsec between two 
electrodes with a spacing of 150 µm by electrofusion machine (CFA 400; Kruess, 
Hamburg, Germany). Fusion was assessed approximately 45 min later by light 
microscopy. At 28-29 hours after onset of maturation, the reconstructed embryos  were 
chemically activated by incubation in 5 µM ionomycin (Sigma) in hepes-buffered TCM 
199 for 4 min followed by a 3.5 hours incubation in 2 mM 6-dimethylaminopyridine (6-
DMAP; Sigma) in CR-1aa culture medium at 39°C.  
 
In vitro culture of activated reconstructed complexes has been performed as described 
for the production of in vitro blastocyst. Developmental rates were assessed periodically 
up to day 7.5 of culture. Produced embryos were used for three purposes in this study. 
First, 5 triplets of both early and expanded blastocysts in were freezed as described 
before. In addition, another group of embryos were fixed overnight in 4% 
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paraformaldehyde for whole mount in situ hybridization. Finally, rest of the blastocysts 
were transferred singly to the synchronous recipients (n=30) by nonsurgical standard 
procedures as described below. 
 
4.1.2.4 Recipient preparation and embryo transfer 
 
Estrous synchronization and transfer of embryos to the recipients has been carried out 
according to the previous report (El-Sayed et al. 2006). Briefly, estrous cycles in normal 
cycling heifers were synchronized by intra-muscular injection of prostaglandin F2a (2 
ml Estrumate; Fa. Essex, Germany) followed by a second administration 11 days later. 
Standing estrus was monitored and embryos were matched with synchronous recipients 
of no more than ~12 h asynchrony. Single NT (n=30) and IVP (n = 20) embryos that 
were of good or excellent quality (Grades 1 or 2) were transferred into the uterine horn 
ipsilateral to the corpus luteum of recipients, respectively. 
 
4.1.2.5 Pregnancy monitoring and retrieval of experimental material 
 
All recipients were monitored for coming back to estrus at day 21. Heifers that returned 
to estrus at day 21 were considered as non-pregnant. Pregnancy diagnosis was 
performed at gestation days 28 and 42 by transrectal ultrasonography (Pie Medical, 5 
MHz) and by rectal palpation at day 42 and 56. A viable pregnancy was defined as the 
presence of fetus with a detectable heartbeat. Beginning on Day 120, recipients 
underwent repeated transabdominal ultrasonography (Pie Medical, 3,5 MHz) every 2–3 
wk until day 220. Recipients of IVP embryos, NT embryos and artificial insemination 
were slaughtered at day 16 (IVP-N=5, AI-N=5, NT-N=5), day 50 (IVP-N=3, AI-N=3, 
NT-N=3) and day 225 (IVP-N=4, AI-N=4, NT-N=4) of pregnancy. Assessment of the 
morphometric quality or any abnormalities in the embryos, fetus and placenta were 
noted accordingly. On day 16, the entire conceptus was weighed together with 
measurement of length; on Day 50 the fetus and placenta were weighed separately; on 
Day 225 the fetus was dissected and the major organs (liver, heart) were weighed and 
the weight of the fetal membranes and number of cotyledons was recorded.  
 
Morphologically similar elongated embryos at day 16, chorioallantois with early 
cotyledon (placentomes) at day 50 and placentomes at day 225 of pregnancy were 
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collected, washed twice in PBS, cut into reasonable pieces if required and stored in 
RNA later (Ambion Inc, Austin, TX, USA) for later use. Three samples of apparently 
same morphological quality from each group were used for the present study. 
 
4.1.2.6 Extraction and purification of small RNAs from placenta 
 
Total RNAs from the three individual frozen placentas (15 mg) of from each group of 
pregnancy (IVP, NT and AI) and fibroblast cells (4x106) were isolated using miRNeasy 
mini kit (QIAGEN GmbH, Hilden, Germany). Large (>200 nt) and small RNAs (<200 
nt)) were separated using special silica membrane spin column and chemicals of RT2 
qPCR-Grade miRNA isolation kit (SABioscienecs, Frederick, MD, USA) according to 
manufacturer’s instructions. For every case, the quality and the concentration of the 
small RNAs and large RNAs were assessed by NanoDrop 8000 spectrophotometer 
(NanoDrop, Wilmington, Delaware, USA). Isolated small RNAs were used for the 
study of expression profiling of 377 individual miRNAs and large RNAs originated 
from the same sample were used for analysis of regulatory miRNAs processing 
transcripts in different groups of placenta.  
 
4.1.2.7 Genomic DNA, total RNA and protein extraction from different stages of 
placenta and embryos 
 
To study the global methylation pattern and quantification of selected transcript at 
mRNA and protein level, genomic DNA, total RNAs and proteins were isolated from 
the same sample. Whole individual elongated embryo at day 16, placenta at day 50 (15 
mg) and placentomes at day 225 (15 mg) of pregnancy from IVP, NT and AI (at least 
three of each) were used for isolation using DNA/RNA/Protein purification kit (Norgen 
Biotek corporation, Thorold, Canada) according to methods recommended by the 
manufacturer. In addition, 5 early blastocysts, 5 expanded blastocysts (from each IVP, 
NT and AI method), donor fibroblast cells with serum starvation and without starvation 
(each in triplicate) were also used to isolate total RNAs using the same procedures. For 
every cases the quality and the concentration of the nucleic acid was assessed by 
NanoDrop 8000 spectrophotometer (NanoDrop, Wilmington, Delaware, USA) and 
subsequent analysis was performed using Agilent, 2100 Bioanalyzer 
(AgilentTechnologies, Santa Clara, CA). Protein quantity was assessed by NanoDrop 
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using the absorbance at 280 nm. All these nucleic acids and protein were stored at -
80°C in aliquots for the downstream experiments. 
 
4.1.2.8 Large scale expression profiling of miRNAs by real-time quantitative PCR 
 
Total of 166 ng small RNAs from 3 placentas derived from every group of pregnancy at 
day 50 (IVP, NT and AI) and donor cells (in triplicate) were synthesized individually 
into first strand cDNAs using RT2 miRNA first strand kit (SABiosciences). Real time 
qPCR of miRNAs was performed using 384-well miRNAs primed PCR plate 
(SABiosciences) comprised of 377 individual miRNAs (most of them are conserved in 
human, mouse and bovine), 4 endogenous controls (U6, Snord44, Snord47 and 
Snord48), 2 reverse transcription controls and 2 positive PCR controls according to the 
protocols provided by the manufacturer. The assays were performed in ABI 7900 HT 
real time PCR system (Applied Biosystems, Foster City, CA, USA) with sybr green 
technology (SABiosciences). Synthesized cDNAs were diluted 10 times, mixed with 2 
ml of 2 X RT2 Sybr green PCR master mixes (SABiosciences) and 1.9 ml of ddH2O. 
Mixed cocktail (10 µl per well of 384 well plate) was added and thermal cycling was 
performed as 95°C for 10 min, 40x of (95°C for 15 sec, 60°C for 40 sec and 72°C for 30 
sec). Multichannel laboratory automation workstation was used pipette the mix into 384 
well plates precisely (Biomek® NXP, Beckman Coulter, Krefeld, Germany). Each 
individual sample was applied to one 384 well PCR plate and quality of the assay was 
assessed by the result of control wells and melting curve analysis as recommended. 
Instrument was set to automatic baseline but threshold value was adjusted manually to 
0.045 (above the background signal but within the lower half to one-third of the linear 
phase of the amplification plot) for all assays performed in the study. Data were 
analysed by ΔΔCt method and normalization was performed by geometric mean of four 
endogenous controls through SAbiosciences’s PCR array data analysis on-line web-
based analysis portal, which is provided with t test 
(http://www.sabiosciences.com/pcr/arrayanalysis.php). Expression levels were 
compared in multiple ways for different group of placenta to find out fold regulation 
and a fold regulation 2 or more with the value of P less than 0.05 were considered as 
significant different expression. 
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4.1.2.9 Whole mount blastocyst in situ hybridization of miRNAs 
 
Whole mount in situ hybridization of miRNAs in the in vitro produced expanded 
blastocysts was performed as described elsewhere (Hossain et al. 2009). At least 3 
embryos were used for the hybridization of each miRNA. According to the expression 
patterns miRNAs in IVP embryos, selected candidate trophoblast and inner cell mass 
specific and imprinted miRNAs were localized to the expanded blastocysts derived 
from AI and nuclear transfer. For hybridization, embryos were rehydrated in series of 
methanol/PBS, post-fixation (4% paraformaldehyde for 10 minutes), acetylation (2.33 
ml triethanolamine, 500 µl acetic anhydride, H2O up to 200 ml, readily prepared and 
treated for 10 minutes) and proteinase K treatment (10 µg/ml, 10 minutes) were carried 
out, where each step was followed by a 3 times brief wash (10 minutes) in PBS. Two 
hours of pre-hybridization was performed at 55-59°C in hybridization solution (50% 
formamide, 5× SSC, 0.1% Tween-20, 50 μg/ml heparin, and 500 mg/ml yeast tRNA). 
Embryos were incubated overnight with 3'-Digoxigenin (DIG) labeled LNA-modified 
oligonucleotide probes (1 pM) for mir-31, -96, -127, -215, -222, -223, -299, -320a, -
302b,- 431, -450, -544 and let-7d, together with U6 RNAs (Exiqon, Vedbaek, Denmark) 
in hybridization buffer in a humidified chamber at the temperature 20°C below the Tm 
of probes. After overnight incubation, embryos were washed briefly in wash buffer 
(similar to hybridization buffer but without tRNA) and serial wash in 2XSSC/wash 
buffer (each time 10 minutes) to final three washes in 0.2X SSC each for 30 minutes at 
hybridization temperature was performed. Blocking, incubation with anti-DIG-AP 
antibody, washing and color development (Fast Red substrate reaction) was performed 
as described previously (Obernosterer et al. 2007). Embryos were mounted individually 
with VectaShield containing DAPI (Vector laboratories, Burlingame, CA) and analyzed 
by confocal laser scanning microscope (CLSM LSM-510, Carl Zeiss, Germany). 
 
4.1.2.10 Reverse transcription and SYBR green qPCR for selected miRNAs 
 
Temporal expression of selected miRNAs has been examined in blastocyst, expanded 
blastocyst, day-16 elongated embryo, day-50 placenta and day 225 placentome (from 
AI, IVP and SCNT). All the reagents and kits used for this purpose were obtained from 
Exiqon (Exiqon, Vedbaek, Denmark). A 36 ng total RNA from each sample was 
applied to synthesize first strand cDNA using Universal cDNA synthesis kit. Real time 
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qPCR was performed using LNA™ PCR primer set for mir- 21, -24, -127-3p, -135b, -
299-5p, -302, -376a, -431, and mir-544a with universal RT primers using SYBR Green 
master mix in ABI PRISM® 7000 sequence detection system (Applied Biosystems, 
Foster City, CA, USA). Dilution of cDNA, preparation of mix and thermal cycling 
condition was performed as recommended by the manufacturer. Data were analyzed as 
mentioned before except, normalization was performed using the mean Ct value of U6 
RNA and 5S ribosomal RNA. 
 
4.1.2.11 Reverse transcription and SYBR green qPCR for miRNA processing genes 
 
Important candidate genes involved in transcription, processing and generating mature 
miRNAs were quantified in day 50 placenta derived from IVP, AI and NT pregnancy by 
qPCR. Primers for qRT-PCR analysis (Table 4.1) were designed using the Primer 
Express 2.0 software program (Applied Biosystems, Foster City, CA) and synthesized 
by Eurofins MWG Operon (Ebersberg, Germany). The sequences of PCR primers are 
listed in Table 4.1. Reverse transcription of 600 ng total RNA from each sample was 
performed using Superscript II Reverse Transcriptase (Invitrogen, Carlsbad, CA) in 
combination with random primers (Invitrogen, Carlsbad, CA) and oligo (DT)23(Sigma). 
The cDNA was stored at -20°C until use. All primers utilized were designed and 
optimized in order to ensure optimum reaction efficiencies both for target and 
housekeeping reference genes (GAPDH, Histone). Triplicate reactions were performed 
for each gene by standard PCR protocol with a 20 µl reaction volume consisting of 10 
µl of iTaq SYBR Green Supermix with ROX (Bio-Rad, Hercules, CA), forward and 
reverse primers at 200-300 nM final concentration and 2 µl diluted template cDNA. A 
universal thermal cycling parameter specified for the instrument was 50°C for 10 sec, 
95°C for 10 min, followed by 40 amplification cycles at 95°C for 15 sec and at 60°C for 
1 min. In addition, at the end of the last cycle, dissociation curve was generated by 
starting the fluorescence acquisition at 60˚C and taking measurements every 7 sec 
interval until the temperature reached 95˚C. The same PCR protocol was used for all 
primers and Data was normalized using ΔCt (average Ct for the housekeeping gene 
minus Ct for the gene of interest) and subsequent analysis was performed using ΔΔCt 
methods (Livak and Schmittgen 2001). One-way analysis of variance with tukey test 
was performed to compare expression of each gene in different types of placenta. A 
probability of P≤ 0.05 was considered to be significant differentially expressed. 
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Table 4.1: List of miRNA processing genes and primers used in this study 
Gene   Sequences (5´-3´) TA (°C) 
Forward AATGGAAAGGCCATCACCATC GAPDH : 
Reverse GTGGTTCACGCCCATCACA 
57 
Forward GCCGTATTCATCGACACCTGA Histone : 
Reverse CTCCACGAATAGCAAGTTGCAA 
55 
Forward AATGGCTTTGCTGCAGAGTT ADAR1 : 
Reverse GCGCTCTGCTTTCTCTGTTT 
55 
Forward GGAAGCTGGCAAACAAGATCC DGCR8  : 
Reverse GGTTGGTTTCATGTGCTCGAA 
55 
Forward AGAGTGGAGTATGCAGTGCTCG EIF2C1/AGO1 : 
Reverse GGGCATCAACATCGTTGTCA 
55 
Forward AGCGCTGCATTAAGAAGCTGA EIF2C2/AGO2 : 
Reverse CCGTCATGTCATCCTTCACCTT 
55 
Forward TTCCACACGGGCATTGAGAT EIF2C3/AGO3 : 
Reverse TATTTACAGAAGCATGGCTGGC 
55 
Forward CAACACCAAGCCACGGAGTAT EIF2C4/AGO4 : 
Reverse GAAATCTTCCGCAGCTGGTCT 
55 
Forward TAGTGGCAGGACAGCGATGTA FMR1 : 
Reverse TTTAAGGTATGGGTCAGGGCC 
55 
Forward TCCCAACAAACCTGCCACA GEMIN4 : 
Reverse TCACTGATGGACAAAACCACG 
55 
Forward TGGTGGGAAATGATGAAGCAC GEMIN6 : 
Reverse GCATGGTTGGACACACATCTG 
55 
Forward AGAGCTGAGTGGGTTTGAGCA GEMIN7 : 
Reverse TGTTACGCTGACCGCTTTGTA 
55 
Forward ACCTGGACGTGGCCAATTT POLR2A : 
Reverse AACATATGGAGGCCTGGGAGA 
54 
Forward AACCTGTGCAGGAAACATGA POLR2G : 
Reverse CTTGGAAGAGTCCACAAGCA 
54 
Forward GATGATTACCTGGGGCTTGT RNASEN : 
Reverse GGCTGCTAAGCCATAGGAAG 
55 
Forward AGGGTCTTCCCATCGATTCT RANGAP1 : 
Reverse GCTTGCTCCCTTAAGCAATG 
55 
Forward GGCACAATTTTCGACTGTTCG SIP1 : 
Reverse AGCCCCTTCAGCACATAACCT 
55 
Forward TCCGACTTGCTCCAACAATGT XPO1 : 
Reverse CAAGGAACCAATGTGAAGGGA 
55 
Forward CAAGGTACACACGGTCCAAAGA XPO4 : 
Reverse GGCTCCAAATGTACAAGCCAA 
55 
Forward TCTTTGTGAAGCCTCTGGTG XPO5 
 
: 
 Reverse TGTTCCTCCAGCATCTCTTG 
55 
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4.1.2.12 Quantification of global DNA methylation 
 
Genomic DNA isolated from the 3 elongated day 16 embryos and 3 day 50 placenta 
from each IVP, AI and SCNT pregnancy was used to quantify the global methylation 
status using Methylamp Global DNA Methylation Quantification Ultra kit (Epigentek, 
Brooklyn, NY) according to user instruction provided by the manufacturer. Briefly 200 
ng of genomic DNA from each sample was immobilized to the strip well specifically 
coated with DNA affinity substance. The methylated fraction of DNA was recognized 
by 5-methylcytosine antibody and quantified through an ELISA-like reaction. Serial 
dilution of positive control (synthesized polynucleotide methylated at every 5-cytosine) 
in 6 points (0.4, 1, 2, 5, 10 and 20 ng/well) was used to generate a standard curve. Color 
was developed and absorbance read was performed in ThermoMax microplate reader 
(Molecular Devices, Sunnyvale, CA) at 450 nm. Slope was determined as OD/ng by 
plotting OD value versus amount of positive control. DNA methylation (%) was 
calculated by using the formula [x 100%] where, 41.7 is the GC content in bovine 
genomic DNA and Methyl DNA (ng) = {Sample OD- Negative control OD)/slope}.  
 
4.1.2.13 Western blotting 
 
Total proteins extracted from three Day-50 placentas from each group (IVP, AI and 
SCNT) were pooled equally (30 µg) and separated by SDS-PAGE (gradient 4-18%) and 
transferred onto a nitrocellulose membrane (Amersham Biosciences) and blocking was 
performed in buffer (20 mM Tris pH 7.5, 150 mM NaCl, 0.05% Tween-20 and 1% 
polyvinylpyrolidone) at room temperature for 1 hour. The membrane was then 
incubated with goat anti-eIF2C2 polyclonal antibody (Santa Cruz Biotechnology, Santa 
Cruz, CA) in the blocking medium overnight at 4°C. Non-specific binding of antibody 
was washed off with six changes of 0.1% PBST. The HRP-conjugated mouse anti-goat 
IgG (Santa Cruz) was used as the secondary antibody. The membrane was incubated for 
1 h at room temperature with secondary antibody, followed by washed with six changes 
of 0.1% PBST. The chemiluminescence was detected by using the ECL plus western 
blotting detection system (Amersham Biosciences) and visualized by using Kodak 
BioMax XAR film. GAPDH antibody (Santa Cruz) was used as a loading control. The 
membrane was stripped by incubation in 2% SDS, 100 mM Tris-HCl and 0.1% beta-
mercaptoethanol for 30 min at 60°C and re-probed with GAPDH antibody. 
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4.2 Results 
 
4.2.1 Differential miRNA expression in Day-50 placenta of different sources of 
pregnancy 
 
The miRNAs expression profiles of the Day 50 NT placenta (n=3) were compared 
either to that of AI (n=3) or IVP (n=3) placenta. In addition, the level of miRNAs 
expression in the IVP placenta has subsequently been compared to that of AI placenta. 
The magnitude and number of differentially regulated miRNAs in different comparisons 
are presented in figure 4.1 and 4.2, respectively. 
 
 
Figure 4.1: Hierarchical cluster of NT, IVP and AI Day 50 placenta compared to each 
other and characterization of differentially expressed miRNAs. The log2 
fold change value of 377 miRNAs from each comparison is cluster arranged 
to highlight global differential miRNA expression. 
 
Of the 377 miRNAs used in the comparison of their expression between Day 50 NT and 
AI placenta, 320 miRNAs were found to be downregulated in NT placenta with 2 or 
more fold change (278 miRNAs with P-value ≤ 0.05), while only 5 miRNAs (miR-527, 
miR-608, miR-637, miR-649 and miR-938) were found as upregulated by 2 or more 
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fold change in NT placenta compared to the placenta of AI group (Figure 4.2). Out of 
these 5 miRNAs miR-608 was uniquely upregulated in NT placenta compared either to 
AI or IVP placenta. On the other side, out of 320 downregulated miRNAs 116 miRNAs 
were uniquely downregulated in the NT placenta compared either to AI or IVP placenta.  
 
 
 
Figure 4.2: Venn diagram of the distribution and the number of differential miRNA 
expression between and specific to different types of Day 50 placenta. Each 
circle represents the number of differentially expressed miRNAs between 
two placenta types out of 377 analyzed miRNAs. For example, NT vs. AI 
represents the number of differentially regulated miRNAs (↓ denotes down 
regulation and ↑ denotes upregulation) in the NT placenta compared to that 
of AI. Similarly IVP vs. AI and NT vs. IVP represent the number of 
differentially regulated miRNAs in IVP compared to AI and the number of 
differentially regulated miRNAs in NT compared to IVP placenta. The 
circle (upper left) shows a total of 325 miRNAs that are differentially 
expressed between AI and NT placenta where 5 are upregulated and the 
rest are downregulated; 1 miRNA (red) are uniquely overexpressed in the 
comparison of NT vs. AI, 4 miRNAs (pink) are overexpressed commonly 
in the comparison between NT vs. AI and NT vs IVP and no miRNA 
(yellow) are commonly upregulated in NT vs. AI and IVP vs. AI placenta. 
Number in the center (gray) shows the common differential miRNAs in any 
of the three ways of comparison. 
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Similarly, the expression profiles in the NT placenta were compared to that of IVP 
placenta. In this comparison, 233 miRNAs were found to be differentially expressed in 
the NT placenta (Figure 4.2). Among them only 21 miRNAs were upregulated (4 
common when compared to AI as mentioned before) and rest (212) were found to be 
downregulated. The 17 miRNAs which are uniquely upregulated in NT placenta 
compared to that of IVP placenta were miR-17*, miR-19a, miR-106b,, miR-219-2-3p, 
miR-296-5p, miR-372, miR-450a, miR-502-5p, miR-520d-5p, miR-548d-3p,, miR-549, 
miR-564, miR-566, miR-612, miR-616*, miR-619 and miR-937. Among the 212 
downregulated miRNAs, 204 were found to be commonly downregulated in NT 
placenta compared to that of AI. The rest (miR-124, miR-302b, miR-302c, miR-525-3p, 
miR-526b and miR-590-3p) were down regulated uniquely in NT placenta compared to 
IVP placenta. Overall, about 62 % miRNAs were found to be differentially regulated in 
the NT Day 50 placenta compared to that of IVP placenta, where 90% of them were 
found to be downregulated.  
 
 
Figure 4.3: Plot diagram of the magnitude of fold regulation of most differentially 
regulated miRNAs in Day 50 placenta of different sources of pregnancies. 
The diagram shows the degree of expression difference of 49 miRNAs in 
Day 50 NT placenta compared to AI (red circle), in Day 50 IVP placenta 
compared to that of AI (blue rectangle) and in Day 50 NT placenta 
compared to that of IVP (green triangle).  
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Additional comparison of miRNAs expression between IVP placenta and AI placenta 
has been performed. Analysis revealed differential expression of 238 out of 377 tested 
miRNAs (Figure 4.2). Of the 238 differentially miRNAs, 230 were found to be 
downregulated and 8 miRNAs (miR-122, miR-302a, miR-302b, miR-302c, miR-525-
3p, miR-526b, miR-590-3p and miR-944) were upregulated in IVP placenta compared 
to their expression in AI placenta. Among the 230 downregulated miRNAs, 215 
miRNAs were also downregulated in the comparison of NT vs. AI and 112 miRNAs of 
them were commonly downregulated in the comparison of NT vs. IVP. So, the rest 15 
downregulated miRNAs (miR-219-2-3p, miR-346, miR-372, miR-502-5p, miR-516a-
3p, miR-520e, miR-549, miR-564, miR-616*, miR-619, miR-632, miR-647, miR-766, 
miR-875-3p and miR-940) were exclusively differential in the comparison between IVP 
and AI placenta and not appeared in any other way of comparison.  
 
4.2.2 miRNA expression profile comparison of donor cells and NT Day-50 placenta 
 
To investigate any source of origin specific expression of miRNAs in the Day-50 NT 
placenta being reflecting ultimate differential expression compared to that AI placenta, 
expression profiling of same 377 miRNAs in the fibroblast donor cells (serum starved 
condition at exactly before nuclear transfer stage condition) has been performed. The 
expression profiles of Day-50 NT placenta were compared to that of fibroblast donor 
cells. Analysis revealed 244 miRNAs differentially expressed in the Day 50 NT 
placenta compared to fibroblast with 2 or more fold change (209 miRNAs with P value 
≤0.05 and 2 or more fold change). Among the 209 miRNAs, 185 and only 24 miRNAs 
were found to be up and down regulated in NT placenta compared to fibroblast. Out of 
the 24 downregulated miRNAs, miR-486-5p, miR-508-3p, miR-519b-5p, miR-519e*, 
miR-548b-3p and miR-885-5p were also found to be down regulated in the Day 50 NT 
placenta compared to that of AI. miR-302b and miR-432 were found to be down 
regulated in NT placenta compared to that of IVP placenta. Among the miRNAs which 
are not differentially regulated (less than 2 fold regulation with P value ≥ 0.05) in the 
Day 50 NT placenta compared to fibroblast, 18% of them were found also not to be 
differentially regulated in NT placenta when compared to either that of AI or IVP 
placenta. Whereas, 22% of them were different to AI and collectively 39% of them were 
different when compared to both AI and IVP placenta.  
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4.2.3 Genomic patterns of deregulated miRNAs in NT and IVP placenta 
 
Majority of the identified deregulated miRNAs in the Day 50 NT and IVP placenta 
compared to placenta from artificial insemination were further characterized bio-
informatically. Chromosomal location of selected all miRNAs were retrieved from 
miRBase v 14 and ENSEMBL genome browser has been used to find out the features of 
genomic regions of interest.       
 
 
Figure 4.4: Genomic region (44kb) of bovine chromosome 21 harboring at least 3 big 
clusters of miRNAs which are down regulated in Day 50 NT and IVP 
placenta compared to that of AI. Text in blue above the black line (forward 
genomic strand) represents the residing miRNAs; number in pink represents 
range and scale of the region in kilo bases (kb) , number in black starting 
with rs- denotes dbSNPs, others are different types of transposone (red or 
orange) namely type I line/SINE, type II, tandem repeats (trf) and pseudo 
transfer RNA (tRNA).     
 
Interestingly, different deregulated miRNAs in the NT and IVP placenta were found to 
be affected in similar patterns and they are located in the chromosome as polycistronic 
clusters. For example, one such genomic region in bovine chromosome 21 is presented 
in figure 4.4 representing 44 kilo bases (66000000-66044000 bases). This region found 
to be harboring at least 3 clusters of miRNAs comprised of more than 38 miRNAs. 
Most of these clustered miRNAs tested were found to be downregulated in NT and 
some in IVP placenta compared to the placenta of artificially inseminated pregnancy. 
Most of the genomic region of the miRNAs cluster were found to be absent of any 
protein coding gene but abundant in a number of other genomic variable region. These 
include different types of transposone elements, (type I LINE, type I SINE, type II), 
tandem repeats (TRF), long terminal repeats (LTRs) and numerous SNPs. However, 
most of these elements were found to be residing out side and no SNPs were present in 
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side the miRNA precursors. So, any transcriptional disturbance or lack of optimum 
transcription process could lead to the deregulation of all miRNAs belong to the same 
cluster.  
 
 
Figure 4.5: Family wise differential expression of miRNAs in different sources of Day 
50 placenta. Log2 fold change of 43 miRNAs belong to 9 miRNA families 
which were deregulated in different sources of placenta were plotted to 
visualize the family wise expression differences in the placenta of different 
sources of pregnancy.      
 
In addition to cluster wise regulation, deregulated miRNAs in the NT and IVP placenta 
compared to that of AI were found to be affected family wise (Figure 5). Forty three top 
deregulated miRNAs were in either three ways of comparison between three sources of 
placenta were found to belong 9 distinct miRNA families. All the 9 miRNA families 
were found to be downregulated in the NT and IVP Day 50 placentas compared to the 
placentas from AI. Similarly most of the miRNAs having highly similar sequence 
between them (denoted and distinguish by a, b, c, etc at the end of miRNA name) were 
also found to be deregulated in the placenta in an identical manner.  
 
4.2.4 Localization of selected miRNAs in expanded blastocyst of NT, IVP and AI origin 
 
Whole mount in situ hybridization of 10 miRNAs in in vitro, in vivo and NT expanded 
blastocyst was performed to identify specific expression pattern either in the 
trophectoderm or inner cell mass. The study has identified several cell specific miRNAs 
in embryo from AI and subsequently compared their expression pattern to the embryo 
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of IVP and NT. Among the localized miRNAs, miR-24, and miR-299 were found to be 
intensively localized to the trophectoderm and miR-203b were inner cell mass specific 
in the expanded blastocyst from AI group (Figure 4.6). Tested other miRNAs were 
found to be generally expressed both in trophectoderm and inner cell mass but when 
their expression patterns in AI blastocyst were compared to that in NT or IVP group, the 
extent of their expression were found to be different. 
 
Figure 4.6: Whole-mount in situ hybridization of miRNAs in in vivo, in vitro and NT 
expanded blastocysts (miRNAs are stained red and blue represents nuclear 
stain by DAPI). About half of the blastocyst comprising approximately 
middle of the inner cell mass and corresponding trophectoderm has been 
visualized in the upper image (a) in each group as obtained by scanning the 
blastocyst at every 2 µm interval using laser scanning confocal microscope 
and projected in three dimensions (3D). Similarly lower image (b) for every 
group of embryos represents a 3D transverse region of upper and same 
blastocyst to visualize inner cell mass and trophectoderm clearly. Scale bar 
represents 50 µm and ‘i’ indicates the region of inner cell mass.  
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Expressions of trophectoderm specific miRNAs were entirely different in the NT 
blastocyst which can be characterized as very low compared to that in AI blastocysts. 
Whereas, their expressions in the IVP blastocysts were similar or in some blastocysts 
slightly decreased compared to AI blastocysts. In case of miR-302b, the expression 
pattern has been identified not to be largely different in the NT or IVP blastocysts 
compared to the blastocyst from artificial insemination. In addition, two other miRNAs 
(miR-127 and miR-431), which are originated from the large imprinted chromosomal 
region were also localized in the NT, IVP and AI blastocysts (Figure 4.6). Interestingly, 
they were found to be similarly expressed either in the inner cell mass or trophectoderm 
of the AI blastocysts but aberrantly expressed in NT blastocyst. In the NT blastocysts, 
miR-127 shows almost depletion of its expression in different part of the trophectoderm 
with no change in the inner cell mass and this pattern was not noticeable in AI or IVP 
blastocysts. On the other side, miR-431 shows opposite pattern in the NT blastocysts, 
where the expression was found to be depleted from the inner cell mass but such 
anomalies was not evident in case of AI or IVP blastocysts. Result of in situ 
hybridization of miRNAs has revealed more aberrant or deregulated sate miRNAs 
expression in the trophectoderm and inner cell mass of NT expanded blastocyst and 
which was less in the IVP blastocysts.       
 
4.2.5 Temporal differences in the expression of selected miRNAs in different sources of 
placenta 
 
Later on expression profiling of the candidate trophectoderm, embryonic specific and 
imprinted miRNAs in the fibroblast, day-7 blastocyst, expanded blastocyst, day-16 
elongated embryo, and day-225 placenta derived from in vivo, in vitro and NT placenta 
has identified that the major deregulations are likely to happen in the NT placenta at 
day-50 of the pregnancy when compared to the in vivo placenta (Figure 4.7).  
 
 
 
 
 
 
 
Part II: Results 123
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: Expression pattern (in fold change) of the candidate trophectoderm/placenta 
specific (A) and imprinted miRNAs (B) in blastocyst, expanded blastocyst, 
Day-16 elongated embryo, Day-50 placenta and Day-225 placentome 
derived from NT pregnancy compared to that of AI pregnancy    
 
However, the extent of this deregulation in IVP placenta at day 50 was not evident and 
showed very less difference compared to the placenta of AI at day 50 (Figure 4.8). 
Moreover the result reveals that deregulation of miRNAs started after construction of 
nuclear transfer embryo due to improper reprogramming and it is progressing to the 
later stage specially in the placenta around day-50 has most aberrant miRNAs 
expression when redifferentiation for placentogenesis is happening. Later stage, (around 
day-225) NT placenta were found likely to recover some anomalies of miRNAs 
expression. 
 
 
A 
B 
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Figure 4.8: Expression pattern (in fold change) of the candidate trophectoderm/placenta 
specific (A) and imprinted miRNAs (B) in blastocyst, expanded blastocyst, 
Day-16 elongated embryo, Day-50 placenta and Day-225 placentome 
derived from IVP pregnancy compared to that of AI pregnancy.    
 
4.2.6 Global DNA methylation status in different sources of elongated embryos and 
placentas 
 
Global DNA methylation has been quantified in the elongated embryos at day 16 and 
placenta at day 50 derived from NT, IVP and AI pregnancies. Level of DNA 
methylation was expressed in percentage compared to the positive control (synthetic 
oligos where every 5 cytosin were methylated). Analysis revealed a global 
hypomethylation of DNA either in three groups (NT, IVP and AI) across two stages of 
A 
B 
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development (Elongated embryo and placenta). Status of DNA methylation is presented 
in figure 4.9. Study has identified that there is no significant differences in global DNA 
methylation in the elongated embryos at Day 50 as well as same in the Day-50 placentas 
of NT, IVP and AI pregnancies.  
 
 
Figure 4.9: Global DNA methylation (%) in Day-16 elongated embryos and Day-50 
placenta of different sources of pregnancy 
 
 
4.2.7 Aberrant regulation of miRNAs processing genes in IVP and NT placentas 
 
 
Figure 4.10: Normalized expression level of significantly differentially regulated 
miRNAs processing machinery genes in Day-50 placenta derived from 
NT, IVP and AI pregnancy. Bars denoted by different alphabet (a, b) 
were found to be significantly different (P≤0.05). 
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Figure 4.11: Expression of AGO2 protein in Day-50 placenta derived from NT, IVP and 
AI pregnancies. GAPDH was used as loading control  
 
Expression profiling of 18 miRNA processing machinery genes (ADAR1, DGCR8, 
AGO1, AGO2, AGO3, AGO4, FMR1, GEMIN4, GEMIN6, GEMIN7, POLR2A, 
POLR2G, RNASEN, RANGAP1, SIP1, XPO1, XPO4 and XPO5), in Day-50 placentas 
from NT and IVP pregnancies was performed and compared to that of AI (Figure 4.10). 
Analysis revealed that most of them except AGO2 are well reprogrammed in NT 
compared to AI palcentas. Expression of the miRNAs processing molecules were found 
to be similar or in some cases upregulation in NT placenta. Whereas, it was not the case 
in IVP placenta, where more machinery genes were found to be deregulated compared 
to AI (Figure 4.10). Among them especially AGO3, GEMIN7, XPO4 including AGO2 
were noticeable. In both NT and IVP Day-50 placentas, AGO2 or EIF2C2 was found to 
be down regulated compared to that of AI. The reduced expression of AGO2 protein in 
the NT and IVP placentas was also observed (Figure 4.11).        
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4.2 Discussion 
 
4.2.1 Day-50 placentas from nuclear transfer and IVP pregnancy 
 
Nuclear transfer and in vitro embryo production are the promising technology with 
potential applications in agricultural as well as biomedical research. However, only 2% 
of NT embryos result in live birth and frequent abnormalities are observed in IVP 
pregnancy. The losses or abnormalities being mostly due to improper placenta 
formation due to nuclear reprogramming error after nuclear transfer and in vitro culture 
(Yang et al. 2007). The normal bovine placenta progressively attaches to the 
endometrium throughout the first trimester and the initial contact with a maternal 
caruncle induces villous processes to undergo hypertrophy and hyperplasia to form 
cotyledons that progress to form large and complex placentomes by Day 42 (King et al. 
1979). Poor viability of somatic cell cloned fetus during Days 35-60 (period of 
placentome development) has been found to be associated with either rudimentary or 
marginal chorioallantoic development (Hill et al. 2000). Due to the critical importance 
of this period, present study has been conducted on Day-50 as a baseline stage of 
placenta from different sources of pregnancies. Placentas from all NT Day-50 
pregnancies were characterized with reduced by half the number of barely visible 
cotyledons having sporadic hemorrhagic areas compared to those in AI placentas. 
Where as, the placentas from Day-50 IVP pregnancies were apparently normal in size 
and similar number of cotyledons compared to those in AI.    
 
4.2.2 miRNAs are deregulated in Day-50 NT and IVP placentas 
 
The aberrant genetic or epigenetic modifications in the NT placenta from nuclear 
reprogramming error have been evidenced due to aberrant non-coding RNA expression, 
imprinting problem, DNA methylation and histone/chromatin modification. Among the 
non-coding RNAs, miRNAs were found to be aberrantly reprogrammed in cloned 
mouse blastocyst (Cui et al. 2009) and bovine Day-17 elongated embryos (Castro et al. 
2010). In addition, miRNAs were also evidenced to be regulated by and/or regulate 
epigenetic processes (Kircher et al. 2008, Williams et al. 2007). Present study has 
identified that most of the miRNAs studied being reprogrammed but a large number 
among them are not reprogrammed correctly in the NT (68% miRNA) and IVP (36% 
miRNA) placentas. Relative expression reveals a massive down regulation of miRNAs 
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in Day-50 NT and IVP placenta compared to the Day-50 placenta from AI pregnancy. 
This difference in expression of miRNAs could be due to the cumulative effects of 
embryos constructed by somatic cell nuclear transfer and in vitro culture of embryos 
which were absent in control AI pregnancies. At least 62% of the miRNA studied in 
Day-50 NT placenta were deregulated compared to IVP placenta, where 90% of them 
were found to be downregulated. This difference could be due to effect of embryos 
constructed by nuclear transfer and transferred to the recipients for establishing the NT 
pregnancy. Overall 36% miRNAs of 377 miRNAs tested were differentially regulated 
between IVP and AI placentas, where about 96% of these differentially regulated 
miRNAs were downregulated in IVP placentas. This difference in the expression of 
miRNAs could be attributed due to the effect of the transfer of embryos which were 
fertilized and cultured in vitro. The study has identified that most of the miRNAs are 
reprogrammed but may not be in proper way or any error in the regulatory molecule for 
regulation of miRNAs expression are responsible for massive deregulation of miRNAs 
in NT or IVP placentas compared to that of AI. These massive deregulations could be 
entailed to the reported radically altered gene expression in cloned placenta (Aston et al. 
2009, Everts et al. 2008, Hall et al. 2005, Oishi et al. 2006) associated to poor 
placentomes development in NT pregnancy in first trimester leading to pregnancy loss.  
 
4.2.3 Major deregulation of miRNAs in NT or IVP happened during Day-50 of 
pregnancy 
 
Reprogramming error in the NT or IVP has been postulated to be happened as a 
multistep process and the effect could be different in different stage of development 
(Jouneau et al. 2006). It has been suggested that the commonly observed low 
developmental efficiency of NT embryos may not be largely due to nuclear 
reprogramming during early embryo development but may be potentially caused by 
abnormal gene reprogramming during postimplantation feto-placental development 
(Smith et al. 2005). Where, NT blastocyst closely resemble to in vivo, but not to in vitro 
fertilized embryos in terms of global gene expression (Smith et al. 2005) but later stage, 
trophoblast lineage was found to be affected more by the reprogramming error arised 
from epigenetic modifications after the blastocyst stage (Jouneau et al. 2006). However, 
differences between trophectoderm and inner cell mass could be different in NT 
blastocyst compared to AI blastocyst which should be exploited to conclude precisely 
Part II: Discussion 129
that they are similarly reprogrammed also in cell specific manner. Comparison of either 
expression of miRNAs as a major modifier of genetic/epigenetic gene regulation or 
global gene expression between different stage of the embryo and placental 
development through out the NT or IVP pregnancy has not been carried out. Present 
study has identified that the major deregulation of miRNAs in the NT placenta are 
appearing at around Day-50 of pregnancy. Although the differences in their expression 
are evident during expansion of blastocyst and at elongation stage, but the deregulation 
are more profound at around Day-50 of pregnancy in NT and less in IVP compared to 
that of AI. In addition, trophectoderm specific miRNAs were found to be aberrantly 
expressed in the NT and IVP expanded blastocysts compared to that of AI. Where as, 
inner cell mass specific miRNAs were less or not aberrantly expressed in either NT or 
IVP expanded blastocyst compared to the expanded blastocyst from AI. In case of 
miRNAs which are located within or nearby imprinted region of the chromosome 
showed a clear abnormality in their expression in NT and IVP expanded blastocyst 
when compared to their expression in the expanded blastocyst from AI. Results of this 
study indicate that trophoblast specific and imprinted miRNAs are aberrantly expressed 
in the NT blastocysts which were not the case for inner cell mass or embryonic stem 
cell specific miRNA. In addition to this result, reported changes of miRNAs during 
trophectoderm specification (Viswanathan et al. 2009) and aberrant epigenetic 
reprogramming and expression of imprinted miRNAs (e. g. miR-127, miR-136) in 
cloned mouse embryo (Cui et al. 2009) suggest that deregulation of miRNAs expression 
due to reprogramming error is the primary cause of early improper placentation and that 
is magnified during Day-50 of the NT pregnancy while the complex placentomes are 
thought to be developed. This is more evident in elongated Day-16 embryo and Day-50 
placenta from cloned pregnancy. In the elongated embryos, the deregulation of miRNAs 
could be attributed also due to their cell specific aberrant expression, but this could not 
be elucidated because the elongated embryos were comprised of embryonic and extra-
embryonic tissues. However, at day 50 the differences of miRNAs expression 
characterized by their down regulation in NT placentas compared to that of AI were 
more clear which was not noticeable in IVP placenta. Interestingly, the degree of 
deregulation of miRNAs at day 225 of pregnancy either in NT or IVP compared to AI 
were found to be very less which shows almost optimum or some increased expression. 
This is possible that those cloned fetuses that survive up to term could recover the 
aberrant expression of miRNAs in the cloned placenta. At approximately Day 50, those 
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fetuses with subnormal placentomes formation and with more deregulated miRNAs 
expression could be slowly starve to death but the fetus that progress beyond this stage 
have better placentome development as studied previously (Hill et al. 2000).                
 
4.2.4 Major causes of miRNAs deregulation in NT and IVP placenta 
 
Major sources of aberrant gene expression in the NT placentas have been found to be 
due to abnormal epigenetic and genetic processes. These include non-coding RNA 
mediated regulation, aberrant DNA methylation, genomic imprinting and chromatin 
remodeling. Maintenance of imprinting has been shown to be less dependent on DNA 
methylation in the placenta than in the embryo, with involvement of repressive histone 
methylation rather than DNA methylation (Wagschal and Feil 2006). Present findings 
revealed that there is no significant difference in global DNA methylation in the Day-16 
elongated embryos and placentas at day 50 between NT or IVP and AI. There is no 
correlation between identified global hypomethylation of DNA to the massive down 
regulation of miRNAs in the NT placenta compared to that of AI. So, it is possible that 
other genetic or epigenetic processes (aberrant regional chromatin remodeling) rather 
than DNA methylation are responsible for massive deregulation of miRNAs in the NT 
or IVP placenta.  
 
Bioinformatic analysis of the deregulated miRNAs reveals that the miRNAs are oftenly 
deregulated as cluster and shows similarities in their deregulation between the members 
of the same miRNAs family. In addition to the own promoters as independent entities or 
as polycistrons, they were found to be transcribed in a large transcription units of coding 
or non-coding genes (Kim 2005). So, any transcriptional or processing disturbance 
during the earlier stage of cloned embryo and extra embryonic lineage differentiation 
due to improper reprogramming of specific regulatory molecules which are responsible 
for global transcription, processing and maturation of miRNAs could be the possible 
reason for global down regulation of miRNAs in the NT or IVP placentas. To elucidate 
these possibilities, present study has profiled 18 well known miRNA processing 
machinery molecules in different sources of placentas under investigation. Results 
indicate that several of such molecules are not well reprogrammed in the NT or IVP 
placentas when compared to that of AI or donor fibroblast cells. Among them, 
eukaryotic transcription initiation factor 2C2 (EIF2C2) or AGO2 has been found to be 
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down regulated in the NT or IVP placenta compared to that of AI, which could be 
linked to massive down regulation of miRNAs as also reported previously (Cifuentes et 
al. 2010, Zhang et al. 2009). Expression of AGO2 has been shown to be important in 
many biological processes and development including mouse oogenesis (Kaneda et al. 
2009), early development (Morita et al. 2007) and maternal-zygotic transition (Lykke-
Andersen et al. 2008). Mouse embryonic fibroblasts and hematopoietic cells from Ago2 
knockout showed subsequent reduction of all mature miRNAs (Diederichs and Haber 
2007, O'Carroll et al. 2007). So, according to the previous reports and our findings, it 
could be postulated that global down regulation of miRNAs in the NT or IVP Day-50 
placenta compared to that of AI is due to down regulation of AGO2 and aberrant 
reprogramming of other factors if there is any.   
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5 General summary 
 
MicroRNAs are the major class of gene-regulating molecules playing diverse roles 
through sequence complementarity to target mRNAs at post-transcriptional level. 
Identification of entire set of miRNAs and study of their expression patterns are the 
fundamental step towards understanding miRNA-guided gene regulation in different 
biological functions. Tightly regulated expression and interaction of a multitude of 
genes for ovarian folliculogenesis and their aberrant expression due to genetic or 
epigenetic modification widely addressed in feto-placental development by different 
assisted reproductive biotechnology could be regulated by these miRNAs. Despite 
increasing efforts in miRNAs identification across various species and diverse tissue 
types, little is known about miRNAs in bovine reproductive tissues specially ovary or 
placenta. For the elucidation of this research gap, two subsequent studies have been 
carried out.  
 
First study hypothesized that tightly regulated expression and interaction of a multitude 
of genes for ovarian folliculogenesis are regulated by miRNAs and thereby aimed to 
identify and characterize them in bovine ovary through cloning, expression analysis and 
target prediction. For this purpose, RNAs of 18 to 26 nt in length from bovine ovarian 
small RNAs (< 200 nt) were purified, small RNA library constructed, sequenced and 
analyzed. A total of 233 concatemer clones were sequenced to generate 479 sequences. 
The 479 sequences identified in the library represented 41% miRNAs, 12% mRNA, 
12% rRNA, 6.3% tRNA, 6.0% repeat associated siRNA, 2.7% small antisense RNA, 
3.5% tiny noncoding RNA, 1% small nuclear RNA and 15.2% sequences that did not 
match to bovine genome. A total of 196 sequences were found to be miRNA like 
molecules, of which 74 revealed distinct miRNAs. Out of these 74 miRNAs, 36 were 
found to be reported in miRBase 12.0 for different species including bovine, 14 were 
registered only in other species and 24 were completely new. All in all, 22 of the 74 
miRNAs were cloned for three or more times where, let-7a, let-7b, let-7c, miR-21, miR-
23b, miR-24, miR-27a, miR-126 and miR-143 were cloned 10, 28, 13, 4, 11, 7, 6, 4 and 
11 times, respectively. This multiple cloning reflects the abundant expression in the 
ovary and potential involvement in ovarian functions. In addition to miRNAs, small 
RNA library has enabled us to identify 57 different endogenous siRNAs.  
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The expressions of 47 miRNAs were analyzed in 11 different bovine tissues using semi-
quantitative RT-PCR. Among these, 44 were detected in both ovarian cells and multiple 
tissues. Seven miRNAs (bta-mir-18a, bta-mir-29a, bomir-140, bta-mir-199, bomir-378, 
bomir-F0132 and bomir-F2422) were found to be expressed at relatively higher levels 
in ovarian cortical portion. On the other hand, all undetected or less expressed miRNAs 
in ovarian cortex have been shown to be highly expressed in cumulus cells or corpus 
luteum. Bta-mir-15b, bomir-409, bomir-652, bomir-C0533 and bomir-D1431 were 
highly expressed in the fetal ovary compared to that of adult ovarian cortex. However, 
bta-mir-29a, bta-mir-199 and bomir-F2422 were found to be expressed at higher level in 
the adult ovarian cortex than that of the fetal ovary. Bta-mir-125b, bta-mir-222, bomir-
542, bomir-652, bomir-H0222, bomir-F0522, bomir-C1931 and bomir-A2143 were 
found to be expressed at very low level, but as abundant in the cumulus cells and 
matured corpus luteum. All these investigated miRNAs were detected at least in one of 
the non-ovarian somatic tissue. Bta-miR-29a was localized in ovarian section by in situ 
hybridization and found to be expressed in different intra-ovarian cells of different 
stages of development.   
 
miRNA target gene prediction and analysis by in silico method has identified the major 
biological processes and signaling pathways in the ovary that are most likely affected by 
a group of miRNAs. From the screened target genes, let-7b, mir-15b, mir-18a, mir-29a, 
mir-101, mir-125b, mir-126, mir-143, mir-145, mir-199a and mir-222 were found to 
have the highest number and overlapping targets. Gene Ontology analyses of the 
miRNAs target genes were found to be associated with reproductive system 
development, function and disorders. These include cell cycle, morphology, cell death, 
cell to cell signaling, cellular growth, development and proliferation, DNA replication, 
recombination & repair, endocrine system disorder and different pathways underlying 
the ovarian functions. So, the results of the first study suggest the presence of miRNAs 
in the bovine ovary, thereby elucidate their potential role in regulating diverse 
molecular and physiological pathways underlying the ovarian functionality.  
 
The second study carried out to identify the expression pattern of miRNAs in the 
placenta at day 50 derived from SCNT, IVP and AI pregnancy. The reasons or 
background behind this study was the abnormal placentogenesis in SCNT and IVP 
which were widely admitted due to genetic and epigenetic modifications. Since, 
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miRNAs have been evidenced as one of important modifiers of genetic and epigenetic 
gene regulation so, this study was aimed to elucidate the differences in expression 
profile of miRNAs in the placenta of different sources of pregnancies by quantifying 
377 miRNAs using qRT-PCR. The miRNAs expression profiles of the Day 50 NT 
placenta (n=3) were compared either to that of AI (n=3) or IVP (n=3) placenta. In 
addition, level of miRNAs expression in the IVP placenta has subsequently been 
compared to that of AI placenta. Of the 377 miRNAs used in the comparison of their 
expression between Day 50 NT placenta and AI placenta, 320 miRNAs were found to 
be downregulated in NT placenta with 2 or more fold change, while only 5 miRNAs 
were found to be upregulated by 2 or more fold change in NT placenta compared to the 
placenta of AI group. The comparison revealed that about 68% of the miRNAs tested in 
this analysis were differentially regulated in Day 50 NT placenta compared to that of 
AI, where 98% of them were found to be downregulated. This difference in expression 
of miRNAs could be due to the cumulative effect of embryos which were constructed 
by somatic cell nuclear transfer, treatment, in vitro culture and transfer to the recipients.  
 
Similarly, about 62 % miRNAs were found to be differentially regulated in the NT Day 
50 placenta compared to that of IVP placenta, where 90% of them were found to be 
downregulated. This difference could be due to effect of embryos constructed by 
nuclear transfer and transferred to the recipients for establishing the NT pregnancy. On 
the other way, 36% miRNAs were differentially regulated between IVP and AI 
placenta, where about 96% of these differentially regulated miRNAs were 
downregulated in IVP placenta. This difference in the expression of miRNAs could be 
attributed to the effect on the transfer of embryos which were fertilized and culture in 
vitro.  
 
Additionally, the expression profiles of Day 50 NT placenta were compared to that of 
fibroblast donor cells which revealed 209 differentially regulated miRNAs Among the 
209 miRNAs, 185 and only 24 miRNAs were found to be up and down regulated, 
respectively in the NT placenta compared to fibroblast. So it could be postulated that 
most of the miRNAs were reprogrammed in NT placenta. However, but due to their 
lower expression compared to that of AI it is evident that they were not reprogrammed 
in a correct manner. Most of the miRNAs were found be deregulated and affected as 
large chromosomal cluster and miRNA families. Further, cell specific localization of 
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miRNAs in the expanded blastocysts and expression profiling in different 
developmental stages of embryos and placenta derived from AI, IVP and SCNT by real 
time qRT-PCR identified that the major difference in miRNAs expression arises at day 
50 of pregnancy. Analysis of global DNA methylation revealed common 
hypomethylation in the Day-16 elongated embryos and Day-50 placentas from NT, IVP 
and AI pregnancy with no significant differences in level among them. So, deregulation 
of miRNAs were found to be less dependent on global DNA methylation, rather 
aberrant miRNA processing molecules were evident as one of the major causes. Among 
the aberrant expression of miRNAs processing regulatory molecules Eukaryotic 
transcription initiation factor 2C2 (EIF2C2) or AGO2 were found to be downregulated 
both in NT and IVP Day-50 placenta compared to that of AI. Hence, deregulation of 
AGO2 could be a reason for global down regulation of miRNAs in the NT or IVP 
placenta, as AGO2 knock out animals evident with such deregulation of miRNAs.  
 
Taken together, present findings suggest that the genome wide aberrant expression of 
miRNAs due to reprogramming error of miRNA processing regulatory molecules for 
example AGO2 or aberrant regional chromatin remodeling or imprinting problem or 
other mechanism if there is any in the NT placenta may result abnormal transcriptional 
regulation leading to the early stage of pregnancy loss.   
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6 Conclusion and future perspectives 
 
Results of the first study revealed the presence of different classes of miRNAs in the 
bovine ovary, thereby elucidate their potential role in regulating diverse molecular and 
physiological pathways underlying the ovarian functionality. The presence of distinct 
miRNAs and other small RNAs, with different expression patterns and various target 
genes in bovine ovary suggest the potential role of such miRNAs in follicular 
development in particular and female fertility in general. Further functional 
characterization of some selected miRNAs including expression profiling and in situ 
localization in the ovarian follicles at different cyclic stages will supplement the results 
of this study and help to get insight into their specific roles in the ovarian function. 
Moreover, the results of this study will help to identify candidate miRNAs targeting 
specific molecular and cellular pathways important for ovarian follicular development, 
atresia, ovulation as well as ovarian dysfunction. The results of the second experiment 
revealed a massive deregulation of miRNAs in the placenta from cloned and IVP 
pregnancies. Most of the miRNAs were found as poorly reprogrammed and affected as 
large chromosomal cluster and miRNA families. Taken together, present findings 
suggest that the genome wide aberrant expression of miRNAs due to reprogramming 
error of miRNA processing regulatory molecules for example AGO2 or aberrant 
regional chromatin remodeling or imprinting problem in the placenta from nuclear 
transfer pregnancy, which may result abnormal transcriptional regulation leading to 
pregnancy loss. Moreover, the result of this study will help to move one step closer 
towards the development of a genetic screen to select healthier genetic profiles in 
cloned embryos and will enable to improve the pregnancy outcome from nuclear 
transfer embryos. Additional research is needed to address whether the low efficiency 
and abnormal placentogenesis in clone pregnancies are caused by the deregulation of 
miRNAs during the first trimester.  
 
Collectively, the present study has discovered miRNAs in the bovine ovary and 
elucidated the pattern of expression of miRNAs along with their regulatory mechanism 
in the placenta derived from pregnancies of various origins. Being an important gene 
regulator, miRNAs could be an interesting avenue to resolve lot of questions on 
different regulatory mechanisms of ovarian folliculogenesis and aberrant genetic or 
epigenetic modification in the placenta from NT or IVP pregnancies along with 
ruminant’s other reproductive processes. 
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